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ABSTRACT 
This thesis records the results of a series of experiments on the 
kinetics of growth of 7 human malignant melanomas in nude mice, with 
particular reference to factors in the host "milieu" that modulate 
proliferation, metastasis and phenotypic expression of the tumours. 
iii. 
Melanoma cell lines were established in vitro, from biopsy material 
obtained from 7 patients with metastatic malignant melanoma. Two of these 
lines synthesized tyrosinase and melanin at a rate that was directly related to 
cell density. The five remaining lines did not pigment in vitro. With the 
exception of one line they all gave rise to tumours when inoculated 
subcutaneously into nude mice. All 7 lines were aneuploid and 5 of the lines 
showed anchorage-independent growth in vitro. 
The growth rate and latency period of these human melanoma cell lines has 
been studied in nude mice as a function of inocul~m size. Considerable 
variation was observed and growth rate.!.!!. vivo correlated poorly with the 
doubling times of the corresponding cells cultured in vitro. 
Passage through nude mice had no effect on in vitro phenotypic 
characteristics of cell lines. In spite of prolonged in vitro passage, in a 
number of instances the histological appearances of the mice tumours were very 
similar to those seen in the original patient. 
Coinjection of either adult or juvenile skin fibroblasts with 
subtumorigenic doses of melanoma cells proIOOted the growth of tumours that . 
would otherwise not have formed. 
One of the melanoma cell lines grew rapidly in a male host at an inoculum 
level that did not give rise to tumours in the female mouse, showing that 
hormonal influences in the host have a definitive effect on the growth of some 
iv. 
melanomas in vivo. Castrated male mice also failed to support the growth of 
this melanoma cell line. Addition of estrogen and dihydrotestosterone pellets 
to the castrated and ovariectomised mice proved in certain cases to be 
effective stimulants of tumour growth. 
By excising the primary tumour before it reached a size which was lethal 
to the host, metastases were m.ail ~ evident in a number of i nstances, Two of t he six 
melanoma cell lines showed metastatic melanoma deposits in 100% of the animals 
inoculated. This occurred within 12 weeks of removal of the primary tumour. 
In one of the two cell lines metastatic spread was directly related to the 
size of the primary tumour. 
One of the cells lines, ucr-Mel 7 elicited an intense desmoplastic 
response in the host and the tumours were heavily infiltrated with host 
macrophages and fibroblasts • . This cell line had a most unusual behaviour 
pattern in the mouse as it grew exponentially for a fairly brief period after 
which a plateaux phase occurred during which no growth took place. This was 
followed by a phase of regression and then a prolonged period of dormancy 
after which a rapid exponential growth phase followed. Tumours transplanted 
to new mice during this latter phase gave rise to rapidly growing neoplasms 
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Since Laennec first described malignant melanoma in 1812 (Laennec, 1812), 
the disease has increasingly attracted the attention of clinicians, patho-
logists, epidemiologists and biologists. 
not difficult to define. 
The reasons for this interest are 
In the first instance, malignant melanoma is an aggressive disease with a 
particular tendency to affect fair-skinned, first world populations with a 
tumour that is usually relentlessly progressive and incurable. Moreover,the 
incidence of the disorder is increasing at an annual rate of about 6% (Elwood 
and Lee, 1974; Elwood et al., 1975). 
Before 1950 malignant melanoma was classified with other skin cancers so 
that early epidemiological data are somewhat sketchy. Scandinavian and 
Australian records covering the past 35 years have, however, been meticulously 
collected and these show an increasing incidence rate with a doubling time of 
about 10 years. ~urrent figures for Scandinavia are approximately 12 new 
cases per 100 000 population per year (Mackie and Young, 1984) and those for 
Australia approximately 32 new cases per 100 000 population per year. 
A large amount of descriptive data has been assembled in an attempt to 
relate this increase to possible predisposing causes in the host or to initia-
ting or proll¥)ting circumstances in the environment. Insulation (Acton et al., 
1983), genetic factors (Anderson, 1971; Wallace et al., 1971), hormonal 
influences (Nesbit, 1979; Rampen and Mulder, 1980; Shaw et al., 1978) ciga-
rette smoking (Shaw and Milton, 1981; Holt and Keast, 1977), contraceptive 
use (Lerner et al., 1979; Helmrich et al., 1984; Bera! et al., 1977; Holly 
et al., 1983; Lederman et al., 1985) complexion (Bera! et al., 1983; Gellin, 
et al.~ 1969; Reintgen et al., 1982) and trauma (Allen and Spitz, 1953; 
Balch et al., 1980; McGovern et al., 1982) are some of the agents that have 
been considered, but none has emerged as the single most likely etiological 
3 
factor. The reasons for the increase remain obscure and a challenge to epide-
miologists. 
Secondly, therapy of the disease has, on the whole, been disappointing • 
. 
Early excision of Clark Stage I primary lesions undoubtedly carries a better S 
year survival rate (approximately 79%) than does removal of Stage II lesions 
where the results are poorer (approximately 34% S year survival rate)(Shah 
and Goldsmith, 1972; Rogers et al., 1983). It is not entirely clear, however, 
how much this improvement represents the "lead time" effect of earlier diag-
nosis, the effect of natural selection for less aggressive disease or the real 
effect of instituting treatment before spread has occurred. Definitive data 
that confirm, beyond all doubt, the therapeutic advantage of early surgery are 
lacking. Despite the uncertainties, it is not surprising that continued 
interest and effort has been directed towards the therapy of an easily diag-
nosable tumour that starts in a superficial and readily accessible organ and 
that should, by all accounts, be amenable to early surgery that is curative 
and non-mutilating. 
Thirdly, for the pathologist the disease presents the challenging problem 
of a neoplasm that originates in a well-defined population of cells, all of 
which express a very similar, well differentiated phenotype. Furthermore, in 
the early stages of the disease, most malignant melanomas are histologically 
very much alike. Despite these similarities the natural history of malignant 
melanoma is entirely unpredictable. The literature abourxls with accounts of 
striking differences in growth rates, in the period of dormancy after exci-
sion, and in metastatic potential and a number of cases have been documented 
in which spontaneous remission has taken place (Balch et al, 1983; Morton et 
al.,1974; Cole, 1974). To what then, if the tumour is so similar in other 
respects, can these differences be attributed and how might the natural 
history of the disease be predicted from the early histology? 
Finally, for the biologist, these neoplasms have been a ready source of 
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starting material for the development of robust in vitro cell lines. 
Soon after the first development of cell culture techniques, Burrows, (1914) 
reported his succcessful attempts to grow human malignant melanoma cells 
in vitro. In the 1930's Cloudman (Cloudman, 194i) established a transplan-
table murine melanoma tumour in DBA 2/J mice. This Cloudman S91 melanoma was 
subsequently adapted to culture by Yasumura et al. (1966) and in 1973 Pawelek 
et al., reported that the Cloudman cells responded to melanotropin by increa-
sing tyrosinase activity, melanin formation and changes in morphology. 
Since that time numerous descriptions of short-term cultures of animal 
and human melanoma cells have appeared. Wellings et al. (1960) grew a human 
malignant melanoma in vitro for a period of 4 weeks and Moore et al., in 1962 
reported the establishment of several long term human melanoma cell lines. In 
the last decade numerous authors have reported the successful establishment of 
human melanoma cell lines from primary or metastatic tumours (Gerner et al., 
1975; Liao et al., 1975; Giovanella et al., 1976, Oettgen et al., 1968; 
McCormick et al., 1983; Tveit et al., 1980; Roal-van Helden et al., 1986). 
These lines have a provided a useful system for examining processes that 
are relevant both to this particular class of tumours and, at the same time, 
to cellular biological phenomena of a more general nature. 
Melanogenesis,for example, is an obvious and readily quantifiable marker 
of cellular differentiation that can be used to study factors that govern 
expression of the differentiated phenoty,pe in pigmenting cell lines. Fur-
thermore, as derivatives of the embryonic neural crest, melanoma cells share a 
common origin with a variety of ectomesenchymal structures, cells of the 
autonomic nervous system, calcitonin-producing cells, cells of the carotid 
body and sensory neurones in spinal ganglia and cranial nerves. · It is now 
clear that, in choosing one of these diverse alternative destinies, pluri-
potential neural crest "stem-cells" are influenced by environmental cues that 
come from neighbouring embryonic structures(Le Douarin, 1982). Melanoma 
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cells thus offer potential for studying cellular interactions that influence 
morphogenesis or commitment to a particular developmental programme. 
As with other neural crest cells, pre-melanocytes are remarkable 
for their striking ability to migrate to distant target organs where they 
assume residence and complete their terminal differentiation. These invasive 
and organotropic attributes have obvious implications for the study of tumour 
spread and correlate well with the known tendency of malignant melanomas to 
metastasize in vivo. 
Although circumstantial considerations suggest that metastasis requires an 
aggressive cell type situated in a permissive host environment, the deter-
minants of aggressiveness or permissiveness have not been satisfactorily 
defined. 
Malignant melanomas may spread to intra-epidermal regions (horizontal 
spread) with formation of satellite lesions. They may penetrate into the 
depth of the skin (vertical spread) and finally they may gain access to 
lymphatic channels and blood vessels giving rise to metastasis in · lymph nodes 
or distant organs. In all of these cases it is reasonable to conclude that 
the metastatic process involves the breaching of such anatomical barriers as 
endothelial surfaces, inter-cellular junctions, basement membranes or dense 
fascial planes. One presumes that some form of proteolytic or other destruc-
tive function is involved in the traversal that this implies, but the protease 
or lytic force has not yet been identified with certainty. 
It is also well known (Das Gupta and Brasfield, 1964; Meyer and Stolback, 
1978; Amer et al., 1979) that malignant melanomas often metastasise to organs 
that are infrequent targets for metastatic spread from other primary tumours. 
Furthermore, only a fraction of tumour cells introduced directly into the 
circulation will settle and develop into secondary tumours (Garcia et al., 
1963). These observations have suggested the existence of some form of 
"adhesive" interaction between melanoma cells and the capillary endothelium in 
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the target organ or, alternatively, of some sort of local hormonal or meta-
bolic milieu that is propit~ous for seeding and local survival. Once again, 
the nature of these influences is obscure. 
As far as human tumours go, melanomas are fairly immunogenic, and nume-
rous investigators have documented the existence of melanoma antigens that 
display various degrees of specificity.(Hersey et al., 1~83; Houghton, et 
al., 1982; Winchester et al., 1978; Hollinshead et al., 1982). Clearly, 
the development of melanoma-specific antibodies that did not react with epi-
topes present on other cell types, would hold great promise for the diagnosis 
and immunotherapy of this class of neoplasms. 
My own interest in melanoma research over the past five years has 
involved the study of tumours that arise when human melanoma cells are inocu-
lated into nude mice. This biological and experimental pathological approach 
to the study of the disease has, I believe, been useful in the following 
respects. 
Firstly, by using well-defined and homogeneous cell lines, I have been 
able to examine factors in the host and cellular factors as they interact or 
as they contribute separately to the behaviour of the tumour in vivo. It 
transpired that the hormonal milieu into which the tumour cells were inocu-
lated, the size of the inoculum and the co-inoculation of fibroblasts or other 
cells had a profound effect upon the success with which tumours could be 
established and upon subsequent rate of growth in the host. It was also 
apparent that, striking as these effects were, they were dependent, to a 
greater or lesser extent, on the cell line that was used to produce the 
tumour. 
In the case of one interesting cell line, the interactions between the 
melanoma cells and the host were complex and seemed, eventually, to lead to 
the emergence of a mutant tumour cell line that grew much more aggressively 
than the initial passage from which it was derived. To the best of my know-
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ledge this is the first recorded instance of a human tumour cell line that has 
emerged from a period of prolonged dormancy to assume characteristics that it 
did not possess originally. It is well known that human tumours may behave in 
this way under ordinary clinical circumstances and it is indeed encouraging to 
feel that we may now have a model for studying this phenomenon. 
I was also fortunate in that I was able to develop an unusual melanoma 
cell line that disseminated widely in every nude mouse into which it was 
inoculated. This consistent tendency for the tumour to spread enabled me to 
note the effects of hormonal and other manipulations upon the occurrence of 
metastasis. The most important finding here,perhaps, was the observation that 
tumours derived from this cell line displayed a critical volume above which 
metastatic spread occurred with a great frequency and below which metastatic 
spread occurred only infrequently. Under the controlled conditions of the 
laboratory, therefore, it has been possible to justify the belief that early 
surgery, by removing a tumour before a critical mass has been reached, may 
have beneficial consequences that are independent of the natural history of 
the tumour. 
I have also addressed the question of whether or not melanomas growing in 
the nude mouse bear any relation to melanomas growing in the original human 
host. While there are, quite clearly, differences between the two host envi-
ronments, there are a number of important similarities that could be documen-
ted and a number of differences that could be quantitated. All of these, I 
believe, contribute something to our understanding of this particular class of 
tumours. 
In the chapter that follows immediately upon this introduction, I des-
cribe the growth of melanomas in nude mice as I have observed the phenomenon. 
I give an account of the procedures I have developed for quantitating growth 
kinetics; for documenting the latency period and for correlating the 
behaviour in vivo with the behaviour of the parent cell line in vitro. I 
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record my observations on the appearance of the tumour befor
e and after pas-
sage through mice and I describe the interactions that took 
place between the 
host and the tumour and that were manifest by the population
s of murine cells 
that were attracted into the tumour or by the presence of co
llagen or vascular 
tissue of host origin. 
In Chapter 2 I describe the results of experiments that were
 designed to 
influence the rate of tumour growth in the nude mouse;i.ethe
 size of the 
inoculum, the presence of co-inoculated normal or malignant 
cells. 
In Chapter 3 I present the results of experiments done to st
udy the 
effect of hormones on the growth of human melanomas in nude 
mouse. 
In Chapter 4 I discuss the experiments that I have done to i
nvestigate 
the phenomenon of metastasis in the nude mouse and to define
 the experimental 
conditions that influence the development of this complicati
on. 
In Chapter SI report a series of experiments performed with
 one parti-
cularly interesting cell line that elicited an intense desm
oplastic response 
from the host and subsequently regressed, only to recur in t
he same animal, at 
a much later stage and with a greatly accelerated growth rat
e. On a number 
of occasions repeated passage of this tumour in nude mice el
icited mixed 
murine/human tumours and, in some instances, pure murine tum
ours. 
At the end of the thesis I have added an appendix in which I
 describe the 
cell lines that I have used and the technical procedures and
 protocols that we 





GROWTH OF MELANOMAS IN THE ATHYMIC NUDE MOUSE 
In 1969 Rygaard and Povlsen published the first report
 of the successful 
growth of a human tumour as a xenograft in an athymic 
nude mouse. Since that 
time an extensive literature has accumulated to testif
y to the interest that 
the nude mouse-xenograft model has generated amongst c
linical oncologists and 
tumour biologists. There is no doubt that the use of 
these mutants offers 
exciting opportunities for achieving a deeper understa
nding of the neoplastic 
process and of the way in which the in vivo phenotype 
of human malignant cells 
is expressed or can be modulated. 
A number of comprehensive reviews (Rygaard,1973; Stuttm
an,1977; Kindred, 
1978), monographs (Rygaard,1969, 1974, 1981; Pantelor
is,1971; Giovanella and 
Stehlin, 1973; Wortis,1974; Lozzio et al.,1976b; Gull
inno et al., 1976; 
Rygaard and Povlsen,1974, 1976; Povlsen,1977; Ward et 
al.,1977; Brooks et 
al., 1979; Fogh, and Giovanella,1978; Azar et al.,198
0; Detre S.I.,1980; 
Sharkey and Fogh,1984) and published proceedings of sy
mposia (Rygaard and 
Povlsen, 1974; Nomura et al.,1977; Houchens and Oveje
ra, 1978; Sparrow,1980; 
Bastert et al.,1981; Sordat,1982) have recently appea
red to provide useful 
accounts of the immunology of nude mice and rats and o
f the experimental 
approaches that have been made possible by the availab
ility of these animals. 
It would thus serve little purpose if I were to presen
t an extensive documen-
tary review of the literature myself. I shall, theref
ore, restrict my com-
ments to those of a general nature regarding the sort 
of work that has been 
done using the nude mouse model and the way in which m
y own studies complement 
the results that are already available. In the first p
lace, it is apparent 
that .nany reports in the literature have sought to do 
no more than record the 
remarkable fact that human tumours will grow in an ani
mal that is phylogeneti-
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cally far removed from man and, moreover, will express many of the attributes 
that they demonstrated in the original human host. In the introduction to 
many papers in this category, one frequently finds the justifying hope that 
the work to be reported will lead to the development of assay systems for 
measuring sensitivity to radiotherapy, cytotoxic agents or hormonal therapy, 
thus providing the oncologist with a sound basis for the treatment of the 
malignant disease that affects an individual patient. The approach is simi-
lar to that in which antibiotic sensitivity data assist in the management of 
infectious disorders. I think it is fair to say that, while such reports 
frequently provide descriptive information that is interesting they have 
contributed little of fundamental value, and the hopes that nude mice would 
provide "culture media" for sensitivity assays have not been realized. 
In the second place, and more recently, the results of somewhat more 
interesting studies have appeared in the literature. As an example of these 
experiments one may cite studies in which nude mice have been used to assay 
tumourigenici ty. It .has now been abundantly documented that normal cells, 
when inoculated subcutaneously as a single cell suspension, will not form a 
progressively growing tumour whereas malignant cells frequently will do so. 
Anchorage-independent growth in vitro and tumorigenicity in the nude mouse 
have now become standard experimental criteria for the definition of the 
malignant state. It has thus been possible to identify, at a useful molecular 
level, genetic factors or other circumstances that influence or determine the 
expression of the neoplastic phenotype. The experiments of such persons as 
Thorgeirsson et al.,(1985); Graham and van der Eb,(1973); Barlogie,(1980); 
Stil es and Kawahara,(1978); Freedman and Shin,(1978); Ossowski et al., 
(1973); Geder et al.,(1976) and Freedman et al.,(1976) demonstrate the ele-
gant way in which these approaches can be used. 
Finally, recent major contributions to the understanding of the bio-
chemistry and genetics of the malignant cellular phenotype have come from the 
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laboratories of cellular biologists and experimental pathologists. These 
advances in knowledge have stimulated a large number of systematic and quan-
titative studies of xenografted human tumours in the likely hope that ideas 
born of basic in vitro research will be testable in the intuitively more 
authentic, in vivo nude mouse model. Invasion and metastasis, angiogenesis, 
para-neoplastic syndromes and the complex interactions that take place between 
tumour and host are some of the many aspects of oncology that can only really 
be studied in vivo. What better model for studying them than the immuno-
deficient animal? Here we have a system that provides the experimental 
convenience of tumour bearing hosts whose characteristics are well defined and 
that are available in sufficient numbers to provide adequate statistics and 
controls. Although, for the most part, reports that fall into this group are 
still largely descriptive, many of them do provide the sort of consistent, 
quantitative data that are required to establish a sound basis for further 
more innovative research. 
It is to this latter category that I hope the work I describe in this 
chapter belongs for in it I describe the· in vivo growth characteristics of 
seven human melanoma lines when these were injected into nude mice. I have 
attempted to document the characteristics of these cells and the in vivo 
expression of their neoplastic potential in definitive, quantitative and 
qualitative terms. Where I have been successful I have made observations 
that have served as a point of departure for some of the other work that I 
report in this thesis. I refer, in particular, to experiments that have shown 
that it is technically feasible to obtain individually consistent and reliable 
quantitative data on the kinetics of melanoma cell growth in vivo; that 
tumorigenicity and growth rate are dependent upon the size of the tumour 
inoculum and, in certain instances, on the sex of the recipient animal; that 
certain human melanomas metastasize widely in the nude mouse whereas others do 
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not; certain tumours elicit an intense host response whereas in others this 
response is barely detectable; and, finally, that human melanoma cells 
growing in vivo show diverse behaviour patterns and this heterogeneity is, in 
itself, an interesting subject for further study. 
In this chapter I describe the in vivo growth characteristics of the 
tumours that resulted when cells from these seven human melanoma cell lines 
were injected into athymic nude mice. 
The work that comprises this thesis has been done with seven human mela-
noma cell lines that had already been developed in our laboratory. My choice 
of melanomas for this study was dictated by several factors. Aside from the 
fact that they were already available, these tumours are well known for the 
ease with which they can be cultured in vitro (Romsdahl and Hus, 1972; Liao 
et al., 1975; Gerner et al., 1975; Giovanella et al., 1976; Fidler and 
Nicolson, 1976; Roal et al., 1982; McCormick et al., 1983), and they can 
usually be successfully xenotransplanted to athymic mice. The many melanoma 
cell lines that have been developed and studied by other researchers, testify 
to the convenience of these cells, and the many published reports provided a 
sound basis, in the literature, from which my own work could proceed. Malig-
nant melanomas are also known for their ability to invade normal tissues and 
to spread widely. These cells thus constitute a useful model for research 
into the biology of metastasis. 
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Cell lines 
The melanoma cell lines were derived from biopsies taken from metastatic 
deposits in patients operated upon in Groote Schuur Hospital. The characteri-
stics of the individual cell lines, the techniques used to derive them and the 
manner in which they were maintained in culture and in ~torage have been 
described (Wilson and Dowdle, 1978; Roal et al., 1982) (Appendi x A1-A6). 
Briefly, the fragments of tissue were placed in vials containing sterile 
transport medium (RPMI 1640) and transferred to the laboratory. On arrival 
they were disrupted by gentle teasing, by treatment . with trypsin and 
collagenase. The resulting suspensions of single cells, small clumps and 
debris were plated in plastic tissue culture petri dishes in RPMI 1640 medium 
supplemented with 10% heat inactivated foetal bovine serum and antibiotics 
0 
(RPMI-10). All cultures were incubated at 37 Cina humid atmosphere of air 
and 5% carbon dioxide. 
In the early stages, the cultures were regularly examined by phase 
contrast microscopy for the growth of melanoma cells and various strqtegies 
were used to select against overgrowth by fibroblasts. These usually 
exploited the fact that melanoma cells adhered less tenaciously to the plastic 
substrate than did fibroblasts and could thus be recovered, in enriched 
proportions, by selective trypsinization or by differential adherence. 
Once established, the cultures were maintained in RPMI-10 and passaged at 
intervals dictated by confluence and by the condition of the medium. Re-
peated passage may give selective advantage to cellular variants that arise 
in vitro. To avoid the effect of this genetic drift, I used, for most of my 
experiments, cells derived from stocks that had been frozen down from a single 
passage or from closely consequential passages. Cells were frozen in RPMI-
• 
1640 medium containing 10% foetal calf serum and 10% dimethyl sulfoxide 
(Farrant et al.,1974). 
All of the cells grew as adherent monolayers with the characteristics 
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summarized in Table 1.1 and Table A. 7 in t he Appendix. 
Mice 
Athymic nude mice were bred in the U.C.T. Animal Unit from breeding
 
stocks imported in June 1980 and provided by Dr. B.C. Giovanella of
 the Cancer 
Research Laboratory, St. Josephs Hospital, Houston, Texas, USA. The 
strain 
was developed by Hansen ( 1977) by introducing the "nude" gene ( nu) 
and the x-
linked immune deficiency gene (xid) into N-NIH(S) outbred stock. T
his strain 
thus has combined immunodeficiency (Azar et al., 1980) and has prove
d extreme-
ly susceptible to grafts of human malignant tumours. 
The animals were housed in sterile plastic cages covered with non-w
oven 
spun polyester filter hoods (Laboratory Products Inc., Mainwood, New
 York) and 
sealed with adhesive tape. Clean cages were provided once weekly.
 Access to 
the colony was restricted to essential personnel and all manipulatio
ns were 
conducted in a horizontal laminar flow hood under strictly aseptic 
conditions. 
All supplies entering the housing area were sterilized either by ste
am or 
ethylene oxide. 
The mice were fed a commercially prepared rodent food (mouse pellet
s, 
Epol (Pty) Ltd., Cape Town). The diet of lactating females and wea
nlings was 
supplemented with an autoclaved 3:1 (w/w) mixture of whole wheat br
ead and 
milk powder (Lactogen Baby Formula, Food and Nutritional Products (
Pty) Ltd., 
Randburg). To compensate for the possible loss of vitamins during 
auto-
claving, I added a multivitamin supplement to the drinking water (0
.5ml/litre 
of Pancebrin; Lilly Pharmaceuticals). Cefama.ndole nafate (27 mg
/litre, 
Lilly Pharmaceuticals) was added to the drinking water as prophylax
is against 
infection. To avoid any possible effects of antibiotics on tumour 
growth I 
discontinued the Cefamandole seven days before the start of any exp
eriments. 
The nu gene was maintained by the mating of homozygous nu/nu male m
ice 





FEATURES OF MELANOMA CELL LINES 
Cell Line Doubling time Modal Chromosome No. Pigment 
(hrs) in vitro 
UCT-Mel 1 41 74 + 
UCT-Mel 2 so 61 + 
UCT-Mel 3 58 72 
UCT-Mel 4 52 100 
UCT-Mel 5 58 72 
UCT-Mel 6 33 81 
UCT-Mel 7 52 65 
• 
their growth rate was improv~d by removing nu/+ litter mates
 one week before 
weaning. Mating between homozygous pairs was not practical 
since the homozy-
gous females nursed poorly. As far as was possible with our sma
ll isolated 
colony, I minimised inbreeding in an attempt to preserve vig
our and to prevent 
decline in litter size. Young were weaned at 21 days of age
. 
The breeding data for the colony for the years 1981 to 1985 
are summa-
rized in Table 1.2. The average litter size was approximate
ly 7. Virtually 
all of the nudes were weaned, with a very low pre-weaning m
ortality. The 
productivity was 1.63 young/female/week with a generation ga
p of 3 months and 
each female produced, on average, 2.5 - 3.9 litters every si
x months. 
I attribute much of the success that I have had with the co
lony to the 
strict control that I exercised over the physical environmen
t of the animals. 
Under germ-free conditions in a protected milieu, the lifesp
an of the nu/nu 
mice was the same as that of norm.al laboratory mice. 
Periodic monitoring of the animals for disease was done acco
rding to the 
recommendations of in the British Medical Research Council. 
Occasional 
instances of bacterial contamination by organisms such as St
aphylococcus epi-
dermitis, Bacillus spp and Lactobacillus, were recorded. In
 these cases 
infected animals and "contact" animals were immediately tran
sferred out of the 
colony. 
Growth curves of the mice from the time of weaning until the
y attained 
adulthood at the age of 8-10 weeks are shown in Figure 1.1. 
Histological sections of lymph nodes (Fig 1.2) showed the ty
pical 




STRAIN YEAR PWM MEAN LITTER SIZE PRODUCTIVITY 
NO. OF LITTERS 
NAME % (YOUNG/ ~ /WEEK) 
4-6 MONTHS 
NIH II 1981 3.2 7.0 1.5 
2.8(Fl) 
(nu/nu) 
(outbred) 1982 1.3 6.2 1.9 
2. 5(F2-F4) 
1983 0.7 6.9 1.2 3.9(F5-F8
) 
1984 3.5 7.7 1.5 3.8(F9-F1
2) 
1985 3.2 8.5 2.3 3.7(F13-F
15) 




















21 35 49 63 77 91 105 
Age (days) 
Weight of nude mice as a function of age 
Mice were weaned at 21 days of age and weight measured once a week. The 
points on the graph were obtained by plotting the average body weight of S 
mice. The mice illustrated are as follows: males ea~--•); females (e----~). 
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FIGURE 1 .2 
Figure 1.2 
Comparative histological cross-sectional areas of lymph nodes 
Histological sections of representative lymph nodes were stained 
according to conventional histological techniques (H & E). The lymph
 nodes 
are as follows: 
a) Axillary lymph node of N:NIH(S)· - nu/nu mouse shows a paracorti
cal 
lymphocyte depletion. 
b) Axillary lymph node of an immunocompetent Balb/c mouse shows a n
ormal 




Cells for inoculation into the mice were harvested fr
om the tissue 
0 
culture dishes by washing with pre-w~rmed (37 C) seru
m-free medium and then 
incubating under warmed TBS containing 0.06% trypsin an
d 0.02% EDrA. Intermit-
tent inspection by phase-contrast microscopy and gen
tle tapping ensured that 
the monolayers were not exposed to the trypsin-EDrA s
olution for any longer 
than was necessary to achieve adequate release of via
ble cells. When this was 
complete (usually within 2-5 min) the trypsin was ne
utralized by the addition 
of foetal calf serum to a final concentration of 7 .5%. T
he cells were then 
pelleted and washed once with serum-free medium. 
They were then resuspended 
in serum-free RPMI medium; checked by trypan-blue exclu
sion for viability, 
and then diluted to give the required number of viab
le cells in an inoculum of 
0.1ml. 
Working under sterile conditions in a laminar flow h
ood, I inoculated 
cells subcutaneously into the inter-scapular region o
f 6-8 week-old animals. 
This was best achieved by having an assistant hold th
e mouse steady by gras-
ping a skin fold at the back of the neck with the lef
t hand and the haunches 
with the right hand. The mouse, extended be~ween the
 two hands of the assis-
tant, was then held firmly in the prone position on t
he working surface. I 
then lifted, between finger and thumb of my left hand
, a small fold of skin in 
the middle of the dorsum of the back and through this
 I introduced a 38mm x 26 
gauge hypodermic needle attached to the syringe conta
ining the cell suspen-
sion. The needle was advanced cephalad, taking care 
to remain in the plane of 
the subcutaneous tissues. The entire inoculum of 0.1
ml was delivered slowly 
at the tip of the needle and at the end of the needle
 track. Using this 
technique I could inject reproducible numbers of cell
s into a confined region 
without depositing any along the needle track or hav
ing them regurgitate 
through the inoculation site. 
The animals were then observed for up to approximate
ly 10 months for the 
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appearance of tumours. The mice were wei
ghed once a week and any tumours 
that developed were measured. The tumou
r volume was calculated as the 
product of three major diameters. Genera
lly speaking the tumours assumed a 
spherical or elliptical shape and were co
nfined to a single subcutaneous site. 
Measurement was thus straightforward. 
In most experiments - and particularly th
ose in which we were studying 
metastatic spread of the primary tumour -
tumours were excised when a certain 
desired mass had been achieved. This was
 done under ether anaesthesia. After 
brief swabbing of the skin with 70% alcoh
ol an elliptical incision was made and 
the tumour was removed with the enclosed 
ellipse of skin. In most cases the 
tumour was well defined and very easily r
emoved from the local site of primary 
growth with little, if any, evidence of i
nvasion. The skin wound was closed 
with interrupted stitches using 00 Derma
lon and an atraumatic needle. 
In approximately 10% of cases where tumo
urs were removed from mice that 
had been inoculated with ucr-MEL 3 cells, local recurrenc
e of tumour growth 
was observed. This was rarely seen with 
tumours derived from other cell 
lines. It is of interest to note that, d
espite the immunodeficient status 
of the mice, wound infection did not occu
r and the wounds all healed remarkab-
ly well. 
Representative portions of each tumour w
ere placed into buffered formal 
saline for histology. Regions of the tum
our that appeared viable were put 
into vials containing sterile tissue cult
ure medium and re-inoculated into 
tissue culture dishes or re-implantated a
s fragments, into mice. Small pieces 
of the tumour were also snap-frozen in li
quid nitrogen for enzymatic analysis 
or cryopreserved by gradual freezing in R
PMI-1640 medium containing 10% foetal 
calf serum and 10% dimethyl sulfoxide (Fa
rrant et al., 1974). 
Analysis of tumour tissues 
An estimate of the relative contribution 
of human and murine cells to the 
23 
tumour mass was obtained by agarose gel electroph
oresis of an homogenate of 
the tumour tissue followed by zyroographic localiz
ation of the bands of lactate 
dehydrogenase (LDH) activity. This was done us
ing standard procedures 
(Nichols and Ruddle, 1973; Detter et al., 1968; K
rog, 1976). Human and 
murine LDH were readily distinguishable by differ
ences in electrophoretic 
mobility (Fig. 1.3) 
Formalin-fixed samples were embedded in paraffin,
 sectioned and stained 
according to conventional histological techniques
 (Mayer's haematoxylin and 
eosin). 
Mathematical analysis 
Tumour growth was analysed by fitting the Gompe
rtzian function:-
V(t) = V [ a -St max.exp - - • e 
6 
] ••••••••• eq. 1 
to the tumour volume, V(t) plotted as a function 
of time, t. 
The parameters Vmax, alpha and beta were derived 
as recommended by 
Rofstad, Fodstad and Lindmo (1982) by applying su
ccessive linear regression 





~~ • -S £n V(t) + S £n Vmax V(t) L':.t 
r 
£n ! £n 
L 
Vmax J 
V ( t) - St + £n ( T) 




-·e + £n Vmax 
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FIGURE 1 .3 
Figure 1.3 • 
Lactate dehydrogenase analysis on human tumours removed from nude mice 
6 6 
Mice were inoculated subcutaneously with either 10 or SxlO UCT-Mel 7 
cells (in vitro passage numbers 26', 29';30'). These tumours grew 
exponentially for a ·period of approximately 80 days after which growth ceased 
and tumours regressed. Four to 7 months after initial inoculation of these 
tumour cells tumours started growing once more. They now grew vigorously 
showing exponential growth kinetics. At this stage tumours were removed and 
small explants were implanted subcutaneously into new animals. The tumours 
were ho100genized and LDH activities determined. 
Samples of tumour homogenates were as follows:-
Channel 1, 2 and~ - UCT-Mel 7 tumour tissue homogenate from passage 6, 
7and 7 respectively, showing LDH enzyme bands of both human and mouse 
origin. 
Channel 4 - mouse liver homogenate, showing LDH enzyme band of mouse 
origin. 









3 4 5 
Figure 1.3 
In these equations, alpha represents the first-order rate con
stant that 
describes the increase in growth rate with increasing tumour 
size; beta 
represents the superimposed negative rate constant that descr
ibes the decrease 
in growth rate with increasing size; and Vmax represents the
 theoretical 
maximum tumour volume. 
Since the Gompertzian function gives a curvilinear relationsh
ip between 
lnV(t) and t, one cannot define a global doubling time, (Td)'
 for the tumour. 
I have calculated, instead, the instantaneous doubling time a
t a particular 
3 
volume, V(t). Since measurements of V(t) in the vicinity of 
200nnn were 
usually reliable, I give for each tumour, the Td calculated f
or this volume as 
follows: 
Td(200) =-+ .en [ 1 .en 2 J .en (Vmas/200) 
Since I only examined the mice once weekly, I was unable to d
etermine the 
delay time between inoculation of the cells and appearance of
 the tumour, with 
a precision of more than approximately 7 days. In any event,
 the first 
appearance of a minute tumour would have been rather a diffic
ult event to 
time accurately. 
The "delay time", ( Tdel) for each tumour was therefore derive
d by 
calculating the length of time taken, after inoculation of th
e tumour cells, 
3 
to reach a volume of 100mm on the Gompertzian curve. This was 
calculated by 




· .en [-+ • .en ( 100/Vmax) J 
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RESULTS 
Kinetics of tumour growth 
Of the six melanoma cell lines that I inoculated, all w
ere tumorigenic 
with the exception of UCI-Mel 6. Cells from this line 
failed to form tumours 
despite several attempts to induce growth with larger i
nocula and co-inoculation 
of other cells. 
When tumours did develop, their growth was mathematica
lly well described 
by considering the volume of the tumour as a Gompertzia
n function of time 
(Figs. 1.4 - 1.11). 
Thus V(t) = Vmax.exp (-a/ B.exp(- Bt)). 
3 
Here V(t) is the volume of the tumour in mm at time t;
 Vmax = lim V(t) 
(the theoretical maximum tumour volume) and a and B ar
e constants. The 
Gompertz parameters that I calculated as described in t
he Methods section are 
presented in Table 1.3. 
The time that elapsed between inoculation and the inter
polated theoreti-
3 3 
cal volume of 100mm (i.e. the delay time to 100mm) va
ried from 12 to 22.2 
6 
days for an inoculum size of SxlO cells and from 22.8 
to 33.7 days where 
6 
7 
lxlO cells were injected. When, in a different series
 of experiments, 10 
7 
and SxlO cells for UCI-Mel 1 and UCI-Mel 2 were inject
ed, a similar shorte-
ning of the delay time was seen with the larger inocula
. It is noteworthy 
that the delay times in these experiments were similar 
(or in some cases 
greater) than those seen when ten-fold less cells were 
given in the first set 
7 
of experiments. When 10 UCI-Mel 2 cells were inoculat
ed, for example, a mean 
delay time of 29.7 days was recorded as opposed to 24.8
 days for an inoculum 
6 
of 10 cells. 3 
Theoretical instantaneous doubling times at a volume of
 200mm were 
calculated for 5 of the 6 tumours that grew. The 6th l
ine (UCI-Mel 7) reached 
3 
a plateau at approximately 200mm. Values for this paramete
r varied from 4.9 
to 10.7 days. In general the inoculum size had no con
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0 20 40 60 
Days after Inoculation 
Figure 1.4 
Growth of human melanomas in nude mice 
6 6 
Mice· were inoculated subcutaneously with 10 (a--~---,•-~ or SxlO <•----•) 
UCT-Mel 1 cells (passage number 65') on day O and the tumour volume determined 
at the indicated times. The points on the graph were calculated using the 
Gompertz function and they represent the mean values of 6 mice in the case of 
6 6 
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Growth of human melanomas in nude mice 
7 7 
Mice were inoculated subcutaneously with 10 ~.----••) or 5xl0 (JI-----•) 
ucr-Mel 1 cells passage number 65' on day O and the tumour volumes determined 
at the indicated times. The points on the graph were calculated using the 
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Days after Inoculation 
Figure 1.6 
Growth of human melanomas in nuce mice 
6 6 
Mice were inoculated subcutaneously with 10 ~.y~--w•) or SxlO ~---~ 
UCT-Mel 2 cells (passage number 127') on day O and the tumour volume deter-
mined at the indicated times. The points on the graph were calculated using 















0 10 20 30 40 50 
Days after inoculation 
Growth of human melanomas in nude mice 
7 7 
Mice were inoculated subcutaneously with 10 (?•----~••) or 5xl0 (T----~) 
ucr-Mel 2 cells (passage number 127'). on day O and the tumour volume deter-
mined at the indicated times. The points on the graph were calculated using 
the Gompertz function and they represent the mean values for 5 mice. 
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40 60 80 
Days after Inoculation 
Growth of human melanomas in nude mice 
6 6 
Mice were inoculated subcutaneously with 10 (••~~ .. •) or SxlO (A:-----.t.) 
ucr-Mel 3 cells (passage number 69') on day O and the tumour volumes deter-
mined at the indicated times. The points on the graph were calculated usi~g 
the Gompertz function and they represent the mean values for 5 mice in the 
6 6 
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Days after Inoculation 
Figure 1.9 
Growth of human melanomas in nude mice 
6 6 
Mice were inoculated subcutaneously with 10 (we~~ew) or SxlO (e-----e) 
UCT-Mel 4 cells (passage number 20') on day O and the tumour volumes deter-
mined at the indicated times. The points on the graph were calculated using 
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Growth of human melanomas in nude mice 
6 6 
Mice were inoculated subcutaneously with 10 (••--••) or SxlO (•-- - - •) 
ucr-Mel 5 cells (passage number 27') on day O and the tumour volume determined 
at the indicated times. The points on the graph were calculated using the 
Gompertz function and they represent the mean values for 5 mice. 
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Days ofter Inoculation 
Figure 1.11 
Growth of human melanomas in nude mice 
6 6 
Mice were inoculated subcutaneously with 10 <••----••) or 5xl0 (~---~) 
UCT-Mel 7 cells (passage number 29') on day O and the 
tumour volumes deter-
mined at the indicated times. The points on the graph
 were calculated using 
the Gompertz function and they represent the mean valu





































































































































































































































































































































































































































































































































































































































































































Assuming that the parameter alpha represents the fractional first or
der 
at 
rate constant for exponential growth, i.e. V(t) = V(o)e , I have ca
lculated 
6 
theoretical doubling times for the inocula of 10 cells. In table 1
.4 these 
are compared with the observed doubling times for the corresponding 
cell lines 
cultured in vitro. The cell generation time or doubling time in vit
ro was 
approximately 2 to 3 times less than that of the tuIIX)ur doubling tim
e in vivo. 
I have also included in Table 1.4, reference to observations by Span
g-Thomsen 
et al., (1984) who derived a cell cycle time of 44 hrs for a melanom
a xeno-
graft using a technique in which radioactive thymidine was administe
red to the 
tumour-bearing nude IIX)USe and, at the same time, measured the tuIIX)ur
 volume 
doubling time from a Gompertzian analysis similar to that that I hav
e used. 
Close agreement with my data is evident. 
Iri Figure 1.12 I compare the values for Td(200), a and S that I obse
rved 
with those presented by Rofstad et al., (1982). These box plots, (w
hich 
provide a convenient, non-parametric means of displaying the distrib
ution of 
data arouni the median values) show that the combination of melanoma
 cells and 
nude mice that I studied had Td(200) values that fell well within th
e range of 
those reported by Rofstad although the median values were somewhat s
horter and 
my data showed less scatter. The data for both a and S showed overl
ap between 
the two series; once again my values were smaller, with less scatte
r, than 
those of Rofstad et al., (1982). 
UCI-Mel 7 cells were unusual in that, after a period of early growth (
0 -
approximately 80 days) during which they followed Gompertzian kineti
cs, growth 
ceased at a plateau followed by a regression in tumour size to the p
oint, in 
some cases, where only a small, barely palpable, nodule remained. T
hen, 
surprisingly, and usually 4 to 7 months after inoculation of the tum
our 
cells, the nodule started to grow again, this time as a vigorous tuII
X)ur 
showing simple exponential growth kinetics (Fig. 1.13). 
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Table 1.4 









Doubling time (hours) 












137 - 187 
(1) Cells were cultured, with daily medium replacement in R
PMI-1640 supple-
mented with 10% foetal calf serum and antibiotics. Cells in
 duplicate 
cultures were counted every second day during the period of e
xponential 
growth. 
(2) Calculated from the values for the Gompertzian parameter
, alpha, 
presented in Table 1.3 on the assumption that this represents
 the fractional 
first order rate constant for growth as a function of time. 
i.e. V(t) = V(o). exp(at) 
(3) These results were obtained by the authors (Spang-Thomse
n & Vindelov, 
3 
1984) by administering H-thymidine to tumour bearing mice an
d counting 
labelled mitoses in biopsies taken at intervals thereafter. The
ir data for 
in vivo volume doubling times were derived, as were mine, for
 tumours ranging 
3 





Values for growth rates of melanomas in nude mice: comparison of 
Gompertzian parameters calculated by data presented in this thesis with those 
parameters presented by Rofstad et al. 1982. 
In this figure the data presented in Table 1.2 are summarized 
graphically and compared with those parameters of Rofstad et al. 1982 for 
3 
(a) alpha (b) beta (c) Td(200mm ). 
In each case the data are represented as "box and whisker" plots drawn 
according to the method of Tukey, Cleveland and McGill, 1985. The vertical 
lines . inside the box indicate the 50th percentile value; the left- and right-
hand ends of the box are the 25th and 75th percentiles respectively. The 
short vertical lines at the extremities of the dashed "whiskers" denote the 
"adjacent values" derived as follows: If t = .l.Sx (75th percentile - 25th 
percentile) then the right-hand adjacent value is ·the largest observation that 
is less than or equal to the 75th percentile+ t. The left-hand adjacent value 
is the smallest observation that is greater than or ~qual to the 25th percen-
tile - t. Observations lying outside the range of the adjacent values are 
plotted individually as "maverick" points. Data from a sample with a normal 
2 
distribution with mean values )1 and variance 0- would give adjacent values of 
approximately?.:!::. 2.67cr-. One would thus expect only a small fraction of the 
observations to fall outside the adjacent values. 
Figure 1 . 12 
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Days after Inoculation 
Figure 1.13 
Growth of human melanomas in nude mice 
Each line and set of points represents data accumulated from
 a single 
6 
mouse. SxlO ucr-Mel 7 cells (passage number 30') were inoculated subcuta-
neously into nude mice. After a period of early growth (ap
proximately 80 
days), growth ceased at a plateau followed by a regression 
in tumour size. 
Then, after a prolonged period of time (about 200 days) pos
t-inoculation, the 




Histological appearance of tumours 
The tumours that arose from cells inoculated into 
the nude mice were 
compared, histologically, with the original mater
ial obtained from the 
patient. These comparisons are presented photo
graphically in Figures 1.14. 
In all cases the tumour xenografts were similar, 
in most respects, to the 
original human tu11K>ur material. This was evident 
in the cellular morphology, 
the presence or absence of pigment and in the way 
in which the cells were 
organized within the tumour arid disposed in relati
onship to each other and to 
the neoplastic stroma. It is of particular int
erest to note that, in the 
case of ucr-Mel 2, the tu11K>ur taken from the orig
inal had a variegate appea-
rance with areas of intense pigmentation and othe
r areas that were amelanotic. 
Exactly the same pattern was seen in tumours re11K>
ved from the nude mice 
(Figure 1.15). 
UCT-Mel 3 was a non-pigmented tumour in the patie
nt and grew similarly in 
the mouse without melanin deposition. It charact
eristically caused extensive 
haemorrhage into the tu11K>ur in the mouse and for 
this reason appeared pigmen-
ted due to the presence of a large number of eryth
rocytes and degraded haemo-
globin. (Figure 1.16). 
The original UCI-Mel 4 tumour was deeply pigmented
 with strong epithe-
lioid characteristics. When established in tissue
 culture the cells main-
tained their epithelioid llK>rphology but lost the p
igmented phenotype. The 
graf ted tulOClur was non-pigmented and the histolog
ical appearance after resec-
tion was that of an undifferentiated melanoma. Thes
e appearances were 
similar to those of parts of the original tullK>ur w
hich were similarly undif-
ferentiated. 
UCI-Mel 5 was non-pigmented in both the original 
tumour and the xenograft 
and both showed a mixture of spindle-shaped and e
pithelioid cells. Minor 
differences were noted in the architecture of the 
original and the xenografted 
43 
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FIGURE 1 .14 
• 
Figure 1.14 
Histological comparison of original tumours with tumours after passage 
in nude mice. 
The complete 
of the tumours as 
the corresponding 
the photograph). 
figure displays photographs of the histological appearance 
obtained from the patient (left half of each photograph) and 
tumours after passage through the nude mice (right half of 
It will be noted:-
(a) UCT-Mel 1 - both tumours displayed pigmented, undiffe.rentiated malignant 
melanoma, with vesicular nuclei and large nucleoli. The similarities in this 
case are striking. 
(b) UCT-Mel 2 - the mouse tumour showed undifferentiated tumour cells with 
large nucleoli. Occasional pigmented cells scattered over the whole field can 
be noted. The parent human tumour, on the left, showed similar cells, also 
occasionally pigmented and lightly stained which are at present mainly in the 
right upper quadrant. 
(c) UCT-Mel 3 - the parent tumour was an epithelioid cell malignant melanoma 
and the mouse tumour consisted of undifferentiated malignant melanoma. When 
comparing individual cells one notes that both tumours ·have cells with large 
irregular nuclei and prominent nucleoli; and that the cells on both tumours 
have abundant cytoplasm. The separation of the cells, more obvious in the 
parent tumour, may be no more than an artefact. 
(d) UCT-Mel 4 - in the parent human tumour, on the left, the pigmentation is 
dominant whereas this feature is not illustrated in the mouse tumour. Where 
the parent tumour is unpigm.ented, as in the right lower quadrant the similari-
ties with the mouse tumour are more evident. Both show large vesicular clear 
nuclei and prominent nucleoli. 
(e) UCT-Mel 5 - both tumours were undifferentiated malignant melanomas, with 
mitoses evident centrally in the mouse tumour. The undifferentiated tumour 
cells with large irregular nuclei and prominent, though not really big, nuc-
leoli are evident both in the parent tumour and the mouse tumour. 
(f) UCT-Mel 7 - the parent tumour was a spindle cell type malignant melanoma 
and the mouse tumour was an undifferentiated malignant melanoma which tended 
to form spindle shaped cells. Spindling is more evident in the parent human 
tumour but spindle shaped cells in the mouse tumour can be seen diagonally 
from the lower left to the upper right quadrants. Elsewhere the mouse tumour 
cells are undifferentiated with some large nuclei and nucleoli, but similar 
cells can also be found in the parent human tumour. 





The gross appearance of ucr-Mel 2 following remo
val from the nude mouse 
6 
A partially pigmented tumour removed from a mouse
 injected with 10 ucr-
Mel 2 cells (passage number 127'). The tumour re
moved from the original 
patient had a variegate appearance with areas of 
intensive pigmentation and 
other areas that were amelanotic. Note that exac
tly the same pattern is 
evident in the tumour removed from the nude mice.
 





The gross appearance of UCT-Mel 3 following rem.oval from the nude mouse. 
6 
An apparently pigmented tum.our removed from a mouse injected with SxlO 
UCT-Mel 3 cells (passage number 69'). Histological examination of the tumour 
showed that the dark colour was due to blood. 
Scale marker: each small division corresponds to 1mm. 
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tumour in that "nests" of ep
ithelioid cells surrounded b
y spindle type cells 
that were apparent in the or
iginal tumour were not seen 
in the nude mouse. 
ucr-Mel 7 grew as a mixture of
 both spindle and epithelioi
d cells in both 
the xenograft and in the ori
ginal tumour. The striking
 feature of this parti-
cular tumour, particularly w
hen it reached the exponent
ial plateau phase of 
its growth curve, was the in
tense infiltration of the tu
mour with murine 
fibroblasts, macrophages and
 connective tissue (Figure 1
.17). 
Tumorigenicity as a function
 of inoculum size 
Tumorigenicity of the inocul
um in female mice was studi
ed as a function 
of the inoculum size with ce
lls from three of the lines 
- ucr-Mel 2, ucr-Mel 3 
6 
and ucr-Mel 7. The results sh
owed that 10 or more cells
 were consistently 
5 
tumorigenic in all of the an
imals; 10 cells gave rise 
to tumours in 0-40% of 
the mice inoculated, with va
riability between the cell l
ines studied and 
4 
between different experimen
ts and 10 cells were unifor
mly non-tumorigenic. 
(Table 1.5) 
Growth of tumours in male an
d female mice 
In one case (Ucr-Mel 2) the gr
owth of melanoma cells in m
ale and female 
mice was compared and a stri
king difference was noted, 
between the two sexes, 
5 
in the size of the inocula r
equired to produce tullk)urs. 
Inocula of 10 cells 
5 
regularly gave rise to tumo
urs in male mice whereas 10 
cells were consis-
tently non-tumourigenic in f
emales. Once established the
 tullk)urs grew with 
the same kinetics in males a
nd females. Data are presen
ted in Figure 1.18. 
Metastatic spread 
Provided the primary tumours
 that arose at the site of 
inoculation were 
excised before they attained
 such a size that ulceration
, haemorrhage or other 
complications led to the dea
th of the hosts, all of the 




UCT-Mel 7 removed from the nude mouse and stained for reticulin 
A histological section of UCT-Mel 7 was stained for reticulin (Gordon and 
Sweet, 1936). The tumour shows abun:lant reticulin arranged in bun:lles or 
aroun:l cells. UCT-Mel 7 tumours cultured in vitro were always heavily 
contaminated with mouse fibroblasts and macrophages. 






TUMORIGENICITY AS A FUNGrIO
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Figure 1~18 
The effect of sex on the growth of human melanomas in nude mice. 
5 6 
Male and female mice were inoculated subcutaneously with 10 or 10 
melanoma cells on Day O and the tumour volume determined at the indicated 
times. The points on the graph were calculated using the Gompertz function 
5 
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and they represent the mean values for 2 mice in the case of 10 cells in male 
6 
mice or 5 mice in the case of 10 cells in male and female mice. 
It will be noted:-
5 
(a) that 10 melanoma cells were consistently non tumorigenic, when inoculated 
into female mice, whereas in male mice they regularly gave rise to tumours; 
(b) that the larger the inoculum size the shorter ~he delay time. 
The lines are as follows:-
5 
10 UCT-Mel 2 cells/female <•--->; 
UCT-Mel 2 cells/female (a--tl). 
5 
10 UCT-Mel 2 cells/male ( ............. ); 
6 6 
10 UCT-Mel 2 cells/ male (T---T); 10 
tumours, with the exception of UCT-Mel 7, metastasized to a g
reater or lesser 
extent. 
The presence or absence of metastases was determined by deta
iled autopsy 
of the animals that were killed, or that died spontaneously 
after the excision 
of the primary tumour. Killing the animals too soon 
(i.e. before metastatic 
foci had grown to a readily detectable size) would have resu
lted in an under-
estimate of the metastatic frequency. Leaving them t
oo long before scoring, 
on the other hand, would have caused logistic difficulties in
 housing and 
maintaining the mice for long periods. It was therefore nec
essary to define 
criteria for deciding when to terminate the experiment on ea
ch mouse. 
Taking the diameter of a melanoma cell as 20 microns, its vo
lume would be 
-6 3 
4.2xl0 mm. A spherical tumour comprising a million such c
ells would thus 
3 
have a volume of 4.2mm, or a diameter of 2mm. 
size should be readily visible. 
A metastatic deposit of this 
Assuming that small tumours grow exponentially in vivo with 
a doubling 
time of 4 days (cf. Table 1.3) it should have taken approxim
ately 80 days for 
a single cell to give rise to a visible deposit. Observing 
the mice for at 
least 120 days after excision of the primary tumour should h
ave provided a 
reasonable chance of detecting any metastases that were going
. to develop. In 
some cases this criterion was used and mice were not autopsie
d for at least 
four months after excision of the tumour. 
In most cases, however, I relied upon the useful observation
 that 
the presence of metastases in otherwi~e apparently healthy an
imals could 
usually be detected by following the bqdy weight with time. Ex
cision of the 
primary tu!IX)ur usually resulted in an increase in body mass 
to a plateau which 
persisted until metastases developed whe~ a decline in weigh
t was observed 
(Figure 1.19). 
The cell lines differed remarkably i~ the frequency with whi
ch they 
formed metastatic tumours (Table 1.6), ran~ing from 6% in the
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53 
Decline in body weight after removal of the primary tumour. 
Each line and set of · points represents data accumulated from a single 
6 6 
mouse. Mice were inoculated subcutaneously with 10 or 5xl0 ucr-Mel 3 cells 
(passage number 69'). Tumours were removed on Day 0, when they reached appro-
3 
ximately the size of 2000-3000mm. Note that the excision of the primary 
tumour usually resulted in an increase in body mass to a plateau after which a 




METASTASES IN NUDE MI CE 
Cell line No. of mice Metastases Maximum period Site of 
of observation metastases 
No. % (days) 
UCT-Mel 1 17 1 6 260 Lung 
UCT-Mel 2 26 3 12 380 Lung 




UCT-Mel 4 10 1 10 270 Lung 
UCT-Mel 5 22 3 14 313 Lung 
UCT-Mel 7 10 0 0 370 
l to 100% with tumours from UCT-Mel 3. Tumours arising from the interscapular 
primary mass were deposited in a number of sites including the abdominal 
cavity, the gonads, kidney, lungs and liver. 
Metastases detected at autopsy were re-implanted into mice and repeatedly 
passaged as subcutaneous tumours in vivo. Their in vivo growth kinetics were 
compared with those of the parent primary tumour from which they were derived. 
No significant differences in growth characteristics were observed (Table 1.7 
and Figs. 1.20 to 1.24 and Appendix Table A.8). 
DISCUSSION 
Growth kinetics 
In most respects the observations that I have made on the growth of 
tumours that develop from human melanoma. cells inoculated into nude mice are 
55 
in accord with observations made by others (Rofstad et al., 1982; Fodstad et al., 
1980; Giovanella et al., 1972, 1973, 1984; Fogh et al., 1977; Aubert et al., 
19 7 6, 19 80) • 
Following a period of latency that was inversely related to the number of 
cells implanted, tumours developed in most cases. These grew progressively 
with a decelerating growth rate. 
Several mathematical models have been proposed to describe growth curves 
(Peters, 1983; Defares and Snedden, 1964). Four of the most popular are the 
Gompertzian, the Logistic, the von Bertalanffy and the "mononuclear". 
All require, in one form or another, three constants: 
(i) The minimum size to which the equation applies (Vo), or a maximum size to 
which the volume of the function tends (Vmax), 
(ii) An experimental rate constant of growth (alpha in our case) 
(iii) A second rate constant that modifies the fractional change in growth 
rate as a function of size. In our case this is represented by beta. 
Usually these alternative models all give an equally good fit to the 
Table 1.7 . 






































(1) Metastatic deposits were removed from mice inoculated w
ith cells cultured 
in vitro and these were re-implanted subcutaneously into fre
sh recipients. 
The tumours that resulted were repeatedly passaged in vivo 
and their growth 












































Days after Implantation 
50 
Growth in vivo of UCT-Mel 1 parent primary tumour and metastatic deposits 
removed from the lung. 
6 
Mice were inoculated subcutaneously with SxlO melanoma cells (in vitro 
57 
passage number 65') or metastatic explants of in vivo passage 4, on Day O and 
the tumour volumes determined at the indicated times. The points on the graph 
were calculated using the Gompertz function and they represent the mean values 
• 
for 5 mice in the case of the parent tumour or for 4 mice in the case of the 
metastatic explants. Note that no significant differences in growth characte-
ristics were observed. 
The tumours illustrated are as follows: UCT-Mel 1/parent tumour ( .. ----a); 
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30 40 
Days after Implantation 
50 
Growth in vivo of UCT-Mel 2 parent primary tumour and metastatic deposits 
removed from the lung. 
6 
Mice were inoculated subcutaneously with SxlO melanoma cells (in vitro 
58 
passage number 124') or metastatic explants of in vivo passage 6, on Day O and 
the tumour volumes determined at the indicated times. The points on the graph 
were calculated using the Gompertz function and they represent the mean values 
for 5 mice in the case of parent tumours or for 2 mice in the case of metasta-
tic deposits. Note that no significant differences in growth characteristics 
were observed. 
The tumours illustrated are as follows: UCT-Mel 2/parent tumour (/J&A~~.t.); 
UCT-Mel 2/metastatic deposits (a-----a). 
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Figure 1.2 2 
Growth in vivo of ucr-Mel 3 parent primary tumour and metastatic deposits 
removed from the lung. 
6 
Mice were inoculated subcutaneously with 2xl0 cells obtained from a 
metastatic deposit from the lung which had been cultured in vitro for 11' 
6 
passages or SxlO UCT- Mel 3 melanoma cells ( in vitro passage number 69') on day 
0 and the tumour volumes determined at the indicated times. The points on 
t he graph were calculated using the Gompertz function and they represent the 
mean values for S mice in the case of the parent tumour or for 4 mice in the 
case of the metastatic deposits. Note that no significant differences in 
growth characteristics were observed. 
The tumours illustrated are as follows: ucr-Mel 3/parent tumour (a----a); 



















































/ / . 
50 
Ooys ofter Inoculation 
Growth in vivo of UCT-Mel 4 parent primary tumour and metastatic deposits 
removed from the lung. 
6 
Mice were inoculated subcutaneously with SxlO melanoma cells (in vitro 
passage number 20') or metastatic explants of in vivo passage 1, on Day O and 
the tumour volumes determined at the indicated times. The points on the 
graph were calculated using the Gompertz function and they represent the mean 
values for 5 mice in the case of the parent tull¥)ur and 2 mice in the case of 
the metastatic deposits. Note that no significant differences in growth 
characteristics were observed. 
The tull¥)urs illustrated are as follows: UCT-Mel 4/parent tumour(+--+); 
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Days after Implantation 
60 
Growth in vivo of OCT-Mel 5 parent primary tum
our and metastatic deposits 
removed from the lung. 
6 
Mice were inoculated subcutaneously with SxlO (i
n vitro passage number 
61 
27') melanoma cells or metastatic explants of in v
ivo passage Son day O and 
the tumour volumes determined at the indicated
 times. The points on the graph 
were calculated using ' the Gompertz function an
d they represent the mean values 
for S mice. Note that no significant differenc
es in growth characteristics 
were observed. 
The tumours illustrated are as follows: UCT-M
el 5/parent tumour C•----e) ; 
UCT-Mel 5/metastatic deposits (•a1--~••)· I 
experimental data (Ricklefs, 1967) and I know of no sound a priori 
reason for 
choosing one to the other. 
In two papers published 20 years ago, Laird (1964; 1965) drew atten
tion 
of oncologists to the Gompertz equation and since, I suspect, there
 has been • 
no compelling reason to seek more accurate OK>dels, the Gompertzian 
function 
has stayed with us. 
Although useful devices for describing the dynamics of tuOK>ur growt
h, 
these mathematical llX)dels are not generally used to give quantirativ
e 
expression to well-defined underlying biological processes and one 
does not 
find any tendency in the literature to sustain rationale for their 
use. 
This, in spite of the fact that it is reasonable, on first principl
es, to 
think of tul!X)ur growth as the result of two processes: (a) an expo
nential 
increase in tumour size that will cause the tumour to enlarge at a 
rate that 
is proportional to its size and (b) modifying phenomena such as lim
itation of 
blood supply or diffusion of nutrients, that exert a negative effec
t upon 
growth rate that is also dependent on size i.e. the larger the tumo
ur the more 
rapidly its growth rate will decelerate. The magnitudes of alpha 
and beta 
give some idea of the relative contribution of these two processes 
but it 
should be remembered that models that involve exponential parameter
s can be 
fitted to many relationships and when, as in the case of the Gompe
rtzian 
curves, double exponentials are involved the models become even mor
e suspect. 
As Gauss is reputed to have said, "give me three parameters and I' 1
1 draw you 
an elephant; give me a fourth and I'll make it wag its tail!". Th
e value of 
in vivo growth measurement as a function of time is greater if thes
e are 
considered in conjunction with simultaneous cytokinetic data obtaine
d with 
in vivo cell labelling techniques and determination, by flow cytome
try, of the 
fraction of cells in different stages of the cell cycle. This subj
ect has 
been extensively reviewed by Steel (1977). The value of this combi
ned experi-
mental approach to the analysis of the kinetics of tuOK>ur growth ts
 well 
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illustrated by the papers of Spang-Thomsen and Vindelov,(1984), Shirakawa et 
al., (1970) and Rofstad et al., (1982). 
The empirical fact of the matter is that my data were well fitted by a 
Gompertzian curve and the parameters obtained could be used to calculate 
theoretical delay times and instantaneous doubling times at a given tumour 
volume. They could also be used to compare the results that I obtained with 
those of others who have studied mice bearing human melanoma xenografts. 
The kinetic data that I have accumulated warrant comment in the following 
itemized respects: 
(i) The Gompertzian parameters that I calculated were very similar to those 
reported by others (Spang-Thomsen et al., 1980; Rofstad et al., 1982). My · 
data showed slightly less scatter than those of Rofstad et al., (1982) (Figure 
1.13), due, in all probability, to differences in the strain of nu/nu mice 
used, the tumours studied and techniques used to measure tumour volume. 
(ii) Volume doubling times in vivo (approximately 4-5 days) in the mouse are 
longer than the cell cycle time (30-50 hr) as measured in vitro or in vivo by 
DNA cell labelling techniques (Quastler and Sherman, 1959). There is general 
agreement that, while this difference may be attributable in part, to a dimi-
nished growth fraction in vivo, it is due to a greater extent, to cell loss 
from metastasis, exfoliation or cell death (Frindel et al.,1967,1968; 
Shirakawa et al., 1970; Spang-Thomsen and Vindelov, 1984; Rofstad et al., 
1982; Steel,1977). Furthermore, the retardation in growth rates seen as 
tumours enlarge is similarly due to an increase in the cell-loss factor and 
not due to a decrease in growth fraction (Frindel et al., 1967; Steel, 1967; 
Tannock, 1969). 
(iii) Few reports are available on melanoma-volume doubling times in vivo in 
man. Nathenson et al (1967) have reported values of 2-16 weeks with a median 
of 6 weeks for metastases in the lung of patients x-rayed sequentially. A 
similar study reported by Rampen (1982) recorded doubling times ranging from 
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2-15 weeks (median approximately 6 weeks). Th
ese data and common clinic 
experience, tell us that tull¥)urs grow much mo
re rapidly in nude mice than they 
do in man. This may well be due to the fact t
hat the growth fraction of 
melanomas in the human host is 20% - 25% (Shir
akawa et al., 1970) when xeno-
grafted melanomas in mice show growth fraction
s of 60-80% (Spang-Thomsen and 
Vindelov, 1984) although Rofstad et al (1982) 
found that only 5-25% of xeno-
grafted melanoma cells were in the S phase of 
the cell cycle. 
3 
(iv) The time taken to reach a theoretical vo
lume of 100mm provided a 
reasonable estimate of tull¥)ur latency that sho
wed the expected inverse 
correlation with inoculum size. Since, all
 other things being equal, an 
increase in inoculum size should mean an incre
ase in the number of clonogenic 
cells injected, the Tdel(lOO) might be used as
 a measure of the effect of 
hormones, drugs or other manipulations on the 
number of clonogenic cells in 
inocula of constant size. I have used this a
s one of the parameters to study 
the effect of hormones on in vivo tumour growt
h (Chapter 3). 
In summary, the experiments that I report in t
his section have shown that 
it is possible to evaluate growth rates for hu
man melanomas xenografted into 
nude mice and that, within limits, these data 
are consistent for any given 
line and amenable to measurements with suffici
ent precision to permit their 
use in experiments designed to identify factor
s that modulate tumour growth. 
It should, however, be emphasized that volume 
growth in vivo in the nude ioouse 
is the complex result of several factors that 
involve host factors, the cells 
themselves and interactions between the two. 
Furthermore, there are obvious 
differences be~#een growth rates in man and th
e mouse that indicate the need 
for caution in extrapolating conclusions from 
one species to the other, 
despite the great similarities that exist betw
een the histological appearances 
of the tumour in the original human host and i
n the xenograft (Fig.1.14). 
Two of the cell lines behaved atypically when 
inoculated into nude mice. 
The first, UCT-Mel 6, did not form tumours de
spite all efforts to induce 
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growth by increasing the inoculum size or by c
o-inoculation of the tumour 
cells with fibroblasts. It is of interest to 
note that these cells, although 
from a tumour that was confidently diagnosed a
s a malignant melanoma, were 
unlike other melanoma cells in other respects.
 When studied in vitro they 
failed to grow in an anchorage-independent man
ner and they synthesized plasmi-
nogen activators of the urokinase type (wherea
s other melanomas all synthe-
sized tissue plasminogen activator) and they la
cked the melanoma-specific M19 
antigen (Roal-van Helden et al., 1986). I ha
ve no good explanation for the 
lack of tumorigenicity shown by these cells. 
It is a question that clearly 
deserves further study for the light that it m
ay shed on phenotypic variation 
in melanoma cells and the way that these influe
nce host:tumour cell inter-
Kt~~. 
The second anomalous cell line, UCT-Mel 7, beh
aved consistently in the 
most interesting manner. After a period of ra
pid initial volume increase the 
tumour size remained constant and then regresse
d to l?ecome barely palpable. 
Finally, the fourth phase was seen in which th
e tumour abruptly recurred and 
grew with exponential vigour. The tumour was
 also of interest for the 
remarkable desmoplastic response that it elici
ted. More detailed studies with 
this cell line are reported in Chapters. 
Tumorigenicity 
As I have already indicated, all of the cell l
ines, with the exception of 
UCT-Mel 6, gave rise to tullk)urs. I should lik
e, at this point, to emphasize 
the fact that tumorigenicity in the nude mouse
, although generally regarde:l as 
a qualitative attribute that characterizes mal
ignant cells, has a quantitative 
component that may, in fact, be more informati
ve. I refer to the fact that 
the cells from UCT-Mel 2, 3 and 7 showed a cle
ar relationship be~~een tullk)ri-
gencity and the size of the inoculum. This sim
Llar relationship has been 
well-documented by others for melanomas ·and ot
her tullk)urs (Kindred and 
65 
Wechsler,1978; Stiles et al.,1976; Peters and He
witt,1974; Woodruff and 
Dunbar,1974; Denys,1972; Vladimer et al., 1978) 
although relatively few 
(Porter et al • , 1973; Hewitt and Wilson, 1959; Hew
itt et al., 1967) have 
published systematic studies of this phenomenon. 
It is assumed that an inoculum will only cause a tu
mour if it contains 
one or more clonogenic cells. If there are an ave
rage of m clonogenic cells 
per inoculum, the probability of a failure to prod
uce a tumour is given by the 
-m 
Poisson distribution asp= e Finney, (1964
) has developed a useful bio-
assay, based on this relationship, for determining
 the TDSO (i.e. the inoculum 
size that will give rise to a tumour in 50% of rec
ipients) and for detecting 
anomalous transplantation kinetics where "single c
lonogenic cell" kinetics do 
not apply. 
Where experiments aim to quantitate the effects of
 various manipulations 
on the "tumorigenicity" of a cell line, it would c
learly be desirable if 
precise methods for estimating tumorigenicity could
 be devised based upon a 
TDSO rather than upon a binary "yes/no" appraisal 
of whether or not the cells 
could be induced to grow. I take this matter up a
gain in Chapter 2. 
It is also apparent, from data that' I present in F
ig.1.18, that the 
likelihood of a tumour developing from a marginall
y (or a sub-) tumorigenic 
inoculum may be related to the sex of the recipien
t. Relatively few studies 
have produced definitive experimental evidence sho
wing that human melanomas 
are hormonally dependent tumours. I consider this




THE EFFECT OF CO-INOCULATED CELLS ON TUMORIGENICITY OF HUMAN MEL
ANOMA 
CELLS IN THE ATHYMIC MICE. 
In 1956 Revesz made the interesting observation that the gro
wth of an 
experimental transplanted tumour was greatly enhanced by ad
ding lethally 
irradiated tumour cells to the viable inoculum. This was m
anifest as an 
earlier and higher incidence of progressively growing tumou
rs and a decreased 
survival time of the tumour-bearing host. Two years later
 he published a 
, , 
second paper (Revesz, 1958) in wich he reported the results 
of a remarkably 
scholarly and systematic experimental analysis of the phenom
enon. He showed 
that inocula of tumour cells that would ordinarily not have 
been tumorigenic, 
by virtue of the low number of cells that they contained or 
by virtue of a 
host environment that was not propitious, could be induced 
to form tumours if 
co-injected with normal or irradiated cells that were not tu
morigenic in their 
own right. 
His inocula thus comprised two fractions: a population of 
potentially 
tumorigenic cells and a complementing cell fraction. No enh
ancement of poten-
tially tumorigenic cell growth was seen if the complementing
 cells were 
deposited at a different anatomical site or killed by heat 
treatment. There 
was thus a need for intimate, local contact between the pot
entially tumori-
genic cells and a complementing cell fraction that was viab
le in the metabolic 
sense if not in the proliferative sense. 
The effect did not seem to be due to the induction of local
 inflammatory 
response by the complementing cell fraction nor did prior lo
cal irradiation of 
the transplant bed cause enhancement. 
;' " Revesz thus concluded that the comple-
menting cells elaborated "growth factors" analagous to those
 that had been 
described by Sanford et al., 1948, in "conditioned medium" a
nd that would 
promote the growth of single cells in culture. 
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, , 
At the time at which Revesz made his original observations it was n
ot 
common practice to apply Poisson statistics to the analysis of tran
splant 
data. He did not, therefore, plan his experiments in such a way th
at it was 
possible to draw a clear distinction between an effect of compleme
nting cells 
on the growth rate of the potentially tumorigenic cell fraction or 
on the 
number of clonogenic cells that it contained. In 1973 Hewitt, Blak
e and 
Porter showed, with a number of syngeneic tumours, that the Revisz 
effect was 
~ 
due to an increase in the proportion of potentially tumorigenic cel
ls that 
contributed to the initiation of tumour growth. Whereas as 6900 ce
lls was 
6 
required for 50% takes (TDSO), the addition of 10 complementing ce
lls 
reduced the TDSO to 4 cells with the retention of the Poisson relat
ionship. 
, , 
I found the Revesz effect interesting for a number of reasons. 
In the first place it is well known that human tumours will only gr
ow in 
• the nude mouse if a minimum number of cells is transplanted. It would seem 
appropriate to ask if this requirement for a critical inoculum size
 means that 
only a small fraction of the tumour cell population· is potentially 
clonogenic 
or whether a Revlsz phenomenon operates in the sense that the bulk of a
 suc-
cessful inoculum comprises cells that function as. complementing cel
ls. 
Secondly, most work on the Revesz effect to date has been done with
 
syngeneic systems. When Hewitt et al., (1973) attempted to use all
ogeneic 
potentially tumorigenic cell and complementing cell combinations th
ey obtained 
highly variable results and they were unable to show enhancement of
 growth if 
the potentially tumorigenic cells and the host were histo-incompati
ble. The 
nude mouse, by providing an immunologically bland environment, shou
ld allow 
experiments designed to establish the extent to which potentially t
umorigenic 
cell:complementing cell relatedness is required. 
Thirdly, I thought it should be possible to use the nude mouse to d
evelop 
assay systems for quantitating complementing cell function and so t
o contri-
bute methods for the study of intercellular interactions that influ
ence 
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expression of the neoplastic phenotype in man. 
Finally, several major reports on the use of nude mice for the study of 
human tumours have recently appeared (Baldwin and Pimm, 1980; Bellet et al., 
1979; Carrel et al., 1976; Dexter et al., 1982; Fogh et al., 1977; Fodstad 
et al., 1980; Giovannella et al., 1974a;b; 1978; 1983; 1984; Giovanella 
and Fogh, 1978; Giovanella and Stehlin, 1974; Gershwin et al., 1977; Hata 
et al., 1978; Helson et al., 1975; Merenda et al., 1975; Reid et al., 1977; 
Stiles et al., 1976a;b;c; Sordat et al., 1974; 1978; Sordat and Bogenmann, 
1980; Sordat and Merenda, 1977) without mention of the phenomenon and a 
citation index literature search back to 1974 produced only 27 papers that 
refer to the Revisz effect and, of these only two - both from the same labora-
tory - (Lozzio et al., 1976a; Lozzio et al., 1976b) reported on the enhancing 
effect of fibroblasts on the growth of the human malignant cell line, K-562, 
in the nude mouse. Stiles et al. (1976c) demonstrated the Revisz effect in 
nude mice transplanted with SVT2 cells or HeLa cells using embryo fibroblasts 
of murine or hUII!cin origin. He did not, however, study the phenomenon syste-
matically. If nu/nu mice are to be used to set a value on the tumorigenicity 
of human cells, the apparent lack of attention that has been paid to the 
phenomenon requires, in my opinion, rectifying. 
For these reasons I embarked upon a series of experiments in which I 
studied the effect of co-inoculating fibroblasts and other cells on the tumo-
rigenicity of human melanoma cells. In this chapter I report the results of 
I I 
these experiments which showed that the Revesz effect is, indeed, demonstrable 
with xenotransplanted cells and that it has a number of interesting features. 
MATERIALS AND METHODS 
Cell lines 
Three of the seven human melanoma cell lines (UCT-Mel 2, UCT-Mel 3 and 
UCT-Mel 6) described in the previous chapter were used for this study. Human 
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fibroblasts were obtained from cultures of adult skin,
 neonatal foreskin and 
skin of a female embryo; murine fibroblasts were prep
ared from a near-term 
embryo. These cells were prepared using conventional 
techniques (Freshney, 
1983). 
UCT-Br1 is a breast carcinoma. cell line that was esta
blished in this 
laboratory from a bone metastasis from a patient with 
primary carcinoma of the 
breast. UCT-Br1 was chosen for the fact that, like U
CT-Mel 6, we have not 
been able to induce it to form tumours in the nude mo
use. • 
Tumour cells and fibroblasts were cultured in vitro, 
removed from petri 
dishes and inoculated alone or in combination subcutan
eously in nude mice as 
described in detail in Chapter 1. Mice were then weig
hed and the tumour 
volume measured at weekly intervals. 
RESULTS 
Enhancement of melanoma. cell growth by co-inoculation
 of fibroblasts was 
clearly demonstrated in the case of UCT-Mel 2 and UCT-M
el 3 (Table 2.1). 
5 
Tumours did not result from inocula containing 10 
6 
cells from either of these 
5 
two lines whereas 10 cells consistently gave rise to 
tumours. When 10 
6 
cells were injected with 10 normal adult skin fibroblas
ts, tumours resulted 
in all animals injected. 
Despite large inocula of tumour cells, either alone o
r with fibroblasts, 
UCT-Mel 6 was steadfastly non-tumorigenic (Table 2.1). 
Diagrams depicting tumour volume as a function of tim
e for different 
inocula are shown in Figs. 2.1 to 2.5. In each case, Go
mpertzian curves have 
been fitted to the average data points for each exper~
mental set as indicated 
in the figure legends. These results warrant comment 
in the following res-
pee ts: 
5 





cells caused tumours in all cases. When 10 were inocula







TuIIX)rigenicity of human melanoma. cells in nude mice 
Effects of co-inoculated fibroblasts 
No. of cells Fibroblasts Tumours (2) 
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of mice) 
(1) Adult skin fibroblasts were mixed with the melanoma. cells or dil
uted in 
medium to give the stated inocula in 0.1ml volumes. 
(2) Mice were observed for a minimum period of 240 days before being
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Figure 2.1 
Tumour volume as~ function of time for different inocula 
5 6 -
Mice were inoculated subcutaneously with 10 or 10 UCT-Mel 2 melanoma 
6 
cells, either alone or mixed with 10 viable skin fibroblasts. The points on 
the graph were calculated using the Gompertz function and they represent the 
6 
mean values of 6 mice for each case. When 10 fibroblasts were injected 
alone, no tumours were observed after 240 days. 
5 6 
Note that, when 10 cells were co-inoculated with 10 skin fibroblasts 
all mice developed tumours that appeared with a shorter delay time than was 
6 
seen after 10 cells had been injected, but they grew at the same rate. 
5 5 
The 1 ines are as follows: - 10 UCT-Mel 2 cells (0---0); 10 UCT-Mel 2 
6 6 
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Mice were inoculated subcutaneously with 10 or 10 ucr-Mel 3 melanoma cells, 
6 
either alone or mixed with 10 viable skin fibroblasts. The points on the 
graph were calculated using the Gompertz function and they represent the mean 
6 
values of 5 mice in the case of 10 
5 
melanoma cells injected alone or 3 mice in 
6 
the case of 10 
6 
melanoma cells co-inoculated with 10 skin fibroblasts. When 
10 fibroblasts were injected alone no tumours were observed after 195 days. 
· 5 6 
Note that, when 10 melanoma cells were co-inoculated with 10 skin 
fibroblasts 3 out of 5 mice developed tumours that appeared with a shorter 
6 
delay time than was seen after 10 cells had been injected. However they grew 
at the same rate. 
5 
The lines are as follows:- 10 
6 
cells+ 10 skin fibroblasts C.----..); 
5 
ucr-Mel 3 cells (L:.· ··· ··6); 10 
6 
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Days after Inoculation 
Tumour volume as a function of time for different inocula 
5 
Mice were inoculated subcutaneously with 10 ucr-Mel 2 melanoma cells, 
3 4 5 
either alone or mixed with 10 , 10 or 10 viable skin fibroblasts. The 
points on the graph were calculated using the Gompertz function and they 
4 
represent the mean values of 2 mice in the case of 10 skin fibroblasts co-
5 
74 
injected with melanoma cells or 4 mice in the case of 10 skin fibroblasts co-
injected with melanoma cells. 
5 
Note that, 10 
3 
melanoma cells alone or mixed with 10 skin fibroblasts 
4 5 
did not form tumours, whereas the same tumour cell inoculum with 10 or 10 
skin fibroblasts produce tumours that grew at the same rate but with delay 
times inversely related to the number of complementing cells. 
5 
The lines are as follows:- 10 ucr-Mel 2 cells ~ ..... .. 17); 
3 5 4 
5 
10 ucr-Me1 2 
cells + 10 fibroblasts ('v- ·- ·-v); 
5 
10 ucr-Mel 2 cells+ 10 
5 
fibroblasts . 
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Figure 2.4 
The effect of murine fibroblasts on the growth of melanomas in nude mice. 
s 
Mice were inoculated subcutaneously with 10 UCT-Mel 2 melanoma cells, 
6 
either alone or mixed with 10 mouse embryo fibroblasts. The points on the 
graph were calculated using the Gompertz function and they represent the mean 
values of 4 mice. 
s 
Note that, 10 melanoma cells inoculated alone did not form tumours in 
6 
mice; however when co-inoculated with 10 mouse embryo fibroblasts 4 out of S 
mice grew tuioours with a long delay time after which they showed exponential 
growth. 
The lines are as follows:-
6 
s 
10 UCT-Mel 2 cells ('yt----v'); 
cells+ 10 mouse embryo fibroblasts(~). 
s 
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Figure 2.5 




Mice were inoculated subcutaneously with 10 melanoma cells, either alone 
6 
or mixed with 3xl0 UCT-Br 1 breast carcinoma cells. The points on the graph 
were calculated using the Gompertz function and they represent the mean values 
6 
of 5 mice. When 3xl0 · breast carcinoma cells were injected alone no tumours 
were observed after 360 days. 
5 6 
Note that, when 10 melanoma. cells were co-inoculated with 3xl0 ucr-Br 1 
breast carcinoma. cells all mice developed tumours. 
5 
The lines are as follows:- 10 UCT-Mel 2 cells (?·····'v); 
6 6 
5 
10 UCT-Mel 2 
cells + 3xl0 UCT-Brl cells (,__.); 3xl0 UCT-Brl cells. ?-----v 
blasts all of the mice developed tumours that appeared with a shorter delay 
6 . 
time than was seen after 10 cells had been injected but they subsequently 
grew at the same rate. (Fig. 2.1). Exactly the same results were obtained 
with ucr-Mel 3, although in this case the differences in delay time were less 
striking (Fig. 2.2). 
A dose-response effect was seen when different numbers of fibroblasts 
5 
were used as complementing cells (Fig. 2.3). 
3 
In this experiment 10 ucr-Mel 
2 cells alone or with 10 
4 
fibroblasts did not cause tumours. 
5 
The same tumour 
cell inoculum with 10 fibroblasts and with 10 fibroblasts produced tumours 
that grew at the same rate but with delay times that were inversely related to 
the number of complementing cells injected. Murine fibroblasts (Fig. 2.4) 
and breast carcinoma cells (Fig. 2.5) also functioned as complementing cells. 
Growth kinetics observed with the mouse fibroblasts were interesting in that a 
long delay time was observed before tumours appeared after which they grew 
more rapidly than ucr-Mel 2-derived tumours usually do. This experiment has 
not yet been repeated. 
Inoculation at separate sites. 
If, as seemed possible, the effects of the fibroblasts were mediated by 
some systemic mechanism involving the host, one might have expected that 
inoculation of the melanoma cells and complementing cells into different sites 
would produce enhancement of growth in much the same way when injected into 
the same site. This did not occur (Table 2.2); enhancement was only seen 
when the two cell types were inoculated as a mixture. 
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Sequential inoculation of potentially tumorigenic cells and complementing cells. 
Revesz, Littbrand and Modig (1967) were able to show enhancement of 
potentially tumorigenic cell growth even if complementing cells were injected 
into the same site as long as six weeks later and Wallace (1965) found that 
potentially tumorigenic cells from a C3HBA tumour implanted intramuscularly 
could be stimulated by complementing cells injected after 24 hrs. Hewitt, 
Table 2.2 
Inoculation of UCT-Mel 2 and adult skin fibroblasts as a mixture 
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6 ip 0/2 
r.flank 
• 
(a) SC ;a subcutaneous 
ip = intraperitoneally 




Blake and Porter (1973) recorded an experiment in which murine potentially 
tumorigenic cells and complementing cells were implanted, in either sequence, 
into the peritoneal cavity. When these two injections were given concomi-
tantly, tumours developed in 10/11 recipients. A high take rate was still 
seen if an interval of 3 hours separated the injections but the effect of the 
complementing cells was abolished if 23 hrs elapsed. When I gave sequential 
injections of melanoma cells and fibroblasts into the same site, I obtained 
the results shown in Table 2.3. Enhancement was only seen if a mixed inoculum 
was given. 
Different cell types 
In Table 2.4 I set out the effects seen when different cells were used as 
5 
complementing cells. In each case 10 UCT-Mel 2 cells were inoculated with 
6 
10 complementing cells and the number of tumour takes was recorded. The non-
tumorigenic breast carcinoma cell line, UCT-Brl was used to see if cells 
other than fibroblasts would function as complementing cells. The skin fibro-
blasts used hitherto had been obtained from an adult male patient or from 
5 
preputial tissue. Since (see Chapter 1) 10 UCT-Mel 2 cells were tumorigenic 
in male mice but not in females, it was necessary to see if female complemen-
ting cells would serve as well as male fibroblasts. For that reason fibro-
blasts isolated from a female foetal skin were used. One would have imagined 
that murine skin fibroblasts would have been abundantly present in subcuta-
neous tissue of the nude 100use and, had these been adequate to act as comple-
menting cells, there would have been no need for extraneous complementing 
cells. This raised the possibility that murine fibroblasts, by virtue of a 
species difference, were functionally inadequate as complementing cells. 
Fibroblasts were thus prepared from nu/nu embryo tissue and these were used. 
Finally, ethanol-fixed fibroblasts were used to see if metabolic via-
bility was a pre-requisite of effective complementing cell function. 
79 
Table 2.3 5 








and 10 fibroblasts. 
No. of takes/ 





(a) After the inocula of melanoma cells had been delivered, t
he needle was 
withdrawn completely and the fibroblasts were injected through
 a needle re-
inserted, as closely as could be judged, through the same trac




Efficacy of different cell types as complementing cells 
for 
5 









6 ucr-Br 1 
3xl0
6 ucr-Br 1 alone 
10
6 
female foetal fibroblasts 
10
6 
ethanol-fixed fibroblasts (1) 













(1) Ethanol fixed fibroblasts were prepared as follows:
 
Adult male. skin fibroblasts were detached from confluent
 monolayer cultures by 
gentle trypsinization and washed several times in RPMI m
edium. The cells were 
0 
then pelleted gently ( 400g; 5 min; 20 C) and resuspended
 in 1 ml of 70% 
O· 
ETOH. After 3 min of incubation at 37 C the cells were
 pelleted once 
more, washed 3 times with PBS and resuspended in RPMI at
 the appropriate 
concentration for inoculation. 
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All of the cell types tested, with the notable exception of the ethanol-
fixed cells, functioned as complementing cells. 
Titration of the fibroblast effect 
In a large experiment involving 98 mice, I performed an incomplete 
checkerboard titration of ucr-Mel 2 cells and fibroblasts to obtain the 
results summarized in Table 2.5. 
5 
The data show, once again, that 10 or less ucr-Mel 2 cells, when inocu-
6 
lated without fibroblasts, do not form tumours. Inocula of 10 tumour cells 
6 
consistently did give rise to tumours. When 10 fibroblasts are used as 
complementing cells however, as few as 10 ucr-Mel 2 cells caused tumours in 3 
out of 5 mice, and the enhancing effect of the fibroblasts is well seen in the 
4 
other combinations. Of most interest is the observation that 10 melanoma 
4 
cells, given with 10 fibroblasts gave rise to tumours in 4 out of 5 mice. 
Fibroblasts thus serve as more efficient complementing cells than do live 
tumour cells from the same line! 
DISCUSSION 
The data I present in this chapter demonstrate unequivocally that the 
successful transplantation of xenogeneic tumours irito nude mice can be marked-
ly enhanced by the addition of complementing cells to the inocula. The 
, , b . d Revesz phenomenon can thus e shown using human tumours in the nu e mouse. 
The characteristics of the Revesz phenomenon that I have observed are, in 
all essential respects, similar to those observed by others who have studied 
experimental tumours inoculated into mice or rats. The complementing cells 
reduced the delay time without affecting the growth rate, indicating that the 
effect was to increase the number of cells in the inoculum that initiated 
tumour growth. Fibroblasts killed by ethanol fixation no longer served as 
complementing cells, indicating a need for metabolic viability. 
Human fibroblasts isolated from adult skin, neonatal foreskin and female 
82 
Table 2.5 








Number of tumours/No. of mice inoculated 
UCT-Mel 2 cells in inoculum 
10
3 
0/5 0/5 0/5 0/5 
0/5 0/5 0/5 
0/5 4/5 2/3 
1/5 3/5 4/5 
5/5 5/5 4/5 5/5 
5/5 
(1) Ratios in each cell in the array show the number of mice that de
velopd 
tumours as a fraction of the number of mice inoculated with each indi
cated 
combination of fibroblasts and UCT-Mel 2 cells. 
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foetal skin all functioned as complementing cells as did murine fibroblasts 
and a non tumorigenic line of breast cancer cells. This capacity would t
hus 
seem to be possessed by diverse cell types and unrelated to any readily 
identifiable attribute. Generally speaking, the biological research communit
y 
tends to lose interest in phenomena that are non-specific or that cannot be 
associated with some readily identifiable and particular phenotypic characte-
ristic. One report (Peters and Hewitt, 1974) has noted that lymphocytes and 
bone marrow cells failed to function as complementing cells but no attempt 
appears to have been made to follow up this observation and the Revesz effect
 
has not, in my opinion, received the attention it deserves. I believe that 
this is because research into the effect has had the wrong emphasis and that 
, , 
appropriate quantitative techniques for measuring the Revesz effect have not 
been available. Given the supportive and immunologically propitious environ-
ment provided by the nude mouse host, it should, in theory, be possible to 
induce a tumour by the injection of a single malignant cell. In practice, 
however, this is usually not the case and one finds that the likelihood of a 
tumour developing is directly related to the number of cells injected. As a 
general rule, therefore, one may conclude that, for any particular set of 
experimental circumstances, a critical inoculum size range exists below which
 
tumours will not occur and above which they will. · 
Although human tumours growing in the athymic mouse do not provide an 
entirely valid model for their behaviour in the natural host, the requirement
 
for a critical inoculum size raised a number of questions of possible relevan
ce 
to human tumour biology. 
It is generally believed, for example, that human neoplasms are clonally 
derived from a single deviant mutant cell. What, then, are the factors that 
operate to sustain the proliferation of a tumorigenic cell under these sponta
-
neous, natural circumstances yet do not operate to secure the survival of a 




Are these "factors" generated locally by adjacent cells in the natural 
case and provided by complementing cells in the experimental situation? Is 
the success or failure of a metastatic "take" in any way related to the 
"complementing environment" in which a migrating cell is deposited? Is the 
Revesz phenomenon, in short, a useful experimental tOC>del for studying the 
cellular modulation of a micro-environment that one may reasonably presume 
contributes to tutOC>ur progression or distant metastasis? 
, , 
Use of the Revesz effect with human neoplasms in the nude tOC>use thus 
offers considerable potential for studying a number of processes of interest 
' 
to tumour biology. One may say with confidence, however, that this potential 
is unlikely to be realized until (a) it is generally appreciated that the 
interest lies in the complementing cell fraction itself and not entirely in 
the clonogenic potential of the tumour cell inoculum and (b) procedures are 
devised for quantitating complementing cell function. "Specificity" in bio-
logical systems has usually started out as a qualitative concept that becomes 
modified, by methodological progress, to become a quantitative one. Con-
sidered in this light our observation that adult skin fibroblasts and murine 
fibroblasts both function as complementing cells would indicate a lack of 
specificity. It is entirely possible however, that if the specific activity 
of these two cell types could be measured important differences would be 
discovered. 
The results I present in Table 2.5 and Fig. 2.3 clearly demonstrate the 
feasibility of establishing such an assay and give some indication of the 
interesting possibilities that quantitative methods might offer. 
It is evident, from the data in the table that, for each sub-tumorigenic 
dose of UCT-Mel 2 cells, a fibroblast dose-response effect could be discerned. 
5 
When 10 UCT-Mel 2 cells were inoculated for example, no tumours developed if 
3 
10 or less fibroblasts were co-inoculated. Larger co-inocula of complemen-
85 
ting cells resulted in an increasing proportion of takes until tumours formed 
6 4 5 
in 100% of animals with 10 fibroblasts. When 10 or 10 potentially tumori-
genie cells were injected, the TD50 for the complementing cells lay between 
3 4 2 
10 and 10 cells; when 10 potentially tumorigenic cells were injected the 
5 6 
complementing cell TD50 rose to between 10 and 10 cells. 
As it stands, the assay is probably not sensitive enough to detect subtle 
differences in complementing cell function. Useful statistical techniques 
are, however, available to improve the design and interpretation of bioassays 
of this sort (Finney, 1964), and it is my intention to exploit these in the 
near future. 
The system was certainly sensitive enough to demonstrate the superiority 
of fibroblasts over melanoma. cells as complementing cells. 
4 4 
A co-inoculum of only .10 fibroblasts complemented 10 UCT-Mel 2 cells to 
the extent that tumours developed in 4/5 animals receiving this combination. 
4 
In remarkable contrast, none of the animals developed tumours when 9xl0 
viable UCT-Mel 2 cells were "co-inoculated" with the same number of poten-
tially tumorigenic cells. One may conclude, therefore, that the fibroblasts 
were at least 9 times more effective tha.n melanoma. cells as complementing 
cells. 
I have, as yet, no definitive explanation for the surprisingly superior 
performance of the fibroblasts in this experiment. Two possible reasons come 
immediately to mind, however, and it is my intention to explore them in the 
near future. 
In the first place, it is well known that fibroblasts are able to synthe-
. 
size sotnatomedins (Atkison et al., 1980; Clemmons et al., 1981) and other 
growth factors (Puck and Marcus, 1955) and it may simply be that, quantita-
tively, they released more of these compounds than did melanoma cells. If 
the Revesz effect does, indeed, reflect a local "conditioning" of the tumour 
bed by complementing cells this would be an adequate explanation. Most growth 
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factors have molecular weights well below the limits for glomerular retention 
or slow diffusion, so that failure to demonstrate complementation by comple-
menting cells inoculated at a distant site may simply reflect loss of these 
factors by excretion, dilution or degradation before they reached the poten-
tially tumorigenic cell targets. 
As alternative explanation for the superior fibroblast effect is sugges-
ted by two observations. The first was reported by Peter and -Hewitt (1974) 
, , 
who showed that the Revesz effect could readily be demonstrated when a throm-
boplastic extract of brain tissue or fibrin clots were substituted for comple-
menting cells. 
, , 
They suggested, on the basis of these results, that the Revesz 
effect was mediated by the thromboplastic action of complementing cells which 
caused local generation of fibrin. This enmeshed the tumour cells in a 
protective retaining web at the site of inoculation and that prevented their 
loss from the area and kept them in a local concentration that was high enough 
to ensure that their critical requirements for cooperative proximity were met. 
The second observation was reported by Roal et al (1983) wlv> showed that 
fibroblasts possess avid surface receptor-mediated mechanisms for the uptake 
and degradation of tissue plasminogen activator. This is a potent fibrino-
lytic enzyme that is known to be produced by UCT-Mel 2 (Wilson et al., 1980). 
It may well be, therefore, that the fibroblasts functioned well as complemen-
ting cells by virtue of their ability to inhibit fibrinolysis and so retard 
emigration of the potentially tumorigenic cells from the inoculation site. 
Since UCT-Mel 2 cells release tissue plasminogen activators, a much higher 
dose of the cells would be required to secure a tumorigenic balance between 
loss, by migration, from the site and the local persistance of a sufficient 
fraction of the inoculum to form an established tumour. This idea is readily 
amenable to experimental verification. 
My observations of the Revesz effect merit comment in one further and 
final respect: the growth of UCT-Mel 6 could not be enhanced by fibroblasts, 
87 
nor could that of UCT-Br1 • It is likely, from these results
 and from reading 
the literature on the subject that the Revesz effect will on
ly prove to be 
demonstrable with host-cell combinations that do allow some m
easure of tumour 
growth without complementing cells. This emphasizes the obv
ious need that 
exists for well-defined experimental systems. This need stem
s from the fact 
' , , 
that the magnitude of the Revesz effect seen in any given ex
perimental situa-
tion represents the extent to which complementing cells mitig
ate the adverse 
circumstances un:ler which an inoculum of potentially tumorig
enic cells is 
implanted. The adversity may be a function of cell numbers 
(i.e. a small 
inoculum will not form a tumour), the environment (e.g. an ir
radiated tumour 
bed or a castrated host) or a combination of both (e.g. in th
e case of our 
s 
UCT-Mel 2 cells that will not form tumours in female mice if
 10 cells are 
injected whereas in males, inocula of this size are consiste
ntly tumorigenic). 
" " Any quantitative study of the Revesz effect, therefore, that requires 
measurement of a difference between implant behaviour with an
d without comple-
menting cells, should attempt to maximize this difference by
 optimizing the 
condition of adversity. Clearly these should not be so sev
ere (as in the 
case of UCT-Mel 6 or UCT-Br1 ) that clonogenic potential in 
the inoculum is 
effectively zero. Equally, this should not be so mild that 
complementing cell 
function is obscured by circumstances so propitious that com
plementing cells 
are not required. 
I am unable to offer any useful explanation for the fact tha
t UCT-Mel 6 
and ucr- Br 1 did not form tumours in the nude mice despite the fact that they 
clearly arose from malignant cells and they are capable of u
nrestrained perma-
nent growth in vitro. UCT-Br1 · cells were nevertheless able to fu
nction as 
complementing cells and the tumours that resulted when UCT-M
el 2 and UCT~Br1 
were co-inoculated had the histological appearances of UCT-M





THE EFFECT OF HORMONES ON THE GROWTH OF HUMAN MELANOMAS IN THE NUDE MOUSE~ 
Although a number of authors (Clayton, 1946; Pack and Scharnagel, 1951; 
Hadley, 1952; Byrd and McGanity, 1954; Stewart, 1955) had previously ob-
served a deterioration in the clinical status of patients with malignant 
melanoma during pregnancy, it was (to judge from the number of times it has 
been sited) un:loubtedly the paper published by Allen in ·1955 that most 
effectively emphasized the possible adverse effects of pregnancy on the 
natural history of this disease. 
He reported the remarkable case of a 38 year old woman who had a malig-
nant melanoma excised from her right forearm. Approximately a year later she 
became pregnant and, as her pregnancy advanced, so the tumour disseminated 
widely. When seen in the third trimester, multiple blood-borne and lymphatic 
metastases were observed. One of these was removed and the diagnosis of an 
amelanotic melanomatous deposit was confirmed histologically. When seen two 
months after the delivery of her child, most of the nodules had disappeared. 
This improvement was sustained and she remained apparently free of disease for 
the next twelve years at least. This striking deteriqration with pregnancy, 
and more significantly, complete remission following termination of the preg-
nancy, gave double proof of the association; it implied, quite clearly, that 
melanomas were subject to hormonal control in much the same way as were many 
other tumours; and it suggested an approach to the management of a tumour 
that was notoriously radio-resistant and unresponsive to other forms of 
therapy. 
Pregnant women were known to be subject to cloasma gravidarum and pigmen-
tary changes, and the findings in the serum and urine of pregnant women of 
substances that stimulate melanocytes supported the notion that humoral 
controls, possibly mediated by melanocyte stimulating hormone, might accele-
rate the course of the disease. 
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Further circumstantial support for the concept of endocrine control of 
the malignant melanoma phenotype came from observations that (i) prognosis in 
females is better than in males (White, 1959; Cochran, 1969; Nathanson et 
al., 1967b; Shaw et al., 1978; 1980); (ii) that the disease is rare before 
puberty (Sadoff et al., 1973); (iii) that approximately 50% of biopsy samples 
from melanoma. patents showed oestrogen receptor activity (Fisher et al., 
1976); (iv) that women who had used oral contraceptives had a higher inci-
dence of melanoma than those who had not (Ellerbroek 1968; Beral et al., 
1977; Lerner et al., 1979); and (v) that hormone therapy using drugs such as 
ta~xifen (Nesbit et al., 1979; Meyskens and Voakes 1980; Masiel et al., 
1981), ablative procedures (Bodenham and Hale, 1972) or the administration of 
hormones (Levi and Lewison, 1952; Johnson et al., 1966; Sadoff et al., 1973; 
Fisher et al., 1976; Lederman et al., 1985) might alter the course of the 
disease for better or for worse. 
Unfortunately, the effects of hormonal perturbation (e.g. pregnancy, 
menopause, contraceptive use or endocrine therapy) have been .clinically and 
epidemiologically inconsistent (Shiu et al., 1976; Adam et al., 1981; 
Danforth et al., 1982; Helmrich et al., 1984; Stevens et al., 1980; Gill 
Grantley et al., 1984; Karakousis et al., 1980; Shaw et al., 1978; Neifeld 
and Lippman, 1980; Rampen, 1980, 1982) and the endocrine-dependent status of 
malignant melanoma. is uncertain. 
Factors that control cellular proliferation, differentiation and spread 
are important - not only in the therapeutic or prognostic context, but equally 
so as objects of scientific enquiry and it is somewhat surprising that so 
little work appears to have been done to assess humoral responsiveness of 
melanoma. cells in the experimental systems that are available. 
Numerous melanoma. cell lines are available, for example, yet, as far as I 
am aware, only two reports have appeared in the literature to indicate that 
the in vitro effects of b>rmones on cultures of melanoma cells have been 
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studied. 
Neifeld and Lippman (1980), in a review article on steroid hormone recep-
tors and melanoma, state that, in their investigations of 21 melanoma cell 
lines, they were unable to detect estrogen binding activity. In 5 of the cell 
• 
lines that they tested for estrogen responsiveness, none showed an effect of 
3 14 
estrogenic or anti-estrogenic compourds on H-thymidine or C-leucine incor-
poration. No data were provided and this work has not subsequently appeared 
as a definitive report. 
Chaudhuri et al., (1979) correlated hormone-binding activity with hormone 
responsiveness in 4 of 6 melanoma cell lines, but these observations could not 
be confirmed by others. 
The lack of correlation between hormone-binding and in vitro response is 
not a matter of great concern since it has been clearly shown by Sirbasku 
(1979) that the biological effects of estrogen may be mediated, in viv~, by 
the indirect action of "estro-medins", or estrogen-induced "paracrine" growth 
factors that are derived from cells in the neighbourhood of the tumour cells 
rather than directly by effects upon the tumour cells themselves. Further-
more, the in vitro proliferation of most cells requires the presence of serum, 
and since sera contain variable concentrations of estrogens and other hor-
mones, it is difficult to achieve experimental conditions in which cellular 
behaviour in the presence of a single hormone can be reliably compared with 
that in the absence of the compound. 
In vitro studies are thus beset with problems in interpretation and 
experimental execution that have probably made them unattractive to research 
workers. 
The nude mouse system circumvents many of these problems. As I have 
indicated in Chapter 1, xenografts of human melanoma cells usually grow well 
in the athymic mouse to produce tumours that are remarkable for their 
similarity to the parent tumour from which they were derived. Sustaining 
9 1 
host-cell functions (and presumably these include estro-medin synthesis) are 
available to support tumour development in an environment that is more physio-
logical than that of the petri-dish; and it is likely that these functions 
would be susceptible to endocrine control. Finally, it is relatively easy to 
manipulate the endocrine status of the mouse by ablation or supplementation in 
ways that have potential clinical relevance. 
Exploitation of these useful features of the xenograft model to study 
hormone responsiveness of breast carcinoma and choriocarcinoma are exempli-
fied by the report of Brunner and Visfeldt (1982), Shafie and Grantham, ( 1981) 
and Kam.eya et al.,(1976) respectively. 
Few authors, however, seem to have availed themselves of the advantages 
that the nude mouse model has to offer for the study of hormone-dependence of 
human malignant melanoma. Beattie et al.,(1979) studied two cell lines, one 
of which bound estrogen and the other not. They found that estrogen receptor 
activity in the line correlated with an inhibitory effect of estrogen on the 
growth in the nude mouse in as much as the receptor positive line grew more 
slowly in females with the estrogen than the estrogen receptor negative line 
whereas these differences were not seen in males. Furthermore, alternate-day 
subcutaneous estradiol administration retarded growth of the estrogen receptor 
positive lines in males. Giovanella et al.1(1974) published an abstract in 
1974 in which they stated that a melanoma line derived from a male patient 
grew preferentially in female mice and Kozlowski et al~(1984) demonstrated an 
increase in the metastatic potential of two human melanoma cell lines as a 
result of estradiol administration. 
I felt that more could be done to resolve the question of human respon-
siveness of melanomas using the nude mouse system and in this chapter I record 
my experimental observations with the xenograft model. 
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MATERIALS AND METHODS 
Mice 
Athymic nude mice that were homozygous for the~ and the xid genes on 
the NIH Swiss backgrourn (Azar et al., 1980) were raised and maintained as 
described in detail in Chapter 1. 
When the experiment called for castrated animals, the ovaries and the 
testes were removed urner sterile conditions from 5-6 week old animals that 
were anaesthetized with ether and held in the supine position. 
Each ovary was delivered, attached to its mesosalpinx and fallopian tube, 
through a lower abdominal midline incision. The gonad was excised after 
ligation, with a purse string suture, of the ovarian vessels and attachments 
to the mesosalpinx and the associated structures were returned to the perito-
neal cavity. The skin incision, abdominal wall . and peritoneal cavity were 
then closed with clips. 
In the case of males, the testes were delivered through a ventral inci-
sion in the scrotal skin and removed by severing the sperma~ic cord and 
vessels distal to a purse-string ligature. The scrotal incision was then 
closed with a clip. 
Sham-operated animals were anaesthetized and had the skin incisions 
without castration. 
days. 
The skin clips were removed from all animals after 4-5 
Despite the immunodeficient status of the animals they withstood the 
procedures without complications and infection was not a problem. 
Experiments were started when the animals were 8-10 weeks old. 
Hormonal therapy 
Hormones were administered to the animals as pellets that were implanted 
subcutaneously and that gave sustained, slow release of the hormone over a 
prolonged period of time. The pellets were obtained from Innovative Research 
93 
of America, Gaithersburg, Maryland 20877, USA and came with the specifications 
summarized in Table 3.1. 
Table 3.1 
















(1) Determined by measurement of serum horllk>ne concentration as a function of 
time after implantation into castrated animals. 
The pellets, which came supplied as discs with a diameter of approxi-
mately 2 ·mm and a thickness of 1 mm were implanted under the midline skin of· 
the back in the scapular region or, in some cases, near the base of the tail. 
To do this, I made a small (approximately 2mm) nick in the skin of the anaes-
thetized animal with pointed scissors. Through this I introduced a trochar 
and cannula and advanced it, in the subcutaneous plane, until the tip was 
approximately 2.5 cm from the incision and at the point where I wished the 
pellet to reside. The trochar was then withdrawn and the pellet was deposited 
in the tissues at the end of the cannula, by inserting it into the cannula, 
replacing the trochar and gently advancing the trochar until it was fully 
home. The assembled trochar and cannula were then removed from the animal and 
inspected to ensure that the pellet had been delivered intact. The small skin 
incision was closed by apposition. It did not require clipping or suturing. 
Control animals received pellets that contained the compressed vehicle and all 
other ingredients save the active hormone. 
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The implantation of sustained-release pellets proved to be a remarkably 
effective, reproducible and convenient way of administering long-term hormonal 
treatment. 
Cells 
The melanoma cells used for the experiments and their preparation for 
inoculation have been described in detail in Chapter 1 and Appendix section 
(Al to A6). 
Experimental protocols 
For each experiment to be described in this Chapter I used a group of 
mice, all of whom had been born within the same two-week period. Each proce-
dure (e.g castration, implantation of pellets, inoculation of tumour cells or 
measurement of tumour size) was performed on all members of the experimental 
group on the same day. Within any experiment, therefore, circumstances were 
consistent in as much as they related to the batch of animals, pellets or 
inoculated cells that were used or to the environmental conditions that 
prevailed during the course of the experiment. 
I divided each experimental group into control and test sub-groups accor-
ding to a factorial protocol that enable~ me to test the effect of up to three 
variables in the same experiment, so economizing the use of valuable animals. 
This protocol is illustrated by the experiment in wich I wished to examine the 
effect of sex (i.e. male or female), castration and di.hydrotesterone (DHT) 
therapy alone or in all possible combinations. Since, in this case, there 
were three variables (sex, castration and DHT therapy) each with two alter-
natives (respectively male/female; sham operated/castrated; control 
3 
pellet/DHT pellet) this gave 2 = 8 combinations. I allocated 5 mice to each 
combination, thus the experiment comprised 40 animals. In other experiments 
(as described in the Results section) as few as 3 or as many as 6 mice were 
used in each combinatorial subgroup. 
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The factorial experimental protocol gives results that are ideally suited 
to statistical evaluation by the analysis of variance and it was for this 
reason that I designed most of my experiments in this way. As I point out in 
the Results section, however, parametric statistical techniques based on the 
analysi~ of variance did not accommodate cases where tumours failed to develop
 
and, in retrospect, a different experimental design may have been preferable. 
In most cases pellets were implanted when the animals were 8 - 10 weeks 
of age and melanoma cells were inoculated the following day. The animals were
 
marked and examined weekly for at least six months. When tumours developed, 
their volumes were recorded weekly. Gompertzian growth curves were fitted
, 
by repeated least-squares regression, to these data and from these doubling 
3 
times required to reach a volume of 200mm (Td 200) and latency times (i.e. 
3 
the time taken to reach a size of 100mm - T(del)lOO) were calculated. 
methods are described in detail in Chapter 1. 
Estrogen and progesterone receptor measurements 
These 
Estrogen and progesterone binding activity in the melanoma cells used 
in these experiments were assayed by the method of Zava et al. (1976) using 
3 3 




Hormonal control of the growth of melanoma xenografts 
All told, 10 experiments were done to determine whether or not the growth 
of human melanoma cell xenografts was in any way influenced by the endocrine 
status of the recipient mice. These experiments involved the inoculation of 
different numbers of melanoma. cells from different cell lines into a total of 
431 mice that had been prepared to receive the inocula by choice of sex (M/F), 
castration or sham operation (Cx/Sx) or the implantation of a pellet of 17B 
estradiol (E2), dihydrotestosterone (DHT), progesterone (PROG) taIIX)xifen 
(TAM),or a vehicle control. 
As described in the methods section, these preceding variables and their 
corresponding reference controls were assigned either singly or, where 
possible, in factorial combination. Most experiments comprised 8 to 12 sub-
groups, each of which usually contained S mice and observations were recorded 
weekly on each mouse for periods that varied from several weeks (in the cases 
where tuIIX)urs develo.ped and grew) to six months (in those cases where they did 
not). 
I have thus accumulated several thousand observations and the question 
arises as to how to present a concise and coherent summary of these results 
that will best convey their substance and import. 
My initial experiments led me to believe that growth curves constructed 
from in vivo measurement could be described with Gompertzian parameters with 
sufficient accuracy for me to use these parama.ters (or the delay times and 
doubling times derived from them) to measure the effects of hormonal manipula-
tions and for me to apply standard parametric statistical procedures to the 
estimation of the significance or differences that I observed. Unfortunately 
my expectations in this regard were not fulfilled. 
Deviations from precise Gompertzian kinetics were quite frequent and, 
when these occurred, it was often obvious, from inspection, that the fitted 
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curves did not portray the data accurately. Furthermore, it frequently 
happened that, in one or more mice in a group, tumours did not develop. In 
these cases delay times and the doubling times were infinite and the analysis 
of variance did not take kindly to infinite values. 
Procedures may well exist to handle results that combine rational and 
nominal values in the same data set, but the statistical advice to which I had 
access did not suggest a ready solution. I have, therefore, chosen to present 
the data in the form of individual growth curves without statistical analysis. 
For each experiment I have included a short table that summarises the experi-
mental design and tumorigenicity data and the average t(del)lOO and Td200 for 
tumours within a particular group where it was possible to compute these. In 
certain cases the effects of hormonal manipulation were most clearly seen when 
groups were compared at a particular time after inoculation. To illustrate 
these time selected data I have constructed bar graphs depicting averages for 
each group. These graphs emphasize differences on a linear scale that are not 
always apparent when tumour sizes are presented for visual comparison on a 
logarithmic scale in the growth curve plots. Only those data that are con-
vincing and that are pertinent to the conclusions that I wish to draw are 
presented here. A full account of the experimental results is presented in 
the Appendix Table A9-Al2. 
The effects of hormonal manipulation were most clearly documented in the 




Sex Males Females 
Operation Sx Cx Sx Cx 
Treatment 
Tumour No. 4/4 0/4 2/5 2/5 
T(del)lOO 97 66 48 
Td 200 8 7 4 
Male (8) and female (10) mice were each divided into two groups (Table 
3.2). Mice in one group had the gonads removed while the corresponding con-
s 
trol groups were subnitted to the sham-operation. UCT-Mel 2 cells (10) were 
inoculated into the 4 groups three weeks later and the animals were observed 
for tumour development. Tumours developed in all of the sham-operated male 
mice but in none of the castrated males (Fig. la). Only 2/5 female mice in 
the sham-operated group developed tumours; the oophorectomised animals showed 
the same incidence of tumours. Tumours formed in female mice did so earlier 
in castrated animals than in sham-operated females (Fig. lb). It is also 
evident from Figs. la and b that tumours developed in females approximately 
one month earlier than they did in males. Once established, however, the 
tumours grew at the same rate in males and females. Fig. le depicts the size 
of the tum:>urs in castrated and control male and female mice 100 and 66 days 
after inoculation respectively. The tumours which grew in the ovariectomized 
3 
females were far larger(+ 680mm) than the tum:>urs in the sham-operated 
3 -
female mice (:t_ 30mm) when measured 66 days after inoculation of tuioour cells. 
5 
It thus appeared, from this experiment, that an inoculum of 10 UCT-Mel 2 




FIGURES 1a and 1b 
Figure la 
Growth of human melanomas in castrated and sham-operated male nude mice. 
5 
Male mice were inoculated subcutaneously with 10 UCT-Mel 2 cells (124') 
on day O and the tumour volumes determined at weekly time intervals. The 
shaded area represents the range of tumour volumes of 4 control mice. The 
lines terminating in encircled numbers at the bottom of the figure indicate 
mice (4) in which tumours failed to develop. 
f ··· ········· ) castration (4) 
Note that, tumours failed to grow in castrated male mice. 
Figure lb 
Growth of human melanomas in ovariectomised and sham-operated female nude mice 
5 
Female mice were inoculated subcutaneously with 10 UCT-Mel 2 cells 
(124') on day O and the tumour volumes determined at weekly time intervals. 
The dashed lines in the figure were constructed by plotting tumour volume as a 
function of time for 2 individual ovariectomised mice. The shaded area repre-
sents the range of tumour volumes for 2 control mice. The lines terminating 
in encircled numbers at the bottom of the figure indicate animals in which 
tumours failed to develop. 
<-- ···············) castration (3) 
(~~~) control (3) 
Note that castration reduced the delay time of the tumour; however the 
tumorigenicity was similar in both cases. 
• 
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Figure le 
The effect of castration on the growth of UCT-Mel 2 tumours in nude mice 
5 
Male and female mice were castrated and 3-4 weeks later 10 UCT-Mel 2 
melanonoma. cells (124') were inoculated subcutaneously. Sham operated mice 
were similarly inoculated. Tumour volume was measured 66 days later in the 
case of female mice or 100 days later in the case of male mice. 
102 
Note that castration inhibited the growth of tumours in male mice whereas 





males and non-tumorigenic in castrated males and would thus provide a useful 
basis for developing a semi-quantitative assay of host environmental factors 
required for melanoma xenograft growth. 
103 
It should be noted that, at the time at which the experiments reported in 
5 
chapter 2 were performed, inocula of 10 ucr-Mel 2 cells were consistently 
non-tumorigenic. In these experiments they were now marginally so. I have no 
good reason to offer for this subtle variation in tumour incidence; the reason 
may lie with the cells or with the animals. 
I, therefore, performed the following experiments with this intention -





Operation Sx Cx 
Treatment Cnt Cnt DHT 
Tumour No. 2/5 0/5 2/5 
T(del )100 59 77 
Td 200 14 Not done 
Fifteen male mice were divided into three groups of five each (Table 
The first group was sham-operated; mice in the second group were 
castrated; and those in the third group were castrated and treated with DHT. 
Each mouse received an inoculum of 1.5 x 10 ucr-Mel 2 cells. 
5 
As observed previously none of the castrated males developed tumours. On 
this occasion, however, tumours developed in only 2/5 sham-operated males. 






















DHT Cnt DHT Cnt DHT 
3/5 1/4 2/5 1/5 5/5 
44 so 54 41 57 
Not 7 11 s 9 
done 
In this experiment, summarized in Table 3.4, I studied the effects of 
sex, castration and DHT supplementation in all combinations on the ability of 
5 
2xl0 UCT-Mel 2 cells to cause tulOClurs. Here oophorectomy plus DHT supplemen-
tation provided the most favourable (5/5) host environment for tumour develop-
ment. Surprisingly, in this experiment, sham-operated males showed a lower 
take rate (1/5) than did castrated males (3/5). 
DHT did not increase tulOClrigenicity in orchidectomised males. 
Experiment (iv) 
Table 3 .5 
Sex Males Females 
Operation Sx Cx Sx Cx 
Treatment Cnt E 2 DHT Cnt E 2 DHT Cnt E 2 DHT Cnt E 2 DHT 
Tumour No. 3/5 5/5 3/4 4/5 5/5 4/4 1/5 4/5 3/5 3/4 4/4 4/5 
T(del)lOO 68 28 43 32 27 31 37 30 38 39 26 36 
Td 200 7 5 10 5 6 13 6 5 6 7 10 7 
104 
5 For this experiment I inoculated 4xl0 UCT-Mel 2 cells into each of 56 
mice allocated to the twelve treatment groups identified in Table 3.5. 
The effects of estrogen implantation were striking. Tumours grew in 
only 1/S females (Fig. 2a) and 3/5 males (Fig. 2b) whereas 4/S females (Fig. 
2a) and 5/5 males (Fig. 2b) developed tumours after E2 implantation. 
An effect of E2 was also seen in castrated animals. Oophorectomised 
females supported tumour growth in 3/4 cases but in 4/4 cases after E2 implan-
tation (Fig. 2c). In males, E2 pellets increased the take rate from 4/5 to 
5/5. As can be seen from Fig. 2c and 2d and Table 3.5, the latent period for 
tumour development was shorter in E2-treated animals. Castrated females 
3 
required on average, 39 days for a tumour of 100mm to be reached whereas E2 
supplementation reduced this period to 26 days. Castrated males treated with 
estrogen required 27 days for a similar sized tumour to develop compared to 32 
days for castrated animals and 68 days for intact male mice. 
Fig. 2e .shows the size of tumours in the various groups of mice 36 days 
after inoculation of cells. The stimulatory effect of estrogen on tu11X>ur 
volume can be noted in all groups of mice. 
DHT treatment increased the tumour take rate in all groups. Tumour 




FIGURES 2a and 2b 
Figure 2a 
Growth of human melanomas in estradiol treated female nude mice 
s 
Female mice were inoculated subcutaneously with 4xl0 ucr-Mel 2 cells 
(124') on day O and the tumour volumes determined at weekly time intervals. 
The dashed lines in the figure were constructed by plotting tumour volumes as 
a function of time for 4 individual mice treated with estradiol. One of the 
mice treated with estradiol did not develop a tumour. The continuous line 
repi::;.esents tumour volumes for 1 out of S control mice. The lines terminating 
in encircled numbers at the bottom of the figure indicate mice in which 
tumours failed to develop. 
(--------) estradiol treated (1) (~~~) control (4) 
Note that estradiol enhanced the growth of the tumours in female mice. 
Figure 2b 
Growth of human melanomas in estradiol treated male nude mice 
s 
Male mice were inoculated subcutaneously with 4xl0 ucr-Mel 2 cells 
(124') on day O and the tumour volumes determined at weekly time intervals. 
The dashed lines in the figure were constructed by plotting tumour volume as a 
function of time for S individual"mice treated with estradiol. The shaded 
area represents the range of tumour volumes for 3 control mice. The line 
terminating in an encircled number at the bottom of the figure indicates 
control mice (2) in which tumours failed to develop. 
(~~~) control (2) 
Note that estradiol reduced markedly the delay time of the tumours and 
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FIGURE 2c and 2d 
Figure 2c 
Growth of human melanomas in ovariectomised and estradiol treated 
female nude mice 
5 
Female mice were inoculated subcutaneously with 4xl0 UCT-Mel 2 (124') 
cells on day O and the tumour volumes determined at weekly time intervals. 
The dashed lines in the figure were constructed by plotting tumour volume as a 
function of time for 4 individual ovariectomised mice treated with estradiol. 
The shaded area represents the range of tumour volumes for 3 ovariectomised 
control mice. The line terminating in an encircled number at the bottom of 
the figure indicates the control mouse (1) in which tumours failed to develop. 
(~~~) control (1) 
Note that estradiol, as shown previously, increased the growth of the tumours. 
Figure 2d 
Growth of human melanomas in castrated- and estradiol treated male nude mice 
5 
Male mice were inoculated subcutaneously with 4xl0 UCT-Mel 2 cells 
(124') on day O and the tumour volumes determined at weekly time intervals. 
The dashed lines in the figure were constructed by plotting estimated tumour 
volumes as a function of time for 5 castrated mice treated with estradiol. 
-The shaded area represents the range of tumour volumes for 4 castrated control 
mice. The line terminating in an encircled number at the bottom of the figure 
indicates the control mouse (1) in which tumours failed to develop. 
(~~~) control (1). 
Note that estradiol enhanced the growth of the tumours and reduced the delay 
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The effects of castration and hormonal therapy on the growth of ucr-Mel 2 
tumours in nude mice. 
Male and female mice were castrated and 3-4 weeks later dihydrotes-
tosterone (DHT) or estradiol (E2) pellets were implanted subcutaneously. 
5 
Twenty-four hours later 4xl0 ucr-Mel 2 cells (124') were inoculated into 
castrated and sham-operated and control animals. 
sured 36 days later. 
Note the following:-
Tumour volumes were mea-
(a) In all 4 groups of mice hormonal therapy had an effect on the growth of 
ucr-Mel 2. 
(b) Both DHT and estradiol stimulated growth of tumours in untreated male 
mice. 
(c) Castration alone resulted in increased tumour size in male and female 
mice. This was further enhanced in both sexes by estradiol implants. 
















Table 3 .6 
Sex Males Females 
Operation Sx Cx Sx Cx 
Treatment Cnt E 2 DHT Cnt E 2 DHT Cnt E 2 DHT Cnt E 2 DHT 
Tumour No. 5/5 5/5 5/5 3/5 5/5 4/5 5/5 5/5 5/5 5/5 5/5 5/5 
T(del)lOO 38 33 36 41 31 14 40 34 29 43 25 30 
Td 200 7 4 10 3 6 6 5 6 7 5 5 7 
This experiment (Table 3.6) was identical to Experiment (iv) save for the 
6 5 
inoculation of 10 UCT-Mel 3 cells in place of 4xl0 UCT-Mel 2 cells. 
In this experiment E2 had a slight effect on tull¥)ur growth in sham-
operated female or male animals (Figs. 3a and 3b) whereas it had a pronounced 
effect in castrated animals (Fig. 3c and 3d). Melanoma cells inoculated into 
oophorectomised females treated with E2 formed tull¥)urs with a shorter delay 
time (25 days) than did cells injected into untreated oophorectomised females 
(43 days). E2 had no effect on tull¥)rigenicity in this group as tull¥)urs grew 
in all inoculated animals (Fig. 3c, Table 3.6). 
E2 had a pronounced effect on melanoma growth when administered to orchi-
dectomised males and ovariectomised females (Fig. 3c and 3d). The take rate 
in orchidectomised males was increased from 3/5 to 5/5 by the hormone and the 
T(del)lOO was 31 days as opposed to 41 days in the absence of E2. As can be 
noted from Fig. 3d tull¥)urs also developed much earlier in the presence of this 
hormone. 
Fig. 3e illustrates the effect of estradiol and DHT on tµll¥)ur size 43 
days after cell inoculation. Note the stimulatory effect of estrogen on the 
tumour volume which is especially marked in castrated males and females. DHT 
112 
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FIGURES 3a and 3b 
Figure 3a 
Growth of human melanomas in estradiol treated female nude mice 
6 
Female mice were inoculated subcutaneously with 10 UCT-Mel 3 cells (69') 
on day O and the tumour volumes determined at weekly time intervals. The 
dashed lines in the figure were constructed by plotting tu1!¥)ur volumes as a 
function of time for 5 individual mice treated with estradiol. The shaded 
area represents the range of tumour volumes for 5 control mice. 
Note that estradiol treatment slightly increased the growth of the 
tumours and reduced the delay time; however the tumours in both groups 
developed at the same rate. 
Figure 3b 
·Growth of human melanomas in estradiol treated male nude mice. 
6 
Male mice were inoculated subcutaneously with 10 UCT-Mel 3 cells (69') 
on day O and the tumour volumes determined at weekly time intervals. The 
dashed lines in the figure were constructed by plotting estimated tumour 
volumes as a function of time for 5 individual mice treated with estradiol. 
The shaded area represents the range of tumour volume; for 5 control mice. 
Note that estradiol stimulated the growth of the tumours in 
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FIGURES 3c and 3d 
Figure 3c 
Growth of human melanomas in ovariectomised and estradiol treated female 
nude mice 
6 
Female mice were inoculated subcutaneously with 10 UCT-Mel 3 (69') cells 
on day O and the tumour volumes determined at weekly time intervals. The 
dashed lines in the figure were constructed by plotting tumour volumes as a 
function of time for S ovariectomised individual mice treated with estradiol. 
The shaded area represents the range of tumour volumes for S ovariectomised 
control mice. 
Note that in ovariectomised female mice estradiol treatment decreased the 
delay time of the tumours; however the tumours developed at the same rate. 
Figure 3d 
Growth of human melanomas in castrated and estradiol treated male nude mice 
6 
Male mice were inoculated subcutaneously with 10 UCT-Mel 3 cells (69') 
on day O and the tumour volumes determined at weekly time intervals. The 
dashed lines in the figure were constructed by plotting tumour volumes as a 
function of time for S castrated individual mice treated with estradiol. The 
shaded area represents the range of tumour volumes for 3 castrated control 
mice. The line terminating in an encircled number at the bottom of the figure 
indicates mice (2) in which turoours failed to develop. 
(~~-) control (2) 
Note that as shown previously estradiol decreased the delay time of the 
tumour. 
Figur e Jc 
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The effect of castration and hormonal therapy on the growth of UCT-Mel 3 
tumours in nude mice. 
Male and female mice were castrated and 3-4 weeks later dihydrotestos-
terone (DHT) or estradiol (E2) pellets were implanted subcutaneously. Twenty-
6 
four hours later lxlO UCT-Mel 3 (69') cells were inoculated into castrated 
and sham-operated animals. Tumour volumes were measured 43 days later. Note 
the following:-
(a) Castration alone did not result in any alteration in tumour size. 
(b) Estradiol resulted in a significant increase in tumour volume especially 
in the case of ovariectomised female mice. In this instance a 15-fold 
increase in tumour volume was noted. 





















FIGURES 3f and 3g 
Figure 3f 
Growth of human melanomas in ovariectomised and dihydrotestosterone treated 
female nude mice 
6 
Female mice were inoculated subcutaneously with 10 UCT-Mel 3 cells (69 ' ) 
on day O and tumour volumes determined at weekly time intervals. The dashed 
lines in the figure were constructed by plotting tumour volumes as a function 
of time for S individual ovariectomised mice treated with dihydrotestosterone 
(DHT). The shaded area represents the range of tu11X>ur volumes for S ovariec-
tomised control mice. 
Note that DHT treatment decreased the delay time of the tu11X>urs in 
ovariectomised females. 
Figure 3g 
Growth of human melanomas in dihydrotestosterone treated female nude mice 
6 
Female mice were inoculated subcutaneously with 10 UCT-Mel 2 (124') on 
day O and tu11X>ur volumes determined at weekly time intervals. The dashed 
lines in the figure were constructed by plotting tumour volumes as a function 
of time for S individual mice treated with dihydrotestosterone (DHT). The 
shaded area represents the range of tu11X>ur volumes for S control mice. 
Note that DHT treatment stimulated the growth of the tumours in female 
mice. 
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also had an effect, particularly in female mice where it accelerated the 
growth of UCT-Mel 3 in both ovariectomized and sham operated females (Figs. 
3e, f and g). DHT decreased the T(del)lOO from 43 days to 30 days in cas-
trated animals and from 40 days to 29 days in sham operated mice. In 
castrated male mice the T(del)lOO was decreased from 41 to 14 days by DHT. 
Experiment (vi) 
Table 3.7 
Sex Males Females 
Operation Sx Cx Sx Cx 
Treatment Cnt E 2 DHT Cnt E 2 DHT Cnt E 2 DHT Cnt E 2 DHT 
Tumour No. 4/4 5/5 5/5 5/5 5/5 5/5 5/5 5/ .5 4/5 6/6 5/5 5/5 
T(del)lOO 102 52 62 63 78 57 117 
Td 200 54 29 25 19 43 
6 
Mice in 12 groups (Table 3.7) were each inoculated with 10 UCT-Mel 7 
cells to study the effects of castration, DHT or E2 on tum:>ur cell growth. 
This cell line is unusual in as much as it forms tum:>urs that show 
initial rapid growth after which they reach a plateau in size (cf. Chapter 1, 
Fig. 1.13). This deviation from the usual Gompertzian kinetics has meant 
that, in most cases, it has been impossible to derive a Td(200) or a Tdel(lOO) 
3 3 
since the tum:>urs do not usually attain a size of 100mm or 200mm. If they 
3 
do get to be 200mm in size they are usually on the plateau of the growth 
3 
curve with the result that the Td at 200mm is infinite. 
Sex and/or castration had no effect upon the growth kinetics of UCT-Mel 7 
derived tulOC)urs (Figs. 4a, b, c and d). E2 supplementation, however, had a 
striking effect in that some of the tulOC)urs in the E2-treated mice grew more 
121 
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FIGURES 4a and 4b 
/ 
Figure 4a 
Growth of human melanomas in estradiol treated female nude mice 
6 
Female mice were inoculated subcutaneously with 10 UCT-Mel 7 cells (30') 
on day O and tumour volumes determined at weekly time intervals. The dashed 
lines in the figure were constructed by plotting tulIX)ur volumes as a function 
of time for 5 individual mice treated with estradiol. The shaded area repre-
sents the range of tumour volumes for 5 control mice. 
Note that estradiol did not affect the growth of the tumours in the first 
stage of growth, however after 40 days post inoculation the tumour growth 
increased in femal~-treated with estradiol. 
Figure 4b 
Growth of human melanomas in ovariectomised and estradiol treated 
female nude mice 
6 
Female mice were inoculated subcutaneously with 10 UCT-Mel 7 cells (30') 
on day O and tumour volumes determined- at weekly time intervals. The dashed 
lines in the figure were constructed by plotting tulIX)ur volumes as a function 
of time for 5 individual ovariectomised mice treated with estradiol. The 
shaded area represents the range of tumour volumes for 6 ovariectomised 
control mice. 
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FIGURES 4c and 4d 
Figure 4c 
Growth of human melanomas in estradiol treated male nude mice 
6 
Male mice were inoculated subcutaneously with 10 UCT-Mel 7 cells (30') 
on day O and the tumour volumes determined at weekly time intervals. The 
dashed lines in the figure were constructed by plotting tumour volumes as a 
function of time for 5 individual male mice treated with estradiol. The 
shaded area represents the range of tumour volumes for 4 control mice. 
Note that estradiol treatment did not alter the growth rate of the 
tumours in male mice. 
Figure 4d 
Growth of human melanomas in castrated and estradiol treated male nude mice 
6 
Male mice were inoculated subcutaneously with 10 UCT-Mel 7 cells (30') 
on day O and the tumour volumes determined at weekly time intervals. The 
dashed lines in the figure were constructed by plotting tumour volumes as a 
function of time for 5 individual castrated mice treated with estradiol. The 
shaded area represents the range of tumour volumes for 5 castrated control 
mice. 
Note that estradiol significantly stimulated the tumour growth in 
castrated males. 
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rapidly and had growth kinetics that resembled those of other tumours (Fig. 4b 
and 4d). DHT supplementation in normal males had a minimal effect on tumour 
growth (Fig. 4e) whereas in castrated males had a marked stimulatory effect 
(Fig. 4f). There was a slight effect of DHT on tumour growth in ovariecto-
mized female mice. These results can also be noted from Fig. 4g which shows 
the size of ucr-Mel 7 55 days after inoculation of cells. The striking stimu-
latory effect of E2 and DHT on tumour size in castrated males (see also Fig. 




Sex Males Females 
Operation Sx Cx Sx Cx 
Treatment Cnt E 2 DHT Cnt E 2 DHT Cnt E 2 DHT Cnt E 2 DHT 
Tumour No. 5/5 5/5 5/5 5/5 5/5 5/5 5/5 5/5 5/5 5/5 5/5 5/5 
T(del)lOO 25 24 28 24 21 28 25 21 23 26 20 29 
Td 200 5 4 5 5 5 6 7 4 6 6 5 7 
This experiment (Table 3.8) followed the standard protocol described in 
Experiment (iv) and was designed to study the effect of sex, castration, E2 
6 
and DHT on the growth of tumours following inoculation of 10 ucr-Mel 1 cells. 
The cells used in this experiment were a subline of ucr-Mel 1 which had 
been adapted to grow under serum-free conditions. 
The tumours that resulted grew rapidly in male mice (Fig. Sb)and E2 had 
little effect in this group. In females, however, there was a distinct ten-
dency for the tumours to appear and develop more slowly than in males. E2 
administration expedited the appearance of tumours in females so that growth 
126 
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FIGURES 4e and 4f 
Figure 4e 
Growth of human melanomas in dihydrotestosterone treated male nude mice 
6 
Male mice were inoculated subcutaneously with 10 UCT-Mel 7 cells (30') 
on day O and tumour volumes determined at weekly time intervals. The dashed 
lines in the figure were constructed by plotting tumour volumes as a function 
of time for 5 individual mice treated with dihydrotestosterone (DHT). The 
shaded area represents the range of tumour volumes for 4 control mice. 
Note that DHT treatment had no effect on the growth of tumours in male 
mice. 
Figure 4f 
Growth of human melanomas in castrated and dihydrotestosterone treated 
male nude mice. 
6 
Male mice were inoculated subcutaneously with 10 UCT-Mel 7 cells (30') 
on day O and tumour volumes determined- at weekly time intervals. The dashed 
lines in the figure were constructed by plotting tumour volumes as a function 
of time for 5 individual castrated mice treated with dihydrotestosterone 
(DHT). The shaded area represents the range of tumour volumes for 5 castrated 
control mice. 
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The effect of castration and hormonal therapy on the growth of UCT-Mel 7 
tumours in nude mice. 
Male and female mice were castrated and 3-4 weeks later dihydrotestos-
terone (DHT) or estradiol (E2) pellets were implanted subcutaneously. Twenty 
6 
four hours later lxlO UCT-Mel 7 cells (30') were inoculated into castrated 
and sham-operated animals. Tumour volume was measured 55 days later. Note 
the following:-
(a) Both DHT and estradiol stimulated growth of tumours in castrated male and 
female mice. 
(b) Estradiol markedly stimulated the growth of tumours in sham-operated 
female mice. 























FIGURES Sa and Sb 
Figure 5a 
Growth of human melanomas in estradiol treated female nude mice 
6 
Female mice were inoculated subcutaneously with 10 UCT-Mel 1 cells 
(serum-free line) on day O and tumour volumes determined at the indicated 
times. The dashed lines in the figure were constructed by plotting tumour 
volumes as a function of time for 5 individual mice treated with estradiol. 
The shaded area represents the range of tumour volumes for 5 control mice. 
Note that estradiol stimulated the tumour growth in female mice. 
Figure Sb 
Growth of human melanomas in estradiol treated male nude mice 
6 
Male mice were inoculated subcutaneously with 10 UCT-Mel 1 cells (serum-
free line) on day O and tumour volumes determined at weekly time intervals. 
The dashed lines in the figure were constructed by plotting tumour volumes as 
a function of time for 5 individual mice treated with estradiol. The shaded 
area represents the range of tumour volumes for 5 control mice. 
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kinetics in females resembled those in males (Fig. Sa). 
DHT inhibited tumour growth in castrated and sham-operated male mice 
(Figs. Sc and d) but had no effect on tumour development in female mice. 
These results are further summarized in Fig. Se which shows the tumour 
volume of UCT-Mel 1 cells 44 days after cell inoculation. By this time E2 
treated ovariectomized and sham-operated female mice had larger tumours than 
untreated controls. In contrast DHT inhibited tumour growth in castrated and 




Operation Sx Cx 
TAM DHT TAM DHT 
Treatment Cnt E 2 DHT E 2 E 2 Cnt E 2 DHT E 2 E 2 
Tumour No. 4/5 5/5 5/5 5/5 5/5 4/5 5/5 5/5 5/5 4/5 
T(del)lOO 32 34 35 27 32 38 32 35 26 41 
Td 200 6 5 7 6 6 6 6 7 6 16 
Since E2 appeared to have an effect upon the growth of tumours derived 
from UCT-Mel 3 cells (Experiment (v)) it was of interest to note the effect of 
the anti-estrogenic compound, tam::,xifen, on the development of tumours when 
this was given with E2 to sham-operated or castrated females. An experiment 
was accordingly performed in which ten groups of female mice were castrated or 
sham-operated and treated with DHT, E2, DHT + E2, or tam::,xifen + E2 as shown 
in the table 3.9. 
E2, as observed previously, stimulated tumour growth in castrated animals 
(Fig. 6a) and in this experiment had a minimal effect in control mice (Fig. 
6b). However in both these groups of animals, tam::,xifen and E2 given toget-
her had a pronounced stimulatory effect on tumour growth (Figs. 6c, d and e). 
133 
134 
FIGURES Sc and Sd 
Figure Sc 
Growth of human melanomas in castrated and dihydrotestosterone treated 
male nude mice 
6 
Male mice were inoculated subcutaneously with 10 UCT-Mel 1 (serum-free 
line) on day O and· tumour volumes determined at weekly time intervals. The 
dashed lines in the figure were constructed by plotting the tumour volumes as 
a function of time for 5 individual castrated mice treated with dihydrotes-
tosterone (DHT). The shaded area represents the range of tum:>ur volumes for 5 
castrated untreated mice. 
Note that DHT treatment slightly reduced the size of the tumours in 
castrated male mice. 
Figure Sd 
Growth of human melanomas in dihydrotesterone treated male nude mice 
6 
Male mice were inoculated subcutaneously with 10 UCT-Mel 1 (serum-free 
line) on day O and tumour volumes determined at weekly time intervals. The 
dashed lines in the figure were constructed by plotting the tumour volumes as 
a function of time for 5 individual mice treated with dihydrotestosterone 
(DHT). The shaded area represents the range of tum:>ur volumes for 5 control 
mice. 
Note that DHT treatment, as shown previously, decreased the size of the 
tumours in male mice. 
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The effect of castration and hormonal therapy on the growth of UCT-Mel 1 
tumours in nude mice. 
Male and female mice were castrated and 3-4 weeks later dihydrotestos-
terone (DHT) or estradiol (E2) pellets were implanted subcutaneously. Twenty-
6 
four hours later 10 UCT-Mel 1 cells (serum-free line) were inoculated into 
castrated and sham-operated animals. Tumour volume was measured 44 days 
later. 
Note the following:-
(a) Castration alone did not result in any alteration in tumour size. 
(b) DHT suppressed the growth of tumours in both intact and castrated male 
mice. 
(c) Estradiol treatment stimulated tumour growth in ovariectomised and 
sham~operated female mice. 
~ - castrated D - sham-operated 



















FIGURES 6a and 6b 
Figure 6a 
Growth of human melanomas in ovariectomised and estradiol treated 
female nude mice 
6 
Female mice were inoculated subcutaneously with 10 UCT-Mel 3 cells (69') 
on day O and tumour volumes determined at weekly time intervals. The dashed 
lines in the figure were constructed by plotting the tumour volumes as a 
function of time for S individual ovariectomised mice treated with estradiol. 
The shaded area represents the range of tumour volumes for 4 ovariectomised 
control mice. The line terminating in an encircled number at the bottom of 
the figure indicates the control mouse (1) in which tumours failed to develop. 
(~~~) control (1) 
Note that estradiol treatment stimulated the growth of tumours in 4 of S 
cases (see dashed lines). 
Figure 6b 
Growth of human melanomas in estradiol treated female nude mice 
6 
Female mice were inoculated subcutaneously with 10 UCT-Mel 3 cells (69') 
on day O and tumour volumes determined at weekly time intervals. The dashed 
lines in the figure were constructed by plotting the tumour volumes as a 
function of time for 4 individual mice treated with estradiol. The shaded 
area represents the range of tull¥)ur volumes for 4 control mice. The line 
terminating in an encircled number at the bottom of the figure indicates the 
control mouse (1) in which tumours failed to develop. 
(~~~) control (1) 
Note that estradiol treatment had no effect on the growth of tumours in 
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FIGURES 6c and 6d 
Figure 6c 
Growth of human melanomas in ovariectomised and hormonally treated 
female nude mice 
6 
Female mice were inoculated subcutaneously with 10 ucr-Mel 3 cells (69') 
on Day O and tumour volumes determined at weekly time intervals. The dashed 
lines in the figure were constructed by plotting the tumour volumes as a 
function of time for 5 ovariectomised individual mice treated with estradiol 
and ta100xifen (E2 + TAM). The shaded area represents the range of tumour 
volumes for 4 ovariectomised mice treated with estradiol. 
The line terminating in an encircled number at the bottom of the figure 
indicates the control ovariectomised mouse (1) in which tumour failed to 
develop. 
Note that TAM and E2 together decreased the delay time and stimulated 
tumour growth in ovariectomised female mice. 
(--) control (1) 
Figure 6d 
Growth of human melanomas in hormonally treated female nude mice 
6 
Female mice were inoculated subcutaneously with 10 ucr-Mel 3 cells (69') 
on day O and tumour volumes determined at weekly time intervals. The dashed 
l i nes in the figure were constructed by plotting the tumour volumes as a 
funct i on of time for 5 individual mice treated with estradiol and tall¥>xifen 
(E2 + TAM). The shaded area represents the range of tumour volumes for 4 
untreated control mice. The line terminating in an encircled number at the 
bottom of the figure indicates the control untreated mouse (1) in which 
tumours failed to develop. 
(~~-) estradiol (1) 
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The effect of ovariectomy and hormonal therapy on the growth of UCT-Mel 3 
tumours in female nude mice. 
Female mice were ovariectomised and 3-4 weeks later dihydrotestosterone 
(DHT), estradiol (E2), talll)xifen and E2 (TAM+ E2) or DHT and E2 (DHT + E2) 
6 
pellets were implanted subcutaneously. Twenty four hours later 10 UCT-Mel 3 
cells (69') were inoculated into ovariectomised and sham-operated animals. 
Tumour volume was determined 41 days later. 
Note the following:-
(a) Castration alone decreased tumour size in female mice. Growth was 
restored by E2 administration. 
(b) The stimulatory effect of estradiol was further enhanced by talll)xifen 
therapy in ovariectomised animals. 
(c) Talll)xifen + E2 stimulated tumour growth in sham operated animals. 
~ - castrated c=J-sham-operated 
500 









The latent period in castrated animals treated with E2 and ta!Ik)xifen was also 
reduced to 26 days from 38 days (Table 3.9). DHT alone or in combination with 
E2 had no significant effect on tu!Ik)ur growth. 
Experiment (ix) 
Table 3 .10 
Sex Males Females 
TAM PRO 
Treatment Cnt E 2 Cnt E 2 E 2 TAM PRO E 2 
Tumour No. 3/5 5/5 4/5 5/5 5/5 5/5 5/5 5/5 
T(del )100 20 21 19 20 16 20 20 20 
Td 200 10 5 6 5 4 5 6 6 
This experiment (Table 3.10) was designed to study the effects of E2, 
tallk)xifen and progesterone (PRO), either alone or in combination, on the 
6 
growth of tu!Ik)urs from inocula of 10 UCI-Mel 1 cells. The results showed 
that as found previously E2 stimulated the growth of tumours (Figs. 7a and 
7b). As noted with UCI-Mel 3 tu!Ik)ur growth (Fig. 6c and 6d) ta!Ik)xifen and E2 
given together resulted in a still further increase in tumour size (Figs. 7c 
and 7d). Ta!Ik)xifen and progesterone alone and progesterone together with E2 
had no effect on tu!Ik)ur growth (Fig. 7d). 
144 
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FIGURES 7a and 7b 
Figure 7a 
Growth of human melanomas in estradiol treated male nude mice 
6 
Male mice were inoculated subcutaneously with 10 UCT-Mel 1 (serum-free 
line) on day O and the tumour volumes determined at weekly time intervals. 
The dashed lines in the figure were constructed by plotting tumour volumes as 
a function of time for 5 individual mice treated with estradiol. The shaded 
area represents the range of tumour volumes for 3 control mice. The line 
terminating in an encircled number at the bottom of the figure indicates 
control mice (2) in which tumours failed to develop. 
(~~~) control (2) 
Note that estradiol therapy increased tumorigenicity in male mice. 
Figure 7b 
Growth of human melanomas in estradiol treated female nude mice 
6 
Female mice were inoculated subcutaneously with 10 UCT-Mel 1 cells 
(serum-free line) on day O and tumour volumes determined at weekly time inter-
vals. The dashed lines in the figure were constructed by plotting tumour 
volumes as a function of time for 5 individual mice treated with estradiol. 
The shaded area represents the range of tumour volumes of 4 control mice. The 
line terminating in an encircled number at the bottom of the figure indicates 
a control mouse (1) in which tumours failed to develop. 
(~~~) control (1) 
Note that estradiol therapy had no effect on the growth of tumours in 
female mice; however tumorigenicity was slightly increased in estradiol 
treated mice. 
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Figure 7c 
Growth of human melanomas in hormonally treated female nude mice 
6 
Female mice were inoculated subcutaneously with 10 UCT-Mel 1 cells 
147 
(serum-free line) on day O and tumour volumes determined at weekly time inter-
vals. The dashed lines in the figure were constructed by plotting tumour 
volumes as a function of time for 5 individual female mice treated with 
estradiol and tamoxifen (E2 + TAM).. The shaded area represents the range of 
tumour volumes for 5 estradiol treated mice. 
























The effect of hormonal therapy on the growth of UCT-Mel 1 tumours in nude mice 
Male mice were implanted subcutaneously with estradiol (E2) pellets, 
whereas female mice were implanted subcunteously with estradiol (E2), taiooxi-
fen (TAM), progesterone (PROG), TAM and E2 or PROG and E2 pellets. Twenty-
6 
four hours later 10 UCT-Mel 1 cells (serum-free line) were inoculated into 
these mice. Tumour volume was measured 28 days later. Note the following:-
(a) Estradiol stimulated the growth of tumours in male mice. 
(b) Estradiol slightly increased the size of tumours in female mice. 
(c) Taiooxifen and E2 together, stimulated tuioour growth in female mice. 
148 
Experiment (x) 
Table 3 .11 
Sex Females 
Operation Sx Cx 
E 2 E 2 
Treatment Cnt E 2 TAM TAM Cnt E 2 TAM TAM 
Tumour No. 5/5 ·sf s 5/5 5/5 5/5 5/ 5 5/5 5/5 
T(del )100 36 31 22 26 32 27 26 29 
Td 200 10 10 s 6 10 7 6 9 
Female mice were assigned to S treatment groups, 4 of which were sham-
operated animals and the other oophorectomised animals (Table 3.11). Animals 
in each group then received no hormone therapy or they were treated with E2 or 
tarooxifen, alone or in combination. UCT-Mel 2 cells were injected at a dose . 
6 
of 10 cells. 
These results are presented in Figs. Sa, b, c, d and e. In sham-operated 
animals E2 alone had no effect on tumour size (Fig. Sa) whereas ta100xifen 
increased tumour size (Fig. Sb). As can be noted from Figs. Sc,d and fin 
castrated animals E2 and ta100xifen were both slightly stimulatory for tumour 
growth. E2 and ta1l¥>xifen in combination resulted in a further increase in 
tumour size (Figs. Se and Sf). In sham-operated animals the T(del)lOO was 
reduced to 22 days from 36 days and in castrated animals to 26 from 32 days 
(Table 3.11). Fig. Sf depicts tumour size 41 days after inocuation of 
cells and the stimulatory effect of tarooxifen and E2 can readily be noted. 
149 
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FIGURES 8a and 8b 
Figure 8a 
Growth of human melanomas in estradiol treated female nude mice 
6 
Female mice were inoculated subcutaneously with 10 UCT-Mel 2 cells 
(124') on day O and tumour volumes determined at weekly time intervals. The 
dashed lines in the figure were constructed by plotting the tumour volumes as 
a function of time for S individual mice treated with estradiol. The shaded 
area represents the range of tumour volumes for 5 untreated control mice. 
Note that estradiol therapy had no effect on the growth of tumours in 
female mice inoculated with UCT-Mel 2 cells. 
Figure 8b 
Growth of human melanomas in tamoxifen treated female nude mice 
6 
Female mice were inoculated subcutaneously with 10 UCT-Mel 2 cells 
(124') on day O and tumour volumes determined at weekly time intervals. The 
dashed lines in the figure were constructed by plotting the tumour volumes as 
a function of · time for S individual mice treated with tamoxifen. The shaded 
area represents the range of tumour volumes for S untreated control mice. 
Note that tamoxifen increased slightly the tumour growth in female mice. 
Figure Sa 
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FIGURES 8c and 8d 
Figure Sc 
Growth of human melanomas in ovariectomised and estradiol treated 
female nude mice 
6 
Female mice were inoculated subcutaneously with 10 UCT-Mel 2 cells 
(124') on day O and tumour volumes determined at weekly time intervals. The 
dashed lines in the figure were constructed by plotting the tumour volumes as 
a functioq of time for 5 individual ovariectomised female mice treated with 
estradiol. The shaded area represents the range of tumour volumes for 5 
ovariectomised untreated mice. 
Note that estradiol treatment had a slightly stimulatory effect on the 
growth of the tumours in ovariectomised female mice. 
Figure Sd 
Growth of human melanomas in ovariectomised and tamoxifen treated 
female nude mice 
6 
Female mice were inoculated subcutaneously with 10 UCT-Mel 2 cells 
(124') on day O and tumour volumes determined at weekly time intervals. The 
dashed lines in the figure were constructed by plotting the tumour volumes as 
a function of time for 5 individual ovariectomised female mice treated with 
tamoxifen. The shaded area represents the range of tumour volumes for 5 
ovariectomised control mice. 
Note that tamoxifen increased slightly the growth of the tumours in 
ovariectomised female mice. This was also found in the case of sham-operated 
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Figure 8e 
Growth of human melanomas in ovariectomised and hormonally treated 
female nude mice 
6 
Female mice were inoculated subcutaneously with 10 ucr-Mel 2 cells 
( 124') on day O and tumour volumes determined at weekly time intervals. The 
dashed lines in the figure were constructed by plotting the tumour volumes as 
a function of time for 5 individual ovariectomised female mice treated with 
es tradiol and tamoxifen (E2 + TAM). The shaded a,rea represents the range of 
tumour volumes for 5 ovariectomised control mice. 
Note that estradiol and tamoxifen therapy stimulated the growth of 























The effect of ovariectomy and hormonal therapy on the growth of UCT-Mel 2 
tumours in female nude mice 
155 
Female mice were castrated and 3-4 weeks later estradiol (E2), tarooxifen 
(TAM) or TAM and E2 (TAM+ E2) pellets were implanted subcutaneously. Twenty-
6 
four hours later 10 UCT-Mel 2 cells (124') were inoculated into ovariecto-
m.ised and sham-operated animals. Tumour volume was measured 41 days later. 
Note the following:-
(a) Ovariectomy alone reduced the tumour size in female mice. 
(b) Tarooxifen and E2 enhanced profoun:ily the growth of tumours in ovariec-
tomised and sham-operated females. 
~ - castrated; D -.sham-ope rated 
Tumour dormancy and endocrine control. 
The fact that the tumorigenicity of certain of the cell lines could be 
influenced by hormonal manipulation suggested a means of studying tumour 
dormancy in as much as this can be equated with the survival of tumour cells 
that do not proliferate to form a tumour yet retain the potential to do so 
when triggered by the appropriate stimulus. 
Two combinations of cell lines and animal recipients were chosen to 
perform these experiments. 
5 
In the first, l.5xl0 UCT-Mel 2 cells were inoculated into 20 castrated 
male mice on day O. The mice were divided into four groups, as shown in Fig. 
9a. Group 1 received no replacement therapy and, as expected no tumours 
developed over the following year. Mice in the second group received DHT 
pellets on day -1 and again on day 21 (i.e. after an effective pellet dose-
time had expired) and in this group tumours developed in 4/5 animals. The 
third group received DHT pellets on day 6 and day 27; 2/5 mice in this group 
developed tumours. The fourth group received a pellet on day 27 and 1/5 mice 
in this group developed a tumour. 
In the second experiment ovariectomised female mice were inoculated with 
5 
2xl0 UCT-Mel 3 cells on day O and E2 supplementation was given to the diffe-
rent groups on day -1, day 6, day 21, day 27 and day 34 (Fig. 9b ) . Here, once 
again as expected, mice that received no E2 treatment did not develop tumours 
during the course of the ensuing 7 months. Tumours were observed in all of 
the groups that received E2 pellets - even when these were administered as 
late as 34 days after the inoculation of tumour cells into an hormonally 
unfavourable environment. 
The time that I waited for tumours to develop before scoring the mice as 
negative was certainly adequate since when I reviewed the total experience I 
had had with inoculation of human melanoma cells into nude mice (i.e 1065 
156 
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CELL LINE - UCT-Mel 2 
5 cells No. of tumours/ Latency Group 1 . !5x 10 
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Figure 9a 
Effect of DHT on the growth of UCT-Mel 2 in castrated nude mice 
5 
Male mice were castrated and 3-4 weeks later l.5xl0 UCT-Mel 2 cells 
(in vitro passage number 124') were inoculated subcutaneously into these 
animals on day O. The mice were divided into four groups:-
Group 1 received no DHT pellets; 
35,37 
44 
Group 2 received DHT pellets on day--1 and day 21 (the pellets were 
effective for a period of 21 days); 
Group 3 received DHT pellets on day 6 and 27 
Group 4 received DHT pellets on day 27. 
Note that castration alone inhibited the tumour growth in male mice; DHT 
therapy restored the tumour growth in 4 out of 5 mice in group 2, in 2/5 mice 
in group 3 and in 1 out of 5 mice in group 4. 
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Figure 9b 
Effect of estradiol on the growth of ucr-Mel 3 in ovariectomised 
nude mice 
5 
Female mice were ovariectomised and 3-4 weeks later 2xl0 UC!-Mel 3 cells 
(in vitro passage number 69') were inoculated subcutaneously into these 
animals on day o. Mice were divided into four groups:-
Group 1 received no E2 pellets; 
Group 2 received E2 pellets on day -1 and day 21 (the pellets were 
effective for a period of 21 days); 
Group 3 received E2 pellets on day 6 and 27; 
Group 4 received E2 pellets on day 34. 
Note that mice that received no E2 treatment did not develop tumours 
during the course of the ensuing 7 months. Tumour growth was observed in the 
groups of mice that received E2 therapy even when this was administered as 
late as 34 days after the tumour cells were inoculated. 
animals) 81% of them developed tumours. A plot of cumulative tu11¥)ur 
appearance as a function of time after inoculation of the cells showed that 
95% of the animals that were going to develop tu11¥)urs did so in 6 weeks of 
inoculation and all of them within 85 days of inoculation (Fig. 10). 
DISCUSSION 
The results that I report in this chapter support the view that the 
growth of human melanoma cell xenografts in the nude 11¥)use is an endocrino-
logically controlled phenomenon. The following experiments attest to this 
fact:-
5 
(i) Inocula of 10 ucr-Mel 2 cells were tu11¥)rigenic in male mice; 
marginally tu11¥)rigenic in female mice and non-tumorigenic in castrated males 
(Experiment (i)). When females were oophorectomised the take rate was not 
affected, suggesting that the effects of orchidectomy in males are not secon-
dary to the hypothalamic consequences of castration but rather to androgenic 
deprivation. 
The preference shown by limiting numbers of ucr-Mel 2 cells for an andro-
genic environment were not consistently observed. In Experiment (iii) and 
Experiment (iv), for example, larger inocula did not cause tu11¥)urs in 100% of 
sham-operated male mice and equivalent inocula (Experiment (iv)) formed 
tumours in castrated males. I have no good explanation for this variable 
behaviour. The experiments were done at different times so it might well be 
that environmental factors such as feed, time of year, light-dark cycling, 
temperature or any of the many other variables that are known to affect the 
performance of laboratory animals iri complex experiments (Murthy and 
Russfield, 1970; Hoffman, 1973; Kledzik and Meites, 1974) may have caused 
the variability. Alternatively, subtle technical factors such as the density 
of cells prior to harvesting or the preparation of cells for inoculation or 
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Appearance of tumours as a function of time after tumour cell inoculation 
One thousand and sixty five mice were inoculated subcutaneously with 
varying numbers of tmoour cells from UCT-Mel 1, 2, 3, 4, 5 and 7 cell lines. 
Eight hundred and sixty four mice developed tu100urs. The graph represents 
overall tu100ur development in the mice as a function of time. 
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Note that 95% of mice that were going to develop tumours did so 
within 42 days of inoculation and all of them within 85 days of inoculation of 
tumour cells. 
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also have been due to the fact that the strain of mice used was not inbred and 
genetic variation would therefore be expected am:>ng littermates. 
Whatever the cause for the variability may have been, it is important to 
recognize its occurrence to stress the need for experimental systems involving 
nude mice that are stable and reproducible over a prolonged period of time. 
(ii) Experiments showing an effect of E2 on melanoma cell growth were 
more conclusive. Tumour growth following inoculation of UCT-Mel 1, 2, 3 and 7 
was stimulated by E2. E2, in fact, stimulated growth in all 4 of the melanoma 
cell lines investigated. In experiment (vii) (Fig. Sa) E2 stimulated the 
growth of UCT-mel 1 in females and not in males and in experiment (v) (Figs. 
3a,b,c,and d) E2 stimulated the growth of UCT-Mel 3 tumours in both normal and 
castrated male and female mice. The effects of this hormone were however, far 
more pronounced in castrated animals (Figs. 3c, d and e). The effects of E2 
on t he growth rate of UCT-Mel 7 were also more pronounced following castration 
in male mice (Figs. 4d and g). Thus the endocrinological status of the host 
animal was an important factor in determining the manner in which it responded 
to hormonal manipulation. 
It is of interest to note that one of the experiments in which the E2 
effect was most remarkable was that in which E2 implantation, even as late as 
34 days post-inoculation of tumour cells, rescued a non-tumorigenic inoculum 
s 
of 2xl0 UCT-Mel 3 cells in female mice (Fig. 9). 
(iii) DHT was of interest as it had both positive and negative effects 
on tumour growth. 
Both experiments (iii) and (iv) show that DHT prom:>tes tumour growth by 
UCT-Mel 2 cells though not as much as E2. Experiment (iii) shows that DHT was 
especially effective in prom:>ting tumour development in castrated female mice. 
DHT also stimulated tumour growth by UCT-Mel 3 cells especially in female mice 
- both control and castrated (Experiment (v) - Figs.3e, f and g). Experiment 
(vi) shows that tumour growth of UCT-Mel 7 was markedly increased by this 
androgen in castrated male mice (Fig. 4f and g). However, in the case of UCT-
Mel 1 cells, DHT exerted an inhibitory influence on tumour growth. Experiment 
(viii) and Figs. Sc, d and e show that in both normal and castrated ma.le mice 
the androgen diminished the turoour growth rate. 
The effects of androgens and estrogens on melanoma. growth in vivo is 
therefore complex and is probably dependent on a number of factors of which 
the endocrinological status of the host is one of the more important. The 
particular cell line investigated is obviously also important because my data 
show that variation in sensitivity to both androgens and estrogens occurs 
aroong the different melanoma. cell lines used. 
Another important lesson has emerged from my studies. If one wishes to 
show an effect of a modulating compound on tumour growth in the nude mouse, 
one has the best chance of doing so if the tumour cell dose is first titrated 
accurately to determine the tumorigenic threshold. It is clearly in the 
neighbourhood of this threshold that the system would be most sensitive to the 
effects of b:>rmones or other regulatory compounds. The likelihood of 
observing a stimulatory effect would be greatest when using an inoculum size 
that was just sub-tumorigenic. Conversely, the chances of showing an 
inhibitory effect would be optimised if an inoculum size was used that was 
reproducibly but just sufficient to cause tu1IX>rs in all animals tested. 
This leads me to the next point concerning the development of a reliable 
assay system for studying growth modulation of xenografted human tu11¥)urs in 
the nude mouse: of all of the measurements that can be made to quantitate the 
effects of regulatory compounds, tumorigenesis is the most robust, the delay 
time less so and the doubling time or growth rate least of all. It is appa-
rent, in fact, from simple observation of the graphs that I present, that when 
E2 had an effect this was not only upon the growth rate of the tu11¥)ur. It was 
also upon tumorigenicity (Figs. 2a;2b;3d;7a and Tables 3.5; 3.6; 3.10) or upon 
the delay time (Figs. 2b; 2c;2d;3c;3d;Sa and Tables 3.5; 3.6; 3.8). 
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I would thus suggest that compounds are assayed for their regulatory 
activity by scoring for tumorigenicity of marginally tumorigenic or sub-
tumorigenic inocula. It may also be possible, with well-devised protocols, to 
score for metastasis - another nominal quantity. I would not recommend that 
Gompertzian parameters be relied upon for the purpose of quantitating tumour 
growth in this experimental context. 
I am not able to provide a definitive mechanism for the mode of action of 
E2 in the experiments in which I showed an effect. I am, however, able to 
offer the following comments and speculations. 
Firstly, E2 implantation enhanced the tumour take rate and thus, presuma-
bly, the propitiousness of the host environment for xenograft acceptance, 
survival and proliferation. This result is not consistent with the oft-
repeated observation (White, 1959; Nathanson et al., 1967a; Cochran, 1969; 
Shaw et al., 1978; 1980) that the prognosis of human malignant melanoma is 
better in females than in males or with the observation that, in one very 
clear cut experiment at least, (Experiment (i)) a marginally tumorigenic dose 
of UCT-Mel 2 cells produced tumours in 5/5 male mice but in 2/5 female mice. 
It is noteworthy that the anti-est~ogen, ta11X>xifen, not only failed to 
inhibit the stimulatory effects of E2 but, on 3 occasions, appeared to syner-
gise with E2 in promoting growth (Experiments (viii), (ix) and (x); Figs. 
6c,6d; 7c,7d; 8e,8f). 
A similar paradoxical effect of ta11X>xifen on the growth of a human 
estrogen-responsive endometrial carcinoma. in the nude mouse was observed by 
Satyaswaroop et al.,(1984) and it is well known that ta11X>xifen may be fully 
estrogenic in the mouse with respect to certain tissues (Harper and Walpole, 
1967; Jordan et al., 1978; Terenius, 1971) whereas it, is usually anti-
estrogenic in humans. Furthermore, Gallez et al.,(1973) showed that another 
human anti-estrogen (nafoxidine) prevented the regression of rat mammary 
tumours after ovariectomy. Had E2 acted directly on the human melanoma. cells 
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I would then thus have expected tamoxifen to have inhibited tumour growth. 
The fact that it did the opposite suggests that both its effect and the 
effects of E2 were indirect and mediated by an action on murine tissues. 
My experience thus suggests that the actions of E2 were complex and did 
not simply involve the stimulation of melanoma. cell proliferation by the 
conventional sequence of biological events in which E2 bound to a specific 
receptor protein for transfer into the nucleus where a stimulatory interaction 
between genome and receptor-hormone complex occurred (McGuire et al., 1975). 
My failure to detect estrogen receptor activity in any of the melanoma. cell 
lines that I studied is in accordance with this suggestion and with the 
observations of Fisher et al., 1978. 
The above observations are consistent with the view that estrogens did 
not act directly upon the melanoma. cells but rather that their effects were 
indirect in the sense:-
(i) that they were mediated by an action on the pituitary or hypothalamus 
which leads to the induction of growth factor release or the suppression of 
inhibitory factor release. 
(ii) that they involved the release of "paracrine" estromedins from 
neighbouring cells that stimulated tumour cell proliferation (Sirbasku and 
Benson, 1979) or 
(iii) that their action was entirely upon supporting systems for tumour deve-
lopment such as angiogenesis (Folkman, _1974), basement membrane synthesis 
(Kramer et al., 1980),fibronectin synthesis (Kramer et al., 1980) etc. 
Fortunately these alternatives are all amenable to experimental enquiry and it 
is my intention to pursue these studies with the benefit of the experience I 





THE METASTATIC SPREAD OF HUMAN MELANOMAS IN THE NUDE MOUSE. 
Of all the clinical features that characterize malignant neoplasms, it is 
their capacity for local invasion and widespread dissemination that distin-
guish them most cogently from normal cells or from their benign counterparts. 
Most deaths from this group of diseases and much of the disability that they 
cause are attributable to metastatic spread and there is no doubt that hope-
lessness, in the individual case, is directly related to dissemination. 
It is scarcely surprising, therefore, that so much research effort has 
been devoted to the study of metastasis and that such a voluminous literature 
has grown around this particular complication of malignant disease. 
It is apparent, from a survey of this literature, that most of the 
research that has been done into metastasis has taken the view that the spread 
of malignant tumours is the end result of a number of processes operating 
sequentially. When considered against the background of biological knowledge 
generally or in the light of information that has been gleaned from 
descriptive observations, these processes are seen to have certain necessary 
requi rements for their successful completion. Experiments are then designed 
to explore the need for the particular requirements or, frequently, they 
assume that the requirement exists and the research is directed at defining 
the way in which it is met. 
These processes may be summarised as follows:-
(i) Cells dislodge from the primary tumour 
This process is seen to require circumstances such that forces promoting 
separation of the cells (lytic enzymes, tissue movement or handling of the 
tumour) exceed those that are responsible for cohesion or adherence (cell 
junctions, cell association molecules and mechanical restraints). Experiments 
have been performed to show that malignant or transformed cells may, indeed, 
produce proteol ytic enzymes with collagenolytic or tryptic specificity (Liotta 
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et al., 1981; Ossowski et al., 1973; Strauch, 1972) the tumour cells adhere 
to each other and to a substrate less tenaciously than do normal cells (Coman, 
1961; Willis, 1973), or that structures such as gap junctions or molecules 
that are involved in cell-cell adhesion are deficient in malignant cells 
(Foste, 1977; Weinstein et al., 1976; Sheridam, 1976; Weiss, 1976); and that 
surgical manipulation of tumours causes the release of showers of tumour cells 
into the venous circulation (Golinger et al., 1977; Griffiths et al., 1973; 
Salsbury, 1975). 
(ii) Cells. penetrate the microbarriers that separ.ate the primary tumour 
from the adjacent tissues or from the lymphatic or vascular compartments. 
This penetra~~on may precede dislodgement so that detachment of the 
tumour fragment is effected, mechanically, by the circulation or it may follow 
the detachment of motile cells. In any event cellular penetration requires 
the traversal of basement membranes and other structures. This, in turn, 
requires recognition structures on the tumour cells whereby they attach to the 
basement membrane or other tissue components and hydrolytic enzymes such as 
collagenase or plasminogen activator for the dissolution of the membrane and, 
finally, the capacity for locountion. Correlations between laminin receptor 
density (Liotta, 1986; Hayman et al.,1981 ;Chung etal.,1979; Rao etal.,1983; rerra-
nova et al.,1980; 1983 ), protease sectretion (Sylven and Bois-Svensson, 1960; 
Koono et al., 1974; Strauch, 1972), and migration capacity (Easty and Easty, 
1974; 1984; Enterline and Coman, 1950; Burk, 1973) on the one hand and 
cellular metastatic potential on the other have been reported although these 
results have not always been consistent (Kinsey, 1960; Fidler, 1982; Fidler 
and Kripke, 1977; Hart and Fidler, 1981; Foste and Fidler, 1980; Talmadge 
et al., 1982). 
(iii) Cells survive in the blood stream or lymphatic vessels until 
their arrest in the first capillary filtration bed that they encounter. 
Cellular survival requires the presence of tumour-cell surface receptors 
for growth factors or nutrients or the lack of dependence on such factors. 
There is also a requirement for mechanisms for evading immune attack and 
circulating cells of the immune system and, finally, tumour cells should be 
sufficiently hardy in the mechanical sense, to withstand the buffeting 
environment of the blood stream. 
Capillary arrest requires favourable interactions between the tumour cell 
surface and the capillary endothelial wall so enabling the circulating tumour 
cells to escape from the blood stream and attach to the vessel. Several 
reports (Chew et al., 1976) have implicated thrombogenesis in capillary embo-
lisation by tumours and it has been suggested (Buck, 1973; Lunscken and 
Strauli, 1975) that denudation of the endothelial layer may promote adhesion 
by exposing collagenous or other binding sites or by removing the negative 
charge on the endothelial cell that would presumably constitute an electro-
static barrier attachment of negatively charged tumour cells (Ozakit et al., 
1971). Cell surface negative charge may also be reduced by defective sialyl 
transferase activity (Robbins and Nicolson, 1975; Roblin et al., 1975) that 
diminishes terminal sialic acid residue density on membrane glycoproteins. 
Other cell surface changes have been associated with neoplastic tran-
sformation (e.g. susceptibility to agglutination by plant lectins (Rapin and 
Burger, 1974; Nicolson, 1974) ) and generally speaking, the implication is 
made that such changes · somehow facilitate cell-endothelial interaction that 
favour capillary arrest. 
(iv) Cells that come to rest in the capillary bed penetrate the 
vessel wall. They then infiltrate the adjacent tissues and proliferate. 
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These processes would require lytic and migratory capabilities such as 
those already mentions in (iii) and (iv) above. Furthermore, new environments 
in which they find themselves should provide an auspicious milieu for the 
growth of the micrometastasis in both the immunological and endocrine sense. 
(v) The metastatic deposit acquires a substantive stroma aod blood supply. 
A major restraint upon growth is thus removed. The metastasis is now 
able to function as a source of tertiary metastatic deposits. 
These processes require favourable host-tissue interactions as exempli-
fied by the response of host cells to tumour-cell products such as angiogenic 
factor (Folkman, 1974a,b; 1975; Folkman et al., 1971; Folkman and Tyler, 
1977) or factors that pro1lX>te infiltration of metastasis. Mesenchymal 
celisprovide a framework for cell survival and a possible source of paracrine 
controlling growth factor activity (Sporn and Roberts, 1985; Sporn and 
Todaro, 1980). 
In addition to these experiments designed to examine a particular idea or 
aspect of the metastatic process, there are a number of observtaions of a more 
general nature that have come from the study of human neoplasms with 
experimental tumours. 
In the first place, it is now clear that the mere presence of viable 
tumour cells in the circulation does not necessarily signify metastasis. Only 
a small fraction of such cells implant successfully (Salsbury, 1975; Fidler, 
1970; 1975; Griffiths and Salsbury, 1965; Clifton and Agostino, 1962). From 
this we may infer that the probability that a cell that is metastatically 
equipotential with all other cells will arrest in the right place at the right 
time is small. Alternatively, only a small fraction of the cells that dis-
charge from a primary tumour are stem cells that are capable of establishing a 
metastatic colony. Other cells would be terminally differentiated or transit 
cells with the capacity, perhaps, for a few divisions after which they would 
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die. 
Secondly, it is well known - once again from both clinical and experimen-
tal observations - that metastases may manifest long after the primary lesion 
has been successfully treated and apparently a tumour-free period has elapsed. 
This phenomenon of quiescence followed by the reappearance of overt tumour at 
a distal site is referred to as "tumour dormancy". Several papers (Eccles and 
Alexander, 1975; Wheelock et al., 1977) have appeared on this most interes-
ting aspect of metastatic spread since the phenomenon was first validated 
experimentally by Fisher and Fisher in 1959. 
Thirdly, studies that have measured the fate and distribution of tumour 
cells introduced directly into the circulation have shown conclusively that, 
for certain kinds of cells, their distribution is not random. One finds, 
rather, that an "organotropic" predeliction exists for the cells to arrest, 
reproducibly, in certain specific organs. Fidler's experiments (1978) have 
been most convincing in that he has isolated Bl6 mouse melanoma sublines that 
metastasise preferentially to particular organs or tissues. · clinical and 
autopsy studies in humans have similarly shown that tumours belonging to a 
particular class (e.g. breast) have a significant proclivity for spread to a 
particular se.t of organs (e.g. ovaries). In some cases this may be due to 
cell surface structures that form specific interactions between the tumour 
cell and complementary molecules on the capillary vascular endothelium of the 
preferred organ; in other cases the organ may offer a hormonal or nutritional 
milieu that favours growth of the cell type concerned. 
Many ingenious in vitro and in vivo experimental systems have been 
devised to study invasion and metastasis and the results that have been 
obtained with their use have- enabled one to identify certain characteristics 
that can reasonably be associated with metastatic cells and the tissues that 
they invade. These models have recently been the subject of informative and 
comprehensive reviews (Easty and Easty, 1984; Poste, 1982; Carr and Carr, 
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1982; Gershman, 1982). 
Generally speaking, in vitro studies have used an experimental approach 
in which malignant cells were incubated with substrates for invasion that have 
varied from relatively simple macrom:>lecular layers such as collagen gels 
(Schor, 1980; Yang et al., 1981) through composite organotypic cultures 
comprising structural proteins, mesenchymal and epithelial elements (Wolf, 
1963; De Ridder et al., 1977), natural membranes (Easty and Easty, 1984; 
Hart and Fidler, 1978; Poste et al., 1980) or sponge matrices (Leighton, 
1951); up to complex organ cultures (Wiseman and Steinberg, 1973; Weston and 
Abercrombi, 1967). These in vitro m:>dels, although artificial, have had the 
great advantages that they are relatively simple to construct and that they 
allow quantitative studies to be undertaken by, for example, the use of 
radioactive substrates or the counting of cells that have penetrated the assay 
matrix. Furthermore, in vitro systems have made it possible to test directly 
the processes that the various theories of invasion and metastasis predict. 
If, for example, one proposed that metastatic organotropism involved inter-
actions between complementary recognition structures on tumour cells and the 
cells of the preferred organ, in vitro aggregation or rosette studies could be 
used to support this notion. Liotta (1986) has used this approach to elegant 
advantage to support his views that interactions with laminin and the secre-
tion of type IV collagenase are important components of the invasive 
phenotype. 
Although these simplified approaches have enabled investigators to take 
the metastatic cascade one step at a time, the light that they have shed has 
been circumstantial rather than definitive and the need for in vivo 
confirmation has usually remained. 
The in vivo models that have been used have generally involved the study 
of tumour cell behaviour following grafting into the immunologically bland 
environment of a syngeneic or immunoincompetant host. Although many of the 
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studies in this category have been largely descriptive, the emergence of 
experiments of such workers as Fidler (1970; 1973b;1974a; 1974b; 1976; 1978; 
1982; Fidler and Nicolson, 1976; Fidler and Kripke, 1977; Fidler et al., 
1984; Fidler and Hart, 1982) Nicholson (Nicolson et al., 1976; Nicolson and 
Winkelhake, 1975; 1976) Folkman (Folkman and Tyler, 1977; Folkman et al., 
1971; Folkman, 1975; 1974a, b; 1971), Sordat (Sordat and Merenda, 1977; 
Sordat et al., 1978; Sordat and Bogenmann, 1980), Weiss (Weiss et al., 1974; 
Weiss, 1976; Weiss et al., 1983) and the Fishers (Fisher et al., 1969; 1970; 
1983) have contributed materially to conceptual developments in metastasis 
research. The published proceedings of two recent symposia on this subject 
(Houchens and Ovejera, 1978; Sordat,( 1982) and the eccellent review by Fidler 
(Fidler et al., 1978) provide comprehensive accounts of the knowledge that has 
been gleaned from the study of animal tumours. 
My concern has been largely with the development of procedures for the 
experimental study of the spread of human tumours and, particularly, using the 
nude mouse as a model for investigating the spread of human melanoma. Ossow-
ski and Reich (1980) have used the embryonated hen's egg as a remarkably 
effective system· for studying the growth . and spread of a human epithelial 
tumour, and they were able, with this model, to demonstrate the importance of 
plasminogen activation in the metastatic process. The athymic mouse should 
provide an environment for xenograft acceptance that is every bit as accommo-
dating as the chorio-allantoic membrane of the hen's egg. It should, more-
over, have the theoretical advantages of phylogenetic proximity and close 
anatomical similarity to man coupled with the practical advantages of a longer 
period of time over which observations can be made. In the case of the egg 
one is limited to approximately two weeks; the nude mouse allows slowly 
growing tumours to be observed for periods up to one year. 
A survey of the literature indicates that the nude roouse has not been 
particularly useful for the investigation of metastasis of human tumours. 
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Most authors have noted that human tumours implanted subcutaneously in this 
species give rise to well encapsulated lesions that remain localized at the 
site of inoculation until the death of the animal (Helson et al., 1975; 
Shimosato et al., 1976; Kameya et al., 1976; Giovanella et al., 1978; 
Sharkey and Fogh, 1979; Kanzaki et al., 1979; McCormick et al., 1983). 
In the experiments to be done in this chapter I show that the nude mouse 
provides an excellent and informative model for the investigation of human 
tumour spread provided survival of the animal is prolonged by excision of the 
I 
primary tumour. 
MATERIALS AND METHODS. 
Mice and cell lines 
The mice and the cell lines used for these experiments have been 
described in detail in Chapter 1 and Appendix. 
Experimental protocol 
Mice received subcutaneous inocula of melanoma cells as described in 
Chapter 1. The tumours that developed were excised before they reached a 
size which was lethal to the host or when they had been present for a time 
that was appropriate for each experiment. 
The mice were anaesthetized with ether and the tumours were removed, 
together with an ellipse of overlying skin. The tumours were usually circum-
scribed and could readily be separated from the surrounding normal tissue by 
blunt dissection. The skin incision was then closed with clips which were 
normally removed on the 4th or 5th post-operative day. Haemostasis did not 
present a problem during removal except in the case of ucr-Mel 3 and wound 
healing was invariably rapid without infection. 
The animals were examined frequently for up to one year during the post-
operative period for evidence of metastasis; weight loss provided the most 
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reliable evidence to indicate that this had occurred. 
Detailed autopsies were prepared, under sterile conditions, on all mice 
that died spontaneously or upon animals that were killed when dissemination 
was diagnosed at the end of the period of observation. To increase the 
accuracy of lung metastasis observation at the time of autopsy, lungs were 
insufflated with 15% solution of Indian Ink and washed with Fekete's solution, 
which is a bleach preservative, that facilitates the detection of very small 
lung implants (Wexter, 1966). At autopsy samples of tissue were taken into 
buffered formalin for histology or into sterile tissue culture medium for 
inoculation into fresh recipients or for return to in vitro culture. These 
techniques have been described in Chapter 1. 
RESULTS 
6 
In the first series of experiments to be completed, mice received 10 or 
6 
SxlO melanoma cells from the various cell lines and 120 of these animais 
developed tumours (UCT-Mel 6 was consistently non-tumorigenic). When the 
tumours had grown to a size where they were considered to be life threatening 
to the hosts or when small areas of necrosis were seen in the overlying skin, 
the primary tumour was excised. At the time of excision, most of the tumours 
were circumscribed and easily separated from the fascial planes or muscles of 
the back. While attachment to the overlying skin was common, the tumours 
were usually mobile relative to the deeper tissues with no obvious clinical 
signs of local invasion. This was borne out by the fact that local recurrence 
was a rare phenomenon that was seen in only 8 cases and then exclusively 
with UCT-Mel 2 and 3. 
Mice bearing tumours derived from UCT-Mel 3 consistently showed a 
clotting disorder that I have not been able to elucidate in detail. I 
occasionally saw quite extensive haemorrhage into the tissues surrounding 
these tumours (Fig. 4.1) and; . at the time of excision of the mass, it was 
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Figure 4.1 
A mouse with extensive haemorrhage into the tissue which surrounded 
a UCT-Mel 3 tumour. 
6 
A male mouse was inoculated subcutaneously with 10 UCT-Mel 3 cells 
(in vitro passage number 69'). This tumour cell line frequently gave rise to 
haemorrhagic tumours. 
The picture illustrates extensive subcutaneous haemorrhage which 
surrounded a UCT-Mel 3 tumour. The tumour had been removed through the 
visible incision prior to the photograph being taken. 
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usually only with some difficulty and the patient application of local 
compression that haemostasis could be secured. Blood samples taken from these 
mice formed loose clots that retracted poorly. The blood platelets appeared 
normal in appearance and number but that was as far as I was able to take the 
investigations of this interesting disorder. It certainly merits further 
study. 
After the animals had the tumours excised they were monitored for periods 
of up to one year for signs of metastasis. Weight loss proved to be a very 
useful and reliable clinical indication of the fact that dissemination had 
taken place. 
All of the tumorigenic lines, with the exception of ucr-Mel 7, gave rise 
to metastases with frequencies that ranged from 1/17 (Ucr-Mel 1) to 35/35 
(Ucr-Mel 3). UCf-Mel 2, 4 and 5 disseminated with similar frequencies of 
approximately 10% (Table 4.1). Secondary deposits, in tests of the most 
aggressively metastatic line, ucr-Mel 3, were observed in the lungs, gonads, 
kidney~ liver, intestines and abdominal cavity. In the other four cases the 
lung was the only site of secondary deposition. 
Histological examination of the metastases showed appearances that were, 
for the most part, consistent with the diagnosis of haematogenous dissemi-
nation (Fig. 4.2), although in certain cases (e.g. Fig. 4.3) the metastases 
seemed to arise from spillage into serous cavities when they manifest as 
nodules that burrowed into the substance of the liver or the lung with a clear 
line of demarcation between nol"!]lal tissue and tumour tissue and no sign of 
infiltration. 
Selection for the metastatic phenotype 
I hoped that, by repeated in vivo passaging of tumours derived from 
secondary deposits, I would be able to develop sublines that were more consis-
tently metastatic. I thus transplanted, subcutaneously, fragments of meta-





Metastases of human melanoma. in the nude mouse. 
(a) Metastasis of non-pigmented epithelioid cell type malignant melanoma. 
(Ucr-Mel 3) invading peripheral sinuses of a lymph node. The lymph node is 
represented at this stage by collections of small darkly staining lymphocytes. 
(b) Metastasis of ucr-Mel 3 compressing a normal adrenal gland seen at top 
left. The tumour metastases are seen as nodules of undifferentiated cells 
(note mitoses) and the adrenal gland as columns of highly coloured cells with 
pale foaming cytoplasm. 
(c) Two metastases of ucr-Mel 3 (top left and middle right) in kidney. The 
kidney shows glomeruli and proximal convoluted tubules while the more 
irregular shaped islands of tumour are composed of undifferentiated non-
pigmented cells. 





Metastasis of human melanoma. in the nude mouse. 
Metastasis of UCT-Mel 3 protruding into liver parenchyma from the 
capsular surface. Undifferentiated tumour cells can be seen forming a nodule 
on the peritoneal side and then pushing their way into the underlying normal 
liver. 




















































































































































































































When tumours formed locally they were excised and passaged, as subcutaneous 
fragments, and the recipients from whom the tumours were removed were moni-
tored for metastasis. This procedure was repeated for up to 11 to 14 passages 
with from 2 to 19 mice being used at each passage (Tables 4.2, 4.3). At each 
transfer one of the tumour-bearing mice was selected at random as the tumour 
donor for the subsequent passage. At various transfer numbers (cf. Table 
4.4) the tumours were returned to tissue culture, passaged several times 
in vitro and re-inoculated into animals as single cell suspensions. 
The results of this series of experiments are presented in Table 4.2 and 
Table 4.3 and may be summarised as follows:-
UCT-Mel 3 was consistently metastatic from the start and remained so 
throughout the cQurse of serial in vivo passaging. Metastases with this line 
were always seen but only if the primary lesion was allowed to reach a certain 
minimal size before excision (see below). The metastases used to start the 
transfer series (one from lung and one from the abdominal cavity) showed no 
significant differences either in metastatic potential or organotropic quali-
ties. 
It is of interest to note that an in vitro culture of UCT-Mel 3 that was 
taken at the 6th in vivo transfer and passaged in vitro 12 times retained 
tumorigenicity but appeared to have lost metastatic potential (Table 4.4). 
This interesting non-metastatic subline has been kept for further study and 
comparison with the parent. 
UCT-Mel 5 started with a metastatic frequency of 14%. A lung deposit 
was taken from one of the three mice that developed secondaries and used to 
start the in vivo series. As can be seen from Table 4.2, all of the animals 
after the 7th transfer developed metastases. 
An in vitro culture established from the tumour removed at the 5th 
passage gave rise to a line which caused metastatic tumours in 7 /7 mice after 
5 in vitro passages (Table 4~4). 
180 
181 
Table 4.2 Incidence of metastases with repeated in vivo passage 
UCT-Mel 1 2 3 4 5 
Parent 1/17 3/26 35/35 1/10 3/22 
Passage 1 1/13 0/2 4/4 0/3 2/3 
2 1/2 0/2 4/4 0/3 2/3 
3 6/14 0/2 3/3 1/3 9/14 
4 3/19 0/2 4/4 1/3 3/4 
5 4/19 0/2 3/3 2/2 4/5 
6 1/8 0/2 2/2 0/1 4/5 
7 1/12 0/2 2/2 0/2 2/3 
8 1/3 0/2 2/2 0/5 2/2 
9 0/2 0/2 3/3 0/2 2/2 
10 0/2 0/2 2/2 1/2 ·2/2 
11 0/2 0/2 2/2 0/2 
12 0/2 0/2 2/2 0/2 
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The original metastases from ucr-mel ~ were seen only in the lungs of 3 
affected mice (Table 4.1). As the tendency to. spread increased with in vivo 
transfer occasional metastasis to other organs was found (kidney, peritoneal 
cavity, stomach.and uterus) but for the most part spread to these sites was 
rare. Lung remained the. principal target organ for this tumour. 
ucr-Mel 1-derived tumours gave rise to metastases in 1/17 animals when 
first studied (Table 4.1). the lung deposit that was selected to start the 
in vivo transfer series in this case gave rise to a subline that retained 
tumorigenicity but that appeared to have lost all tendency to spread (Table 
4.2 and 4.3). 
ucr-Mel 4 metastasized with a frequency of approximately 
20%. The lung was the major site of metastatic spread. 
Size of the primary tumour and metastasis. 
Surgical approaches to the management of solid malignant neoplasms in man 
are firmly based upon the belief that the primary tumours should be excised at 
an "early" stage "before spread has occurred". 
I felt that it should be possible, with the uniformly metastatic cell 
line, ucr-Mel 3, to give quantitative meaning to the term "early" in the above 
context by removing tumours at different sizes and/or after different periods 
of subcutaneous growth and noting the frequency of metastasis seen after 
resection. 
The results of two such experiments are recorded in Table 4.5 and in Fig. 
4.4a and 4.4b. The composite graph (Fig.4.5) of all the data shows, most 
clearly, the striking relationship between frequency of metastasis and size of 
the primary tumour at the time of resection. Spread did not occur if the 
primary tumour was removed before it had reached the size of 0.6g; when the 
tumour was allowed to grow to reach a size greater than 1. 6 g, metastasis was 
invariably seen. Tumours of intermediate size metastasized with a correspon-




























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































FIGURES 4.4a and 4.4b 
Figure 4.4a 
Relationship between UCT-Mel 3 tumour size, length of time of tumour 
in the mouse and metastasis 
6 6 
Mice were inoculated subcutaneously with 10 to 5xl0 UCT-Mel 3 cells 
(in vitro passage numbers 69' or 87'). Tumours of various sizes were removed 
at time O. Mice were then observed and were sacrificed. once weight loss 
occurred (this was found to be a reliable indicator of metastatic spread). 
Metastatic spread was observed in all animals and was documented by autopsy 
and histological examination of affected tissues. 
As can be noted from this figure the length of time the tumour was 
present in its host did not affect the incidence of metastasis. The size of 
the primary tumour at the time of its removal determined the incidence of 
metastatic spread. 
<,.-----~ metastasis (63) 
Figure 4.4b 
Relationship between UCT-Mel 3 tumour size, length of time of tumour 
in the mouse and metastasis 
6 6 
to 5xl0 Mice were inoculated subcutaneously with 10 UCT-Mel 3 cells 
(in vitro passage number 69' or 87'). Tumours of various sizes were removed 
at time O. No metastases were observed in these animals. 
As can be noted from this figure the length of time the tumour was 
present in its host did not contribute to the incidence of metastasis. The 
size of the primary tumour at the time of its removal determined the incidence 
of metastasis (see Fig. 4.4a). 
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Relationship between UCT-Mel 3 tumour s
ize and metastasis in the nude mouse 
6 6 
Mice were inoculated subcutaneously wit
h 10 to 5x10 UCT-Mel 3 cells 
(in vitro passage numbers 69' or 87'). 
Tumours of various sizes were removed . 
Mice were then observed aid were sacrifi
ced once weight loss occurred (this wa
s 
found to be a reliable indicator of me
tastatic spread). Metastatic spread was
 
documented by autopsy and histological 
examination of affected tissues. 
Note the following:-
(a) If the tumour was less than 0.6 g
m at the time of surgery no metastasis 
occurred (13 mice). 
(b) If the tumour was between 0.6 - 1
.0 gm when removed 60% of the mice 
developed metastatic malignant melanoma
 (14 mice). 
(c) If the tumour was between 1.0 - 1
.6 gm when removed 85% of the mice 
developed metastasis (42 mice). 
(d) If the tumour was greater than 1.
6 gm at the time of rem.oval all mice 
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Fi gure 4.5 
experiments showed that the effect of mass upon spread could be demonstrated 
reproducibly. 
The frequency with which metastasis occurred was related to the size 
attained by the tumours and not to the period of subcutaneous growth (Figs. 
4.4a and 4.4b). 
Although the number of animals studied is as yet too small to warrant 
emphasis it is of interest to note that, in the case of ucr-Mel 5, the parent 
line showed an inverse relationship between tumour size and metastatic fre-
quency (Fig.4.6). This tendency for large primary tumours not to be asso-
191 
ciated with secondary disease was no longer observed with uniformly metastatic 
sublines derived from repeated in vivo passage (Fig. 4.7 and Appendix Table A.13). 
Time taken for metastases to develop. 
I have previously observed (Fig. 10, Chapter 3) that, in my experience, 
subcutaneous tumorigenic inocula of human melanoma cells invariably produced 
tumours in 84 days or less and that 95% of tumours that were going to develop 
did so within 42 days. In certain respects the deposition of a micro-
metastasis in a target organ may be seen as being similar to the deposition of 
a tumorigenic inoculum into the subcutaneous tissues, so it was of interest to 
see how the time taken for metastasis to manifest after excision of the 
primary compared with the time taken for subcutaneous tumours to develop. 
Data accumulated from many observations of ucr-Mel 3-derived tumours 
(Fig. 4.8) showed that, taking the onset of weight loss as the first sign of 
established metastatic disease, 89% of metastases declared themselves in 140 
days of removing the primary tumour and virtually all within 160 days. One 
case required observation for 210 days before metastases were seen. 
Although there was some tendency for metastases to develop sooner after 
the exicision of large tumours than after the removal of smaller masses, this 
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Relationship between ucr-Mel 5 tumour size in the nude mouse and metastasis 
6 6 
Mice were inoculated subcutaneousiy with 10 or SxlO parent ucr-Mel 5 
192 
cells (in vitro passage number 27'). Tumours of various sizes were removed at 
time O. Metastatic spread was documented by autopsy and histological exami-
nation of affected tissues. 
As can be noted from this figure the size of the primary tumour at the 
time of its removal did not determine the incidence of metastasis in these 
animals. 
(._----A) metastasis (3) 
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Relationship between ucr-Mel 5 tumour size in the nude mouse and metastasis 
6 
Mice were inoculated subcutaneously with 2xl0 ucr-Mel 5 parent cells 
6 
(in vitro passage number 27') or 2xl0 ucr-Mel 5 metastatic subline (in vivo 
passage 5' and in vitro passage number 5'). Tumours of various sizes were 
removed at time O. Metastatic spread was documented by autopsy and 
histological examination of affected tissues. 
As can be noted from the graph, the metastatic subline originating from 
a lung deposit, metastatised in all cases (7/7), whereas the parent tumours 
removed in the same weight range, did not produce metastasis at all (0/10). 
(•----•) metastases (7 /7) 
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Figure 4.8 
6 
Incidence of metastases as function of time following ucr-Mel 3 
tumour removal 
6 6 
Eighty four mice were inoculated subcutaneously with 10 l.8xl0 or 
SxlO ucr-Mel 3 cells ( in vitro passage numbers 69' or 87'). Primary tumours 
of different sizes were removed on day O. The graph represents a plot of 
cumulative metastases appearance as a function of time following the removal 
of the primary tumour. The onset of weight loss was taken as the first sign 
of metastatic disease. Metastases occurred in 63 mice. Eighty nine per cent 
of these metastases were evide?t 140 days following removal of the primary 
t umour. 62/63 mice had metastatic spread by 160 days and the remaining mouse 
by 210 days. 
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Figure 4.9 
The relationship between the mass of the primary tumour and the length 
of time to metastasis 
6 6 
Sixty three mice were inoculated subcutaneously with 10, l.8xl0, 2xl0 
6 
or 5xl0 ucr-Mel 3 cells (in vitro passage numbers 69' or 87') on day O. 
Tumours of various sizes were removed and the tumour mass at the time of 
6 
removal plotted as a function of the time taken for metastases to develop. 
Tumours were removed at a size which ensured metastatic spread (see Fig. 4.5). 
Note that metastases which occurred following the removal of smaller 
tumours were found over a fairly extensive time period, namely 20-210 days 
after removal of the primary tumour. Metastases following removal of larger 
tumours were always detected within 45 days of removal of the primary tumour. 
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Target organs 
As I have indicated earlier, repeated in vivo passage of tumours derived 
from a secondary deposit from ucr-Mel 1 did not appreciably affect the 
metastatic potential of the cells in terms of the frequency with which they 
gave rise to secondary deposits. In the 18 mice in which metastases occurred 
lungs were the preferred site in approximately half the animals with the 
abdomen being involved in about 20% of mice (Fig. 4.10). 
196 
The metastatic deposit from ucr-Mel 2 did not give rise to metastases in 
any of the mice inoculated (Table 4.2). 
ucr-Mel 3 spread consistently to many organs with the lung and abdomen 
being preferred sites (Figs. 4.11, 4.12, 4.13). 
Fig. 4.14 shows a number of metastatic focus in the lung of ·a mouse, that 
6 
was inoculated intravenously with 2xl0 ucr-Mel 3 cells. 
The incidence of metastases did not increase with passage through mice in 
the case of ucr-Mel 4 (Table 4.2). Five mice in this study developed 
metastases, all of which involved the lungs (Fig. 4.15). 
As already mentioned ucr-Mel 5 started with a metastatic frequency of 14% 
and increased to 100% with serial passage through mice (Table 4.2). Metas-
tases from this line were almost exclusively confined to the lungs (Fig. 4.16 
and 4.17). 
Cellular comparison 
The availability of melanoma cell lines with demonstrably different 
capacities for forming metastatic tumours enabled me to compare them with 
respect to certain attributes that may be relevant to the metastatic 
phenotype. 
It is interesting to note that the rate of plasminogen activator release 
by parent cells cultured in vitro was much greater than that of metastatic 
isolates (Table 4.7). I also found that the kinetics of growth 'in vitro or 
in vivo bore little relationship to the metastatic potential of the cells. 
197 
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Figure 4.10 
The location of metastatic deposits following either the subcutaneous 
inoculation of UCT-Mel 1 metastatic deposits from the lung 
6 6 
Eighty six mice were inoculated subcutaneously with either 10 or 5xl0 
UCT-Mel 1 cells (in vitro passage number 65') or with metastatic explants 
removed from a lung deposit which had been passaged several times (12) in nude 
mice. Nineteen mice developed metastasis, primarily of the lung but deposits 
in abdomen, kidney, uterus, gonads, intestine and lymph node were also found. 
* Intestine (1); Lymph node (1). 
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Figure 4 .11 
The location of metastatic deposits following subcutaneous inoculation 
of UCT-Mel 3 cells 
6 6 
Fifty one mice were inoculated subcutaneously with 10 to SxlO UCT-Mel 3 
parent cells (in vitro passage numbers 69' and 87'). All mice developed 
metastases which were widespread and involved primarily the lungs, abdomen, 
gonads, kidney and uterus. However metastatic deposits were also found in the 
lymph node (1) and the sulmaxillary gland (1). 
* Submaxillary gland (1); Intestine (1); Lymph node (1). 
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The location of metastatic deposits following subcutaneous implantation 
of a ucr-Mel 3 lung metastasis 
Thirty five mice were implanted subcutaneously with metastatic explants 
originating from a lung deposit which was passaged several times (13) through 
nude mice. All mice developed metastases primarily of the lung and abdomen, 
but deposits in the gonads, kidney, uterus, eye, lymph node, bladder and 
adrenal gland was also found. 
* 
Eye ( 1); Lymph node ( 1) ; Bladde·r ( 1) ; Adrenal gland ( 1) . 
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FIGURE 4. 13 
Figure 4.13 
Widespread metastasis of UCT-Mel 3 in abdominal cavity of the nude mouse 
6 
Mice were inoculated subcutaneously with SxlO UCT-Mel 3 cells (in vitro 
passsage number 69'). The primary tumour was removed 66 days after 
3 
inoculation, once a size of approximately 2300mm had been reached. the mouse 
was sacrificed once weight loss occurred (this was found to be a reliable 
indicator of metastasic spread). 
Metastatic spread was observed throughout the abdominal cavity involving 
the majority of organs. 
This figure illustrates:-
(a) Kidney metastasis. 
(b) Metastasis in the mesentery. 
(c) Large metastatic tumour involving the left ovary. 
(d) Lymph node metastasis. 




Lung metastasis of UCT-Mel 3 in nude mice. 
6 
A mouse was inoculated intravenously in the tail vein with 2xl0 UCT-Mel 
3 cells (69'). After 6 weeks the mouse was sacrificed and the lungs 
infiltrated with Indian ink and fixed in formalin as described in the text. 
Note from the picture that multiple metastases are visible as unstained 
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The location of metastatic deposits following sub
cutaneous implantation 
of a lung metastasis obtained from ucr-Mel 4 
I I 
A lung metastasis from a mouse inoculated with uc
r-Mel 4 cells was 
removed and passaged 14 times through nude mice. 
Thirty four mice received 
subcutaneous implants of this ucr-Mel 4 in vivo d
eposit. Five mice developed 
metastasis, all of which were founi in the lung. 
Metastatic deposits were 
also founi in the kidney (1 mouse) and the adrena
l gland (1 mouse). 
* Adrenal gland (1) . 
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The location of metastatic deposits following subcutaneous inoculation 
of UGr-Mel S cells 
6 




parent cells (in vitro passage number 27') or with 2xl0 ucr-Mel S metastatic 
subline cells (in vivo passage number Sand in vitro passage number S'). 
Thirty nine mice developed metastasis almost exclusively of the lung, but 
deposits in kidney, abdomen, uterus and stomach were also found. 
* Stomach (1) . 
Figure 4.17 
Lung metastasis of UCT Mel 5 in nude mice. 
6 
A mouse was inoculated subcutaneously with 10 UCT-Mel 5 cells (27'). The 
3 
primary tumour was removed once a size of approximately 2000mm was reached. 
One hunlred and twelve days after the tumour was removed the mouse -was 
sacrificed and the lungs infiltrated with Indian ink and fixed in formalin. 
As shown in the picture four large metastatic foci are evident as 
unstained areas in the lung. 
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In the case of ucr-Mel 5, the highly metastati~ variant derived by the 
repeated in vivo passage had a shorter doubling time in vitro (33 hr)than the 
original parent (58 hr) (Table 4.7). In the case of ucr-Mel 3 the highly 
• 
metastatic subline had a much longer in vitro doubling time (86 hr) than the 
equally metastatic parent cells (58 hr)(Appendix Figs. A.14 and A.15). 
Table 4.7 
Cell line T12 PA Metastases 
6 
in vitro u/10 cells/24hr 
ucr-Mel 3 
Parent 58 9.2 100% 
Subline 86 0.2 100% 
ucr-Me1 5 
Parent 58 3.8 14% 
Subline 33 0.9 100% 
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DISCUSSION 
The results that I report in this chapter show that nude mice bearing 
xenografted human tumours provide useful experimental models for the study of 
tumour metastasis. Five of the six tumorigenic melanoma cell lines that I 
have studied gave rise to metastatic tumours and in at least two cases (UCT-
Mel 3 and 5) these could be used to document interesting features of the 
metastatic process. 
My experience runs counter to that of most other reports in the 
literature since these have been generally unenthusiastic about the nude mouse 
as a suitable host for the study of dissemination of human tumours. In 
excellent review of this subject, Sordat, Ueyama and Fogh (1982) concluded 
that nude mice may serve as useful experimental hosts for metastastizing 
tumours derived from a limited number of cell lines such as the MeWo or the 
SK-Mel 3 human melanomas, but their figures nevertheless showed that 
dissemination during the primary tumour-bearing life of the animal was an 
unusual event. 
By excising the primary tumour I was able to prolong the life of the 
animal and so provide time for metastases to develop and declare themselves. 
The success that I have had is largely attributable to this strategem. It is 
quite clear from the literature, that investigators studying transplantable 
murine tumours were well aware of the fact that metastasis took time to become 
manifest and that their appearance was forestalled by the death of the host 
from the growth of the primary tumour (Reid et al.,1978; Wilson et al., 1984). 
I 
It is somewhat surprising, therefore, that, with the notable exception of 
workers such as Sordat, Schatten and Ketcham (Ozzello and Sordat, 1980; 
Schatten, 1958; Ketcham et al., 1959) this knowledge appears not to have been 
applied as fully as it might have been to xenograft systems. 
The fact that the primary tumours had to be resected to demonstrate 
metastases immediately raises a question that is, in my opinion, central to the 
understanding and preventive management of metastatic disease: is there a 
minimal size that a tumour must attain before metastasis will occur? In 
other words, does dissemination occur at an early stage in the natural history 
of a malignant neoplasm or is it rather a complication of late disease? 
I believe that, in one case at least, my experiments have given an 
unequivocal answer to this question. Mice bearing tumours derived from UCT-
Mel 3 cells survived without metastases if the tumours were excised before 
they had grown to exceed a mass of 0.6g. If the tumours were left until they 
were larger than 1.2g, all of the hosts developed disseminated disease. 
During the course of one effective doubling time, therefore, a prognostic 
transition took place: from 100% cure to 100% failure. 
I have, unfortunately, no definitive explanation to offer for this 
dramatic effect of tumour size upon the outcome of the disease. It is, none 
the less, worth considering possible mechanisms - if only for the value that 
such speculation may have for the formulation of further experiments that need 
to be done. 
In the first place, it is possible that the effect of size upon metastasis 
may be due to the fact that early primary tumours contained a genetically 
unstable population of non-metastasizing cells that progressed to the invasi~e 
and the metastatic phenotype. It is well known that the characteristics of 
tumours may change during the course of their growth so that they assume a 
more aggressive or "malignant" aspect. First studied systematically by 
Foulds (1958) approximately 30 years ago, tumour progression may occur as an 
abrupt> step-wise change over a fairly short period of time (Nowell, 1976) 
and I assume, therefore, that one population doubling might allow sufficient 
time for metastatizing clones within the neoplastic population to evolve. 
Some of the most convincing animal studies on tumour progression have recorded 
the spontaneous development of resistance to cytotoxic therapy (Skippers, 
1983) in experimental tumours. These authors showed that drug treatment of 
207 
small tumours was usually curative whereas failure was frequent if the mass 
was allowed to attain a large size before starting therapy. In these experi-
ments, mutations to a cytotoxic-resistant phenotype were frequent in tumours 
that were an order of magnitude larger than the sensitive counterparts, 
whereas my results showed a much smaller mass difference between confined and 
disseminated tumours. It is for this reason more than any other that I am 
disinclined to accept progression as a likely cause of the acquisition of 
metastatic behaviour in UCT-Mel 3. The appropriate experiments to investi-
gate this possibility, however, have not been done and we should not dismiss 
this explanation until the results of these are available. Clearly it is 
necessary to know whether or not metastases are derived from metastatic sub-
clones. This question would be answered affirmatively if it could be shown 
that subcutaneous tumours established from metastatic deposits disseminated at 
an earlier stage - i.e. before they had attained the mass of 0.6g. Further-
more , if the transition from localized to metastatic were invariably found to 
take place between 0.6 and 1.63 g (as it was in the two experiments that I 
performed) this would argue against progression since it is unlikely that 
random clonal change would consistently produce its qualitative effects within 
such a narrow mass range. 
The second explanation that may be offered for the size affect might be 
that, since the process of metastasis depends upon the rate of entry of tumour 
cells into the circulation (Sordat 1977; Warenius et al.,1980) it would 
depend upon vascularization of the xenograft and the generation of a murine 
stroma. It may well be that the relative vascularity of the UCT-Mel 3 derived 
tumours (i.e. blood flow/gram tissue) is a direct function of size, and that 
at a size greater than l.Og a critical metastatic flow is established. 
Methods, such as those using radioactive microspheres (Domenech et al., 1969) 
are available for measuring regional vascularity in vivo and the application 
of these might well shed ~ight on this possibility. 
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Thirdly, the stroma may also be important if, as suggested by the work of 
De Vore et al., (1980) the fibroblastic and collagenous matrix arourxi the 
tumour cells were to have anti-collagenolytic activity that matched, in quali-
tative terms, collagenase production by a small tumour but was unable to 
inhibit the enzyme produced by mass of twice the size. In the latter case 
free collagenase would be available to mediate invasion. This notion is 
supported by the work of Liotta (Liotta et al., 1981) who has produced con-
vincing evidence to suggest a role for type IV collagenase in tumour spread • 
. Measurement of collagenase activity released by UCI-Mel 3 cells and of the 
inhibition of this action by murine fibroblasts isolated from the stroma of 
the tumour might provide a useful approach to the investigation of this possi-
bility. In similar vein, work from this laboratory has shown that fibro-
blasts, by binding and degrading tissue plasminogen activator (Hoal et al., 
1983), effectively reduce· the concentration of this enzyme. If, as so 
elegantly demonstrated by Ossowski and Reich for urokinase and the spread of 
Hep3 cells (1983), tissue plasminogen activator were to have an important role 
in the dissemination of UCI-Mel 3 derived tumours, it might well be that 
growth of the tumour to the point where a critical tumour cell:fibroblast 
ratio was exceeded, would allow tumour spread to occur. 
In the fourth place, it may be that tumour cells from UCI-Mel 3 do, 
indeed, enter the circulation from a very early stage of primary tumour growth 
but fail to establish themselves as viable metastatic deposits without growth 
factors (or inhibitors of host responses) that are derived from the primary 
tumour. Sordat et al., (1978), for example, have shown that nude mice bea-
ring human colorectal carcinomas support the intra-peritoneal survival of the 
carcinoma cells better than do tumour-free mice, indicating that local tumour 
growth may have a systemic effect upon distant foci. A certain critical 
concentration, or rate of delivery, of these factors might be required and 
this in turn might well be dependent upon the size of the viable primary 
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tumour. I can think of a number of experiments that may shed light on this 
possibility. If, for example, a mouse were to develop metastasis after the 
excision of two tumours, each weighing less than 0.6g but with a combined mass 
of greater than lg this would strongly suggest that a humeral factor of some 
sort was involved in micrometastasis survival. On a slightly different, but 
in principle similar, tack, it may be possible to inhibit spread of a large 
UCT-Mel 3 derived tumour by the simultaneous implantation of the non-metasta-
tic variant of UCT-Mel 3 that was derived by repeated in vivo passage and 
in vitro culture. This would imply that a non-metastatic tumour released 
inhibitory factors. Experimental support for this possibility comes from the 
work of Schatten (1958) and Ketcham et al (1961) who have shown that the rate 
of metastatic spread increased after removal of the primary tumour. Although 
Gorelike et al., (1978) showed that this phenomenon was frequently tumour-
specific, and could therefore involve immunological mechanisms, in the nude 
mouse these should not apply and this system would thus provide a clearer 
indication of the mechanisms involved. 
The fact of the matter is that I have metastatic and non-metastatic 
tumorigenic lines at my disposal, and it should be possible to design experi-
mental protocols that would illuminate present areas of uncertainty regarding 
quantitative relationships between size and metastatic potential. 
UCT-Mel 5 proved to be an interesting tumour in several respects. Most 
prominent aioong these, perhaps, was the observation that repeated in vivo 
passage from a metastatic deposit, even though this passage was done by 
transfe~ of subcutaneous tumours, gave rise to a tumour variant that spread 
uniformly. This is the only instance in which I was able to increase the 
metastatic potential of a line (Table 4.2). Presumably repeated in vivo 
transfer selected for a clone or subpopulation of cells that possessed an 
increased innate capacity for invasion and spread, or that was able to circum-
vent host defences or that was able to interact with the host tissues in such 
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a way that favoured growth. 
Despite the phenotypic drift from low to high metastatic potential, the 
cells from this line did not lose their organotropic preference for deposition 
in the lungs. It would be of interest to compare the variant subline with the 
poorly metastatic parent cells with respect to differences in collagenase 
production, growth factor requirement, plating efficiency, tendency to aggre-
gate with other blood cells or any of the other many functions that have been 
associated with acquisition of metastatic behaviour (Fidler et al., 1978). 
The fact that the aggressive variant line grew more rapidly in vitro than the 
parent line (Table 4.7) is noteworthy. 
Repeated in vivo transfer did not only lead to an increase in metastatic 
tendency; in the case of UCT-Mel 2 the cells appeared to lose such potential 
for spread that they had when first tested. In this case, I presume, the 
process of repeated in vivo transfer selected for a non-metastatic population. 
I was unable to detect any correlation between in vivo metastasis and 
in vitro cellular release of plasminogen activators, so in this respect my 
results do not support the belief that this enzyme is an important 
constitutive determinant of spread. It is possible, however, that in vivo 
induction oft-PA activity or the inducti~n of inhibitor synthesis are more 
important factors than in vitro experiments would suggest. The use of anti-
bodies to achieve specific in vivo inhibition oft-PA, provide a more realis-
tic indicator of the extent to which this enzyme is involved and the role of 
plasmin-mediated proteolysis in spread of melanomas in this system should be 




PHENOTYPIC EVOLUTION OF A HUMAN MELANOMA IN THE NUDE MOUSE 
Tumours that develop following the inoculation of malignant cells into an 
immunological receptive host such as the nude mouse usually grow progressively 
larger until they reach a stage where they outgrow their blood supply. 
Necrosis and ulceration then develop, leading to the death of the host if the 
tumour is allowed to remain in situ. The "natural history" of the tumour is 
usually enacted within the time span of weeks or months - a period that is too 
short to allow study of interesting phenomena such as progression, dormancy, 
genetic instability or other forms of phenotypic change that are frequently 
encountered in human tumours. 
By extending the life of the tumour (and hence the period of observation) 
it has been possible to examine some of these processes. Many strategies have 
been devised to accomplish this. Ossowski and Reich (1983), for example, 
. transplanted tumours onto the chorio-allantoic membrane (CAM) of the 
embryonated hen's egg and passaged the tumours that developed on to fresh 
CAM's or into in vitro culture; and Goldenberg and Pavia (1981, 1982) passaged 
tumours from nude mice into new recipients or re-established the cells in in 
vitro culture. I have shown, in chapter 4, that dormant metastatic deposits 
will manifest if the life of the host is prolonged by excision of the primary 
tumour and, in chapter 3, I showed that it is possible to maintain a subtumo-
rigenic inoculum in a dormant state by witholding the estradiol that is 
required for the tumour to develop. Implantation of an estrogen pellet three 
weeks after inoculation of the tumour cells then allowed the tumour to grow. 
None of these models, however, closely resembles the clinical situation 
where a tumour is presumed to develop by mutation of a single cell and 
thereafter to grow at a rate governed by its innate proliferative potential or 
by genetic influences that regulate dependence on growth factors, blood 
supply, interaction with host stroma, or other modulators of cell division. 
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These growth controls, and the responses that they elicit, frequently 
fluctuate in intensity with the result that the lesion does not increase in 
size as a monotonic function of time. It is more usual to find that periods 
of growth alternate with periods of relative dormancy and even regression, 
culminating eventually, in progression to a more aggressive and rapidly 
growing phenotype. Progression is though to represent a form of clonal 
evolution in which an inherently unstable genome (Nowell, 1986) undergoes further 
changes. The mutants that result are selected for their proliferative 
advantage so that heterogeneous tumours result with growth characteristics 
that differ from those of the parent clone. 
I was fortunate in that one of the melanoma cell lines (Ucr-Mel 7) used 
for this thesis grew in the nude JOC>use in a manner that differed from that of 
tumours derived from other cell lines. Instead of forming, from the start, a 
relentless and progressive tumour, it showed an initial period of rapid growth 
followed by a plateau phase, a phase of regression, a phase of dormancy and, 
finally a phase of rapid exponential growth. All of these phases could be 
documented in the same host without the need to interfere in any way. In 
these respects the tumours simulated the growth of spontaneous tumours in 
man. 
In this chapter I present the results of a series of experiments with 
this tumour that suggest that the phenotypic changes it displayed during the 
course of its evolution were the results of changes that resulted from host -
tumour interactions and were not spontaneous in the random sense. 
MATERIAL AND METHODS 
The following procedures have previously been described in detail in 
chapter 1:-
(a) Subcutaneous inoculation of cells into nude mice. 
(b) Electrophoretic analysis of lactate dehydrogenase enzymes for 
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assessment of relative human and murine contribution to tumours of mixed 
species content. 
Collagen content of tumour samples was measured by hydrolysis and 
assay of the hydroxyproline content of the hydrolysate (Hutterer and Singer, 
1960). 
RESULTS 
As indicated in chapter 1, all of the lines were tumorigenic with the 
exception of UCT-Mel 6, and tumours that developed from inocula of cells from 
UCT-Mel 1 through UCT-Mel 5 showed the pattern of relentless growth that is 
typical of most transplanted tumours. UCT-Mel 7 was a notable exception in 
this regard. Tumours derived from subcutaneous implants of these cells taken 
at the 30th in vitro passage grew initially at a rapid but decelerating rate 
so that, within a matter of weeks after appearance of the tumour, . it reached a 
plateau. This was in striking contrast to the continued growth that developed 
from the other cell lines, of which UCT-Mel 3 provides the example presented 
in Fig. 1. 
Having observed this growth pattern with 30th passage cells, I recovered 
the 10th passage cells from liquid nitrogen storage to see if they would show 
a similar pattern. As shown in Fig. 2, these cells grew exponentially in the 
nude mouse and did not show the "plateau" effect; cells from the 26-30th 
passage behaved as did those from the 30th passage and showed an initial phase 
of growth followed by a plateau. Cells from the 52nd passage in vitro gave 
rise to tumours that grew so slowly that it was not possible to discern a 
phasic growth pattern. They showed, rather, a period of prolonged dormancy 
with eventual exponential growth. When mice bearing tumours derived from in 
vitro cultures of the 26-30th passage of UCT-Mel 7 cells were observed for 
longer periods of time, the interesting and consistent growth pattern seen in 
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Figure l 
Growth of ucr-Mel 7 and ucr-Mel 3 in nude mice 
6 
Mice were inoculated subcutaneously with 10 UCT-Mel 7 (e e) (in vitro 
6 
passage number 30') or 10 UCT-Mel 3 (A----t::,.) (in vitro passage pumber 69') on 
day O and tumour volumes were measured at the indicated times. The lines on 
the graph were calculated using the Gompertz function and they represent the 
mean values for 5 animals. 
Note that UCT-Mel 7 grew initially at a rapid but decelerating rate (30 
days) after which tumo~r growth ceased. This was in contrast to the continued 
growth pattern observed in UCT-Mel 3. 
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Days after Inoculation 
Figur_e ~ 
The .!!!. ~ growth patterns ~ ucr-Mel ?_ tumours derived from passage 10' and 
passage 30' in vitro cultured cells 
6 
Mice were inoculated subcutaneously with 5 x 10 UCT-Mel 7 cells of in 
vitro passage number 10' (••--••) or passage number 30' <•---•) on day 0 
and tumour volumes were measured at the indicated times. The lines on the 
graph were calculated using the Gompertz function and they represented the 
mean values for 5 animals. 
Note that ucr-Mel 7 cells from an early passage (10') in vitro grew 
exponentially in the nude mice and did not show the "plateau" effect exhibited 
by cells of a later passage (30'). 
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FIGURE 3 . _ 
Figure_! 
The Phasic growth pattern of UCT-Mel !._ tumours _!!!. nude ~ 
6 
Mice were inoculated subcutaneously with 5 x 10 UCT-Mel 7 cells of in 
vitro passage number 30' (Figs. 3a and b) on day O and tumour volumes were 
measured at the indicated times. Lines in the figures were constructed by 
plotting tumour volumes as a function of time for a single mouse. 
Note that the initial growth phase (1) was followed by a plateau phase 
(2) during which no increase in size of tumours was observed. This period was 
followed by a phase of tumour regression (3). This regression phase was 
usually followed by a period of dormancy (4) after which an exponential growth 
phase was observed (5) 
Fig. 3(a) demonstrates these phases of growth in a single mouse tumour. 
Fig. 3(b) shows a variation which was occasionally observed. The 
exponential phase (5) followed the regression period (3) without a preceding 
dormant phase (4). 
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Days after Inoculation 
Figu~~ 3c 
The phasic growth pattern of UCT-Mel ?.... tumour~ nude~ 
6 
JI 
A mouse was inoculated subcutaneously with 10 UCT-Mel 7 cells of in 
vitro passage number 56' on day O and tumour volumes were measur.ed .at the 
indicated times. The line in the figure was constructed by plotting tumour 
volumes as a function of time. 
Note that the initial growth phase (a) was followed by a plateau phase 
(2) during which no increase in size of the tumour was observed. ' This period 
was followed by a phase of exponential growth (5), without a preceding 
regression and dormant phase (3 and 4). 
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observed but these were followed by regression to a small, barely palpable 
nodule, a variable period of dormancy and, finally, a sudden escape from 
latency to give rise to an extremely rapidly, exponentially growing tumour. 
I refer to this as the "phasic" growth pattern since five phases could 
readily be discerned: 
(1) A growth phase; 
(2) A plateau phase; 
(3) A phase of regression; 
(4) A period of dormancy; and, finally 
(5) A period of exponential growth. (Fig. 3). 
In table 1 I summarise the data from 3 experiments in which the time 
relationships of these five stages were measured, together with the doubling 
times of the tumours as they grew during the exponential phase. It is evident 
that, once this stage had been reached, the tumours all grew with the same in 
vivo doubling times. 
Tumours that were removed during the phase of exponential growth and 
reimplanted into fresh recipients formed tumours (which I refer to as SP) 
which -also grew exponentially. (Fig. 4). These showed no tendency to revert 
to the phasic growth pattern. During the course of its development in the 
donor mouse, therefore, the tumour changed its phenotype completely to that of 
an aggressively growing tumour. 
As indicated above, cells taken at the 10th in vitro passage grew 
exponentially. (Fig. 2). When a fragment of such an exponentially growing 
tumour was removed and re-implanted, the phasic growth phenotype was seen. 
(Fig. 5). 
It was of interest to observe that there was a paradoxical inverse 
relationship between the in vivo and in vitro proliferative rates of the two 
tumour phenotypes. An exponentially growing tumour, for example, with an 
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Table1 
Mou se No. of cells Phase Du rat ion (a \ota I Phase 
No. Inoculated (days) (days) (days) 
(x 10-6> 1 2 3 4 (b)f:2 
(volume) • cu .mm 
1 1 50 98 * * 148 12 
(30) 
2 1 48 43 * * 91 23 
(50) 
3 1 82 86 * * 168 42 
( 112) 
4 5 56 42 22 21 141 11 
(90) 
5 5 34 51 29 88 202 16 
(143) 
6 5 26 65 23 104 218 14 
(60) 
7 5 42 49 69 84 238 12 
(85) 
8 5 70 (c) 65 62 197 9 
9 5 42 90 22 (d) 154 24 
(70) 
10 5 35 27 14 77 153 12 
(138) 
( a) This column represents the total time to the onset of phas e 5 . 
( b ) T:2 . Tumours grew exponentially during phase 5 and the figure in this 
column represents the time take n for the tumours to double in volume . 
* Mice inoculated with 106 ce l ls did not show a regr e s sion phase followed 
by a dormant phase . Their dormant phase (4) and plateau phase (2) coin-
cided . 
( c ) In this instance regression (Pha se 3) followed the growth phase (Phase 1) 
( d ) In this instance growth commenced immediately after the r egression phase 






Growth patterns of tumours derived from _!E. vitro ~ in vivo passages of ~ 
Mel 7 
6 
(a) Mice were inoculated subcutaneously with either S x 10 ucr-Mel 7 
6 
cells of in vitro passage number 29' <•---•> or with 10 ucr-Mel 7 cells 
which had been derived from exponentially growi ng tumours passed 10 times 
through nude mice and passaged for 10 passages in vitro <•----•). Cells were 
inoculated on day O and tumour volumes were measured at the indicated times. 
The lines on the graph were calculated using the Gompertz function and they 
represent the mean values for S animals. 
Note that tumours that arose from cells that had been passaged through 
nude mice and then in vitro grew exponentially. Those that arose from cells 
that had been passaged exlusively in vitro showed the phasic growth pattern. 
6 
(b) Mice were inocualted subcutaneously with either 10 ucr-Mel 7 cells 
6 
of in vitro passage number 52' (0-----0) or with 10 ucr-Mel 7 cells which had 
been derived from exponentially growing tumours passed 8 times through nude 
mice and passaged for 10 passages in vitro(-.:•~~••)· Five mice were 
inoculated in each case. 
Note that tumours that arose from cells that had been passaged through 
nude mice and then in vitro grew exponentially. Those that arose from cells 
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Figure~ 
6 
Mice were inoculated subcutaneously with 10 UCT-Mel 7 cells (in vitro 
passage number 8') (••~~~•) or implanted subcutaneously with fragments 
obtained from one of these tumours (11----11). Cells or tumour fragments were 
introduced on day O and tumour volumes were measured at the indicated times. 
The tumour volumes are expressed relative to the volumes of both sets of 
tumours scored on day 20. 
Note that tumours. that arose from 8' cells grew exponentially. Tumours 
that arose from fragments removed during this exponential growth displayed an 
altered growth pattern and grew exceedingly slowly with an in vivo doubling 
time of 30 days compared with 12 days for the exponentially growing tumours . 
( JJ,,. •). 
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in vivo doubling time of 8.0 days had an in vitro doubling time of 141 hours. 
The tumours showing the phasic growth pattern were derived from cells with a 
much shorter doubling time of 47 hours. (Fig. 6). 
The histological appearances of the tumours removed at different stages 
of their in vivo evolution from phase 2 to phase S phenotypes differed consi-
derably. As can be seen from the photomicrographs reproduced in Fig. 7 
tumours removed during phase 1 or phase 2 were remarkable for their differen-
tiated appearance and for their extensive network of reticulin fibre 
formation. (Fig.7a and b). Tumours that were removed during phase S were less 
obviously differentiated and reticul~n deposition was far less pronounced. 
(Fig. 7c) Phase SP tumours (i.e. those removed during the exponential phase 
from one mouse and transplanted into a new host), also grew exponentially and 
showed scant reticulin fibre formation. Like the phase S tumours from which 
they were derived, they too showed a poorly differentiated morphology. Phase 
contrast microscopy of in vitro cultures revealed notable differences between 
cells that gave rise to tumours with the phasic growth pattern and cell lines 
derived from tumours removed during phase Sor phase ?P• 
Between the 10th and the 53rd :!.!!. vitro passage cells retained their 
predominantly elongated, spindle shaped morphology (Fig. 8a-l;a-2;a-3), but 
differed in their in vitro rates of proliferation (95 hours at 10'; 47 hours 
at 53' and in the maxiumal cell density they reached. Confluent late passage 
cultures were very much more dense than earlier passages. 
Fragments of phase S tumours were serially transplanted into fresh 
recipient hosts and then returned to in vitro culture. Such cultures differed 
to a greater of lesser extent with each other and with the original parent 
line in terms of their appearance under phase microscopy. They were 
consistently similar, however, in that they proliferated very slowly in vitro 
and, paradoxically, formed rapidly growing phase SP tumours when re-inoculated 
into nude mice. 
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FIGURES 6a and 6b ------------------
Figure~ 
Relationship between growth patterns of UCT-Mel 7 in vitro and in vivo 
(a) UCT-Mel 7 cells at the 52' passage recovered from liquid nitrogen 
storage<••~~••) or fragments from a tumour removed during the exponential 
growth phase and passaged 10 times through mice and established in culture for 
10 passages (•e-----,e•) were seeded in RPMI-FClO on 35 mm dishes on day O. The 
medium was changed 24 hr later and thereafter at 48 hr intervals. At the 




10 UCT-Mel 7 cells at the 52' passage in vitro (.it•~~ ... •) or 10 
UCT-Mel 7 cells derived from an exponentially growing tumour passaged for 10 
passages through nude mice and established in culture for 10 passages <••J--~e•) 
were inoculated subcutaneously into nude mice, on day O and tumour volumes 
were measured at the indicated times. The lines in the figure were calculated 
using the Gompertz function and they represent the mean values for 5 animals. 
Note that an exponentially growing tumour (Fig. 6b, ••J----j••), with an in 
vivo doubling time of 8.0 days was obtained from the inoculation of cells with 
an in vitro doubling time of 141 hrs (Fig. 6a,•e~~-e), whereas the tumours 
showing the phasic growth pattern (Fig. 6b,A•,----•) were derived from cells 
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Morphology of UCT-Mel 7 tumours removed during different phases of growth. 
The composite figure portrays photomicrographs of the histological 
appearance of UCT-Mel 7 tumours removed at di f ferent stages of their in vivo 
evolution from phase 1 to phase SP. The left half of each photograph-;hows 
tumours stained by the H&E method; the right half of each photograph shows the 
same tumours stained for reticulin (Gordon and Sweet, 1936). 
(a) These photographs indicate the appearance of tumours removed during 
phase 1. Theyportray a spindle cell malignant melanoma with a herring bone 
fasciculated pattern containing fairly well formed blood vessels. Abundant 
reticulin fibre formation surrounding individual cells is evident. These 
attributes are those of a well differentiated tumour. 
(b) These photographs indicate the appearance of tumours removed during 
phase 2. They also show a tumour composed of spindle shaped melanoma cells 
but the herring bone pattern noted in (a) is l ess obvious. Reticulin fibre 
formation is also abundant and is present in a swirling pattern which usually 
surrounds individualy tumour cells. This pattern also indicates a well 
differentiated tumour. 
(c) These photographs indicate th~ appearance of tumours removed during 
phasi S i.e. the exponential phase of growth. Striking differences between 
(a) and (b) can be noted. The tumour has a far less differentiated appearance 
and the herring bone pattern is no. longer detectable. The tumour is still 
composed of spindle shaped cells. Reticulin f ibre formation is virtually 
absent. 
(d) These photographs indicate the appearance of tumours removed during 
phase SP (i.e. exponentially growing tumours passaged through new animals). 
The tumours show a spindle cell malignant melanoma which has a barely 
detectable swirling pattern. More reticulin than that present in (c) is 
observed. The reticulin can be noted to be concentrated around supporting 
structures such as vessels. Much less reticul in is evident that is apparent 
in (a) and (b) and the morphological pattern of these tumours is indicative of 
a less well differentiated tumour. The scale marker in (d) represents 100 }1m. 







Phase contrast photographs of UCT-.Mel !_ cells 
Fig. 8a-l. Parent UCT-Mel 7 cells of passage 10' in vitro. Note the 
spindle shaped cells with pronounced cytoplasmic processes. Cells grew to a 
low density. 
Fig. 8a-2. Parent UCT-Mel 7 cells of passage 29' in vitro. The cells 
still had a spindle morphology with cytoplasmic extensions. Cells had a 
tendency to grow in chords. 
Fig. 8a-3. Parent UCT-Mel 7 cells of passage 53' in vitro. In sparse 
cultures a spindle morphology was still evident. This photograph shows that 
the cells from this passage grew to a far higher density than those from 
earlier passages. They also had an increased growth rate (see text). 





Figs. 8b.l and 8b.2 are representative of two such in vitro cultures. 
The cells shown in Fig. 8b.l had a history of having been passaged 30 times 
in 
vitro, serially transplanted 8 times in nude mice (in all cases as 
exponentially growing phase SP tumours) and then passaged a further 8 times 
in 
vitro. These cells had a doubling time in culture of 282 hours and a squat, 
small-celled appearance. 
Fig. 8b.2 shows the spindle-celled appearance of a culture that was first 
inocuated into mice at the 30' in vitro passage. The phase 5 tumour that 
resulted was serially transplanted 10 times in mice as a rapidly growing pha
se 
SP tumour, and it was finally repeatedly passaged in culture. The 
microphotograph shows the cells after the 10th such passage. At this stage 
the cells closely resembled, in their morphology, the original cells from 
which they were derived. They differed greatly, however, in the rates at 
which they proliferated in vitro. These cells had a doubling time of 141 
hours; the original line (at the 30th passage) had a doubling rate of 52 
hours. 
On a number of occasions the tumours that grew during phase 5 were deeply 
pigmented and, on histological examination, intense melanin deposition was 
readily seen (Fig. 9a and b). Phase 1 tumours were invariably amelanotic. 
Despite this apparent differentiation from the amelanotic to the pigmented 
pheotype, phase 5 tumours that were pigmented grew at the same rate in vivo a
s 
their amelanotic counterparts. (Fig. 10). The in vitro cell lines which we
re 
established from phase 5 melanotic tumour samples were always amelanotic. 
Tumours removed during the phase 1 and those excised during phase 5 
differed strikingly in two other respects. 
Firstly, phase 1 tumours were heavily infiltrated with murine fibroblasts 
and collagen whereas exponentially growing neoplasms showed virtually no such
 
reticulin (Fig. 7). These h~stological appearances were confirmed by chemic
al 






Phase contrast photographs~ ucr-Mel?.. cells 
Fig. 8b-l This photograph shows a cell line derived from ucr-Mel 7 
tumours passaged during their exponential phase 8 times through mice. The 
cells had been passaged through 9 in vitro passages. The cells are small and 
squat and differ markedly in appearance from the parent line. They grew 
extremely slowly in vitro (282 hr doubling time). 
Fig. 8b-2 This photograph shows a cell line .derived from ucr-Mel 7 
tumours passaged during their exponential phase 10 times through mice. The 
cells had been passaged through 10 in vitro passages. The cells are spindle 
shaped with long cytoplasmic processes and resemble the original parent cells 
morphologically. They, also however, grow extremely slowly in vitro · ( 141 hr 
doubling time). 
Both these cell lines are of human origin. 




FIGURES 9a and 9b 
Figure 9a 
The appearance of ucr-Mel 7 tumours on removal from nude mice 
The gross appearance of ucr-Mel 7 tumours removed from nude mice during 
phase SP, varied from non pigmented to deeply pigmented. This figure shows 2 
such representative tumours. 
Each small division corresponds to 1 mm. 
Figure 9b 
The histological appearance of~ pigmented ucr-Mel 7 tumour removed during 
phase SP in the nude mice. 
This section shows malignant melanoma cel l s organized in a herring bone 
pattern. Spindle shaped and epitheloid cells are present. Intracellular 
melanin can be noted in some of the cells. 
Melanin deposits were revealed by the method of Masson. 
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Figure 10 
Growth in vivo of pigmented and non-pigmented UCT-Mel 7 tumours 
A pigmented (••----••> and an amelanotic <•----e) melanoma were each 
removed from different mice. Fragments from these tumours were implanted 
subcutaneously into new recipients and tumour volumes were measured at the 
indicated times. Similar doubling times in vivo (9.6 and 10.3 days 
respectively) were recorded. 
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Sand removed during the subsequent passages (phase SP) of these tumours in 
mice. (Fig. 11). 
Secondly, early passages of cultures established from tumours that had 
been removed during phase 2 showed extensive infiltration with murine 
macrophages and fibroblasts. (Fig. 12a and b). This appearance was not 
observed to the same extent when phase S tumours were examined with this 
technique. 
Infiltration of the tumour with murine mesenchymal and stromal elements 
could readily be documented by electrophoretic analysis of lactic 
dehydrogenase enzymes that were present. (Fig. 13). In most cases the human 
enzyme predominated although varying amounts of the murine species were 
usually observed. (Table 2). 
On two surprising occasions, tumours removed during phase Sand passaged 
serially gave rise to cell lines which contained exclusively the murine enzyme 
with no trace of a human band. (Fig. 14). Karyotypic analysis of these 
tumours showed exclusively mouse chromosomes and fragments of the tumours grew 
exponentially when transplanted into immunocompetent nu/+ heterozygous mice. 
I feel certain, therefore, that the tumours that developed in these two 
instances were murine and not human. It should be stressed that the tumours 
that did develop arose in the site previously occupied by the small "dormant" 
phase 3 nodule. 
Table 2 summarises the results of lactate dehydrogenase analysis on five 
phase S tu!Ik)urs which were removed and passaged serially through mice. At the 
indicated passage numbers fragments of tumour were removed for in vitro 
culture and cell lines were established which were also examined for lactic 
dehydrogenase content. As can be noted two of the established cell lines were 
of human origin, one still contained murine cells and in two instances the 
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Figure .!..!:. 
Collagen content of UCT-Mel !_. tumours removed~ different phases of growth 
The collagen content (measured as ng of hydroxyproline per ug of cellular 
protein) of UCT-Mel 7 tumours removed at different phases of their growth was 
determined. The figure is constructed from the results of 6 phase 2 tumours, 
4 phase 5 tuioours and 12 phase SP tuioours. (Individual data are presented in 
the Appendix Table A.16 )". 
Note that phase 2 tuioours (i.e. the plateau period) evoked an 





Phase contras~ photographs of UCT-Mel !_ cells showing contamination with mouse 
macrophages and _fibroblasts 
Fig. 12a A UCT-Mel 7 tumour was removed during phase 2 and placed in 
culture. A nest of tumour cells can be seen to be surrounded by fibroblasts. 
Host macrophages (stellate and round cells) are present in abundance. 
Fig • . 12b A ucr-Mel 7 tumour was removed during phase 2 and placed in 
culture. Tumour cells can be noted in the centre of the picture and are 
surrounded by mouse fibroblasts. Macrophages are not as abundant as in Fig. 
12(a). 







Lactate dehydrogenase analysis on human tumours removed from nude mice 
6 6 
Mice were inoculated subcutaneously with either 10 or SxlO ucr-Mel 7 
cells (in vitro passage numbers 26', 29';30'). These tumours grew 
exponentially for a period of approximately 80 days after which growth ceased 
and tumours regressed. Four to 7 months after initial inoculation of these 
tumour cells tumours started growing once more. They now grew vigorously 
showing exponential growth kinetics. At this stage tumours were removed and 
small explants were implanted subcutaneously into new animals. The tumours 
were holik>genized and LDH activities determined. 
Samples of tumour ho100genates were as follows:-
Channel 1, 2 and 3 - ucr-Mel 7 tumour tissue homogenate from passage 6, 
7and 7 respectively, showing LDH enzyme bands of both human and mouse 
origin. 
Channel 4 - mouse liver ho100genate, showing LDH enzyme band of mouse 
origin. 
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Figure 14 
Lactate dehydrogenase analysis~ UCT-Mel ?_ cells originating~ tumours 
removed during phases SP growth in vivo. 
UCT-Mel 7 tumours removed during phase SP and serially passaged in vitro 
gave rise to cell lines which contained exclusively the murine enzyme, the 
human enzyme or mixed human and murine enzymes. 
This figure shows the LDH analysis of 3 representative cell lines:-
Channel 1 - human breast homogenate, showing LDH enzyme band of human 
origin. 
Channel 2 - UCT-Mel 7 cells from passage number 7' in vitro and passage 
number 9 in the nude mice, showing LDH enzyme band of human origin. 
Channel 3 - UCT-Mel 7 cells from passage number 7' in vitro and passage 
number 7 in nude mice, showing LDH enzyme band of human origin. 
Channel 4 - UCT-Mel 7 cells from passage number 8' in vitro and passage 
number 6 in the nude mice, showing LDH enzyme bands of human and mouse origin. 
Channel S - UCT-Mel 7 cells from passage number 12' in vitro and passage 
number 6 in the nude mice, showing LDH enzyme band of mouse origin. 































































































































































































































































































































































































































































































The experiments that I report in this chapter have documented the growth 
and certain other characteristics of a xenografted human melanoma that behaved 
in a most unusual manner. By the study of this tumour I have been able to 
show, quite clearly, that a striking change in cellular phenotype occured 
during course of a prolonged period of repeated in vitro passaging. 
Subsequently, while resident as tumours in the mouse, the cellular phenotype 
changed even more dramatically. 
Phenotypic drift of cell lines during the course of repeated in vitro 
passaging is well known, (Welch et al., 1983; Neri and Nicholson, 1981) 
and i s, in most cases, reasonably ascribed to the operation of selective 
forces that favour the emergence of subpopulations with characteristics that 
confer survival and proliferative advantage in the in vitro milieu. 
The differences that I observed, between the growth patterns of the 10th 
and 30th in vitro passage cells, would be entirely consistent with this pro-
cess. Cells inoculated at the 10th passage grew, as do most melanomas, 
rapidly and progressively whereas 30' cells grew relatively slowly to reach a 
plateau size that was less than 1/lOth of the volume that was possible for 
other melanomas to attain at a plateau where growth was inhibited by 
inadequate blood supply or nutrition. When fragments of the 10' cell-derived 
tumour were reimplanted into fresh recipients,the phasic growth pattern was 
seen. (Fig. S) I interpret this observation as indicating that the early 
passage cell culture comprise two cell populations - those with the phasic 
growth phenotype and those that will grow normally. Repeated in vitro passage 
selected for the phasic growth cells so that, by the 26th passage these were 
the only cells that remained. It is of interest to note that one passage to 
the nude mouse also selected for survival, in the fresh recipient, of the 
cel l s that grew with aphasic pattern. (Fig. S). 
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Although I have not yet completed enough experiments to be m
ore convin-
cing on this point, the in vivo growth pattern curve present
ed in (Fig. 3) 
suggests an extension of this interpretation since further e
volution of the 
-
growth phenotype seemed to occur between the 30th and 56th i
n vitro passages. 
When 56' cells were inoculated, a barely palpable tumour re
sulted that stabi-
lized at a size that was too small to document the growth, p
lateau or 
regression phases that characterized the phasic phenotype pr
esented in Fig. 3a 
and b. Nonetheless, after remaining ostensibly dormant for 
240 days, this 
tumour too suddenly escaped from the restraints upon its gro
wth and a rapidly 
growing phase 5 tumour developed (Fig. 3c). If subsequent e
xperiments 
confirm this observation, the following interpretation would
 best fit the 
finding. The UCT-Mel 7 line, as first established, containe
d 2 predominant 
populations that, for the sake of argument, I shall refer to
 as "r" (for rapid 
in vivo growth) and "s" (for slow!!!_ vivo growth). 
I now suggest that cells belonging to population "r" have th
e 
characteristics of a "transit cell" population. (Aherne et 
al., 1977). - i.e. 
considerable but limited potential for rapid in vivo prolife
ration. Inocula 
of these cells would thus grow until the · alotted number of d
ivisions had been 
expended and then they would die. This would account for: 
(i) the first three phases of the growth pattern depicted i
n Figs. 3a 
and b; 
(ii) the paucity of r cells in the fragment transplanted in
to the 
fresh recipient described in Fig. S. 
I also suggest that the r cell population was marginally les
s well able 
to survive in vitro with the result that the phenotype was p
rogressively lost 
as the in vitro passaging was continued from the 10' to the 
56' stage. 
The second, "s", population of cells comprised, I suggest, c
ells with the 
characteristics of stem cells that are endowed with the capa
city for slow but 
nevertheless indefinite survival in vivo. The growth of tumours de
rived from 
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inocula of these cells was so slow that it was difficult to document the rate
 
of increase in size of this population until a mutation occured in one of the
 
"s" cell population or in a local murine stroma.l cell, at which point a 
rapidly growing, aggressive tumour developed. The two murine tumours that I 
observed (Table 2) testified to the mutagenic environment that would have 
obtained within the "s" cell tumour for such a mutation to occur. That the 
human phase 5 tumours were also composed largely of mutant cells is suggested
 
by the fact that these cells grew rapidly and aggressively and transplanted 
into fresh recipients and showed none of the growth features of either "r" or
 
the "s" cell parent from which they were putatively derived. 
While this model probably represents an over simplification of the 
complex events that took place during the progression of the tumours from 
phase 4 to phase 5, I believe that it is useful for the fact that it suggests
 
a number of further experiments that should be done and it provides a helpful
 
basis for bringing my results into comparison with those of others who have 
studied the phenotypic changes that occur in experimental tumours during the 
course of their propagation in~ or in vitro. 
In the first place, if I am correct in my interpretation of the data, 
cloning of early passage cultures should enable me to derive pure populations
 
of "r" and "s" cells. These should behave predictably in culture and the "r"
 
cel l s should show senescence in vivo and the "s" cells not. 
Secondly, I ought to be able to demonstrate other mutations in cells from 
the "s" cell tumours. This might be done by assaying the cells for resistanc
e 
to cytotoxic agents such as thio-guanine or methotrexate using similar 
techniques to those used by others to detect mutant sub-populations in tumour
s 
(Yama.shina et al., 1986). Alternatively it might be possible to detect 
oncogenic mutations in murine stroma.l cells by transplanting tumour fragments
 
into immunocompetent nu/+ heterogotes. This latter experiment need not 
examine only phase 5 tumours; it would be most interesting, in fact, if 
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fragments of earlier phase tumours were tumourigenic in heterozygous animals 
since this could be used as the basis for experiments to obtain data on the 
length of time it was necessary for UCT-Mel 7 cells to be in contact with 
.. 
murine cells for effective conversion of the mouse stromal components to the 
malignant state. 
Thirdly, it should be possible with this system, and experiments based 
upon the model that I have suggested, to identify the mutagenic influences 
that presumably operate in the tumours. Goldenberg and Pavia (1981; 1982) 
have also seen murine cell tumours develop in nude mice at the site of human 
xenografts and they favoured~ vivo cell fusion of human tumour cells with 
normal host cells, with subsequent segregation of .human chromosomes or of 
transforming "genes", as the basis for this horizontal transmission of 
malignancy. They produced no evidence, however, to support their preference 
for this idea. If this were the mechanism there should be no difficulty in 
demonstrating human genetic material (either by karyotypic analysis or by 
examining for the repetitive Alu sequences that occur every 10 kilobases in 
human DNA). 
A prominent feature of late passage ·UCT-Mel 7 cells has been their 
ability to elicit an intense desl!M)plastic response accompanied by infiltration 
of the tul!M)ur with murine macrophages (Fig. 12). It is well-known that 
macrophages release factors that stimulate fibroblast proliferation (Hebbs et 
al., 1983) and numerous studies have documented the mutagenic activity of 
these cells in bacterial (Weitzman and Stossel, 1981; 1982; 1983) and 
mammalian cells (Weitberg et al., 1983; Yamashina et al., 1986). There is a 
good deal of circumstantial support for the belief that phagocyte-induced 
mutagenesis is mediated by the generation of active oxygen species that are 
characteristic products of this class of cells. Indeed, Weitzman, et al., 
(1985) have shown that stimulated neutrophils can cause malignant 
transformation of murine fibroblasts and Potter et al., (1985) have produced 
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evidence to support the suggestion that active oxygen species released by 
inflammatory cells serve as the mutagenic agents responsible for pristane-
induced myelomas in Balb/c mice. 
I have shown that macrophage infiltration is a predominent feature of 
phase 2 tumours and, in view of the published data I have cited, it seems 
likel y that these cells were responsible for the progression of tumours to 
phase 5 and for the intense desmoplastic response that was seen. It is of 
interest to note, in this connection, that in the report by Goldenberg and 
Pavia, (1982) of a murine neoplasm arising at the site of a xenografted human 
malignancy, the histological appearances of the tumour that arose from the 
10th passage of a human ovarian carcinoma through the nude mouse showed a 
heavy infiltration with fibroblastic elements. These features are similar to 
those that I noted with UCT-Mel 7 (Fig. 7). 
If host macrophages do, indeed, play the important role that I have 
suggested, it should be possible to inhibit the in vivo progression of UCT-Mel 
7 "s"-type cells _by the administration, to the recipients, of anti-
inflammatory agents such as indomethacin. Similarly one might be able to 
induce a change of "s" cells to the phase 5 phenotype by in vitro co-culture 
with macrophages alone, with macrophages activated by exposure to tumour 
promoters or with macrophages and fibroblasts. It will also be of interest to 
see if macrophages isolated from the tumour behave any differently, in this 
regard, than do those isolated from, for example, the peritoneal cavity. 
In certain respects the model that I have proposed would accomodate the 
observations of Belin and Ossowski (1983) who found that Lewis lung carcinoma 
cel l s comprised two sub-types. The first and predominant type were cells that 
grew rapidly on the chicken CAM to produce tumours that were no longer 
tumorigenic in syngeneic mice. These cells would be analagous to the "r"-
type cells that I propose. Their second cell population could be isolated by 
cloning the parental Lewis lung carcinoma culture. This yielded cells that 
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behaved differently i~ that they grew on the CAM 
and retained tumorigenicity. 
These would correspond to the "s" cells that I ha
ve postulated. 
The effect of the growth environment on the malig
nant phenotype of the 
human HEp3 tumour was dramatically demonstrated b
y Ossowski and Reich, (1983). 
These cells grow as highly malignant tumours in c
hicken embryos. When 
transferred to in vitro culture, however, they ~h
owed a progressive loss of 
tumo r igenicity that was essentially complete by th
e 40th passage. The 
aggressive malignant phenotype could, however, be
 recovered in these cells by 
prolonged exposure to the in vivo conditions of t
he CAM. Although, by virtue 
of the very different experimental system that wa
s used by these authors, my 
resul ts and those that they obtained are not enti
rely consonant, there are a 
number of points of similarity that are noteworth
y. In the first place, the 
lose of tumorigenicity that they observed with pr
olonged in vitro culture 
resembled the transition that I founi took place 
between the 10th and the 56th 
in vitro passage of UCT-Mel 7. The late ~ssage 
cells required prolonged 
exposure (approximately 6 months) to "recover" th
eir malignant potential (Fig. 
3). Ossowski and Reich~ (1983) were limited, by 
the embryonated egg system, to 
observation periods of 1 to 2 weeks in any given 
host; at the end of this time 
further observation of the tumour could only be s
ecured by serial transfer 
onto a fresh CAM. As I have stated in the introd
uction, I was fortunate in 
that I was able to study the complete evolution o
f the slowly growing 
cel l s in a single host. 
.... s 
There are a number of further respects in which t
he data I report merit 
comment. 
It was interesting to observe, for example, the o
ccasional emergence of a 
deeply pigmented phase S tumour from inoculated c
ells that were invariably 
amelanotic. Furthermore, although it was always 
easy to induce pigmented 
phase S tumours to re-establish themselves as per
manent cell lines in culture, 
t hese lines were always non-pigmented. From thes
e results it is possible to 
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draw two conclusions. Firstly, melanoma cells that have lost the c
apacity for 
melanin synthesis unier one set of growth circumstances may recover
 that 
capacity when circumstances change. Common clinical experience tel
ls us that 
malignant melanomas in man characteristically show areas of pigment
ation and 
lack of pigmentation within the same cutaneous tumour. Indeed, this
 variegate 
appearance is a diagnostic hallmark of the disease. It is generally
 assumed 
that this heterogeneity reflects, primarily, a clonal change in the 
tumour 
cell population with the emergence of genotypic variants in which th
e ability 
to make melanin is irretrievably lost. My observations suggest tha
t this is 
not always the case and that melanogenesis is recoverable in an ame
lanotic 
clone provided environmental circumstances are favourable. 
I should also like to draw attention to the remarkable fact that tum
ours 
that grew very slowly~ vivo proliferated quite rapidly in vitro (F
ig. 6). 
This is consistent with the suggestion that I made earlier that "s"
 cells had 
an~ vitro proliferative advantage over "r" cells, so that, by the
 56th in 
vitro passage, essentially no "r" cells remained. Since I have not
 yet 
measured the doubling times of pure "r" cell populations, this comm
ent is not 
strictly valid. I do, however, show data for phase S cells (Fig. 6
) and these 
show that, despite their extremely rapid growth in vivo, their in v
itro 
proliferation was sluggish. 
Finally, it is perhaps worth mentioning once more the possible valu
e of 
the UCT-Mel 7/nude mouse system for the study of the clonal evolutio
n of human 
tumours. 
Two excellent reviews have recently been publi~hed that consider th
is 
matter in detail. In the first, Schnipper (1986) considers the que
stion of 
tumour-cell heterogeneity and rightly emphasises the considerable im
plications 
that within-tumour phenotypic variation has for the management of m
alignant 
disease in man. It is clear, from this scholarly account of the su
bject, that 
the author subscribes to the view that tumours are "malignant" in d
irect 
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proportion to the instability of their genetic apparatus and he leave
s one 
with the sense that this instability is an innate feature of the neo
plastic 
phenotype. The consistent chromosomal abnormalities that are encoun
tered in 
such diseases as chronic myeloid leukaemia or Burkitt's lymphoma or 
the well 
known associations that exist between malignancy and Xeroderma pigme
ntosum or 
Bloom's syndrome certainly lend support to this view. I suspect, ho
wever, 
that interactions between tumour cells and the host environment may c
ontribute 
more genetic change than is currently believed, and the experimental 
system I 
have described may well be used to vindicate this suspicion. 
In the second paper Nowell (1986) has reviewed the subject of tumour 
progression and he, too, gives pride of consideration to the question
 of 
genetic instability. He does, however, consider host factors in clon
al 
evolution and here he ascribes most importance to the immune system a
nd the 
role of "immune surveillance" as forces that provide selective pressu
res that 
determine which mutant clones will expand to become the predominant 
subpopulation at any given time. The implication here is clear. · Fi
rst the 
mutation occurs and only then do host factors become important. I b
elieve 
that ucr-Mel 7 will prove to be a useful model for showing that host 
reactions 
can generate mutants as well as eliminate them, and that the macropha
ge is not 
always the tull¥)ricidal hero. It may play a villainous mutagenic role
 that is 




A.1 Tumour biopsies and primary culture:-
Samples were removed at the time of surgery and placed into bottles 
containing DB medium supplemented with 2% FCS and were immediately sent to the 
tissue culture laboratory. • 
The way in which this samples were treated depended on whether they were 
primary tumours in skin or whether they were metastatic deposits. Size and 
consistency of the specimen was taken into consideration too. Primary tumours 
were cultured as explants. Metastatic tumours were plated as single-cell 
suspensions after mechanical or enzymatic dispersion. When tissue was 
avai lable, attempts were made to culture metastas,~s as explants and primary 
tumours as single-cell suspension. 
A.2 Culture of explants:-
The tissue was cut into small fragments (1 cu mm) with a scalpel blade 
very carefully not to damage the fragments by squeezing or disturbing them in 
any way. The pieces were placed as explants on 60 mm tissue culture dishes, 
moistened with a thin film of tissue culture medium and left overnight. The 
day after the explants were covered with medium and the cultures were then 
observed frequently for evidence of growth. The medium was changed once a 
week. 
A.3 Mechanical dispersion:-
With sterile scissors, the specimen was minced finely, the tumour 
fragments suspended in RPMI medium and pipetted up and down 4 to 5 times 
through the orifice of a 5 ml pipette. The suspension was then allowed to 
stand for a few minutes during which time larger fragments settled and single 
cells remain ingin suspension. Then the supernate was carefully aspirated into 
tubes and the single cells were sedimented by centrifugation at 350g for 5 
min. The remained pellet was then resuspended in DB or RPMI medium 
supplemented with 10% FCS. This final suspension was placed into tissue 
cult ure dishes and observed regularly for evidence of growth. 
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A.4 Enzymatic dispersion:-
Cells that were retained in fragments that settled after mincing and 
pipetting were released by treatment with trypsin, followed where necessary by 
incubation with collagenase. 
For trypsinization, the fragments were transferred to a bottle containing 
0 
0.25% trypsin in TD and gently agitated at 37 C for a maximum of 20 min. The 
digest was left to stand for 5 min. after which the supernatant was removed 
and added to an equal volume of medium containing 10% FCS to neutralise the 
proteolytic activity of the trypsin. The cell suspension was centrifuged at 
350g for 5 min. Then the pellet was resuspended in growth medium and 
0 
transferred to a tissue culture dish and incubated at 37 Cina humid 
atmosphere of 5% CO2 in air. 
This procedure was repeated for any remaining fragments. 
After 3 or 4 sequential trypsin treatments any tumour tissue left undige-
0 
sted was incubated overnight at 4 C with collagenase at 1 mg/ml in RPMI.-§% FCS 
Occasionally a viscous and gelatinous suspension was observed following 
enzymatic digestion. This was the result of DNA release from damaged cells. 
DNAase, at a concentration of lOµg/ml was added to this gelatinous mixture 
0 
which was then incubated at 37 C for 5-10 min. to give a fluid easily 
pipettable solution. 
After 24 hours, all cultures were observed for viable cells. Petri 
dishes were washed gently with fresh medium to remove non-adherent cells which 
were pooled and centrifugated. The pellet was reseeded on to a new petri 
dish. 
A.5 Maintenance and storage of cell lines:-
Once the cell lines were established, the cultures were maintained in 
Dulbecco's or RPMI medium supplemented with 10% FCS (heat-inactivated), 300 ~g 
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penicillin/ml, 200 y.g streptomycin sulphate/ml and lOpg tylocine/ml. The 
0 
cultures were kept at 37 Cina humid atmosphere containing 5% CO2 
in air. 
Cell lines cultured were examined at least twice weekly under phase 
contrast microscopy and were passaged when they approached confluence. 
Passaging was performed by aspirating the medium, and then covering the cells 
0 
with 0.2Si. trypsin in TD at 37 C. After approximately 5 min, the detached 
cells were dispersed by gentle pipetting and the suspension was added to an 
equal volume of medium containing FCS to neutralize the protease. The cells 
were washed by centrifugation at 350g for 5 min, resuspended in medium, and 
adjusted to give the desired cell concentration for reseeding of new cultures. 
To be preserved for long-term periods, cell stocks were frozen in liquid 
nitrogen. After centrifugation, the cell pellet was resuspended in tissue 
culture medium containing 10% FCS and 10% DMSO at room temperature. This 
suspension was distributed in 1 ml volumes into screw-topped 38xl2.Smm nylon 
tubes (Nunc No. 1078) which were kept on chipped ice. These tubes were then 
frozen by vapor-phase liquid nitrogen freezing in a device built in the 
0 
laboratory and designed to give programmed cooling at the rate of 4 C/min, 
0 
until a temperature of -26 C was obtained. The cells were then held at this 
temperature for 20 min, after which they were coUed rapidly to -60°C and 
placed in liquid nitrogen. The freezing protocol proved to be extremely 
satisfactory (Farrant et al, 1974). 
A.5.1 Cell lines 
UCT-Mel 1. It was obtained from an inguinal metastasis of a 67 year old 
Caucasian female who initially had a primary malignant melanoma of Clark's 
level III removed from her right ankle. She died a year later with metastatic 
spread of the abdominal cavity. 
The tissue sample for culture was a deeply pigmented lymph node which, 
on histological examination, showed partial or complete replacement by 
epithelioid malignant melanoma with melanin being its prominent feature. The 
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cells in tissue culture were non-pigmented at low density and they became 
deeply pigmented at confluence. 
They grew in tissue culture with a doubling time of 41 hrs. The cells 
formed tullk>urs in nude mice with doubling times of 6 days. 
UCT-Mel 2 - Tumour tissue was obtained from a metastatic axillary lesion, 
removed from a 67 year old Caucasian female. 
The sample for culture was macroscopically non-pigmented. The histo-
logical examination of the specimen confirmed the diagnosis of metastatic 
malignant melanoma. It was an epithelioid type cell and pigmentation was 
visible in certain areas, while others were non-pigmented. 
Cells were initially passaged twice after which cell division ceased and 
they remained viable but dormant for 4 months. During this time medium was 
changed once a week. After 4 months of dormancy, cells started to divide 
simultaneously, in all ten 60 mm petri dishes. 
The cells were non pigmented at low density, becoming deeply pigmented 
at confluence. They grew in vitro with a doubling time of 70 hrs (DB-FClO) 
and SO hrs (RPMI-FClO) and in nude mice with doubling time of 5 days. 
UCT-Mel 3 - This cell line was established from a metastatic liver deposit 
rellk>ved from a 71 year old Caucasian female. Histological examination 
of the tissue rellk>ved from the liver revealed metastatic malignant melanoma of 
epithelioid type. A Masson-Fontana silver stain was done, showing scanty 
intracellular melanin. 
The cells were non pigmented at low density as well as at confluence. 
They grew in vitro with a doubling time of 58 hrs and in nude mice, with a 
doubling time of 8 days. 
UCT Mel 4 - This cell line was established from a left inguinal lymph node 
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metastasis, removed from a 67 year old Caucasian female. The lymph node was 
macroscopically pigmented. Histology revealed a deeply pigmented metastsatic 
melanoma of epithelioid type. Cultured cells were non pigmented, even at high 
density, and had a doubling time in vitro of 52 hrs (RPMI-FClO) and 6 days in 
the nude mice. 
UCT Mel 5 - Tumour tissue was obtained from a metastatic brain deposit removed 
from a 48 year old Caucasian female. The brain metastasis obtained for 
culture did not show melanin. Histological examination revealed it to be 
metastatic malignant melanoma of a mixed spindle and epithelioid cell type. 
The cells in tissue culture were nonpigmented even at high density. 
The doubling time in vitro was 58 hrs and 8 to 10 days in nude mice. 
UCT-Mel 6 - This cell line was established from a metastatic malignant mela-
noma . deposit removed from the left inguinal region of a 68 year old Caucasian 
female. 
The sample for tissue culture was non-pigmented. The histological report 
confirmed the diagnosis of metastatic malignant melanoma, of spindle cell 
type, with no melanin pigment present. 
The cells in tissue culture were non pigmented even at high density. 
The doubling time in tissue culture was 33 hrs and this tumour failed to 
grow in the nude mice. 
UCT-Mel 7 - This cell line was established in tissue culture in May 1980, from 
from a secondary malignant melanoma removed from the left femoral gland of a 
52 year old negro female. 
The sample for culture was non-pigmented. Histological examination 
showed secondary malignant melanoma of spindle cell morphology and minimal 
production of pigment. 
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The cells in culture were non-pigmented, even at high density. 
The doubling time in vitro was 52 hrs and 9 days in nude mice. 
These cell lines were studied in vitro and characterized in more deta
il 
by E. Hoal, 1981, in her Ph.D thesis and Roal-van Helden (1986). 
A.6 Mycoplasma contamination 
All the cell lines used were tested for mycoplasma contamination. The 
method used was that described by Chen (1977). This involved staining
 
cultures with a DNA-specific fluorescent stain. 
Cells were cultured for 7 days in medium from which tylocine had been 
omitted. Cells were then fixed with acetic acid:methanol (1:3) and st
ained 
with bisbenzimide fluorochrome (Hoechst No. 33258) at 0.5 ug/ml in Ha
nk's 
balanced salt solution for 30 min. The cell layer mass was well rinse
d in 
deionized water and mounted in buffer containing 0.02M citric acid, 0.
06 M 
disodium phosphate and 50% glycerol, pH 5.5. Cultures were examined w
ith a 


































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































10 5 u__1-_1-_1-_J__J_-L--L-__L___L_--!-::--'--::=_._-::=_,_, 
20 30 40 50 60 70 0 10 
TIME (hours) 
Growth curve of UCT-Mel 5 cells in vitro 
6 A lung metastasis from a mouse inoculated subcutaneously with 5x10 UCT-
Mel 5 cells ( 27' ) was sequentially passaged through nude mice. The tumour 
was removed at the 5th in vivo passage and cultured in vitro for 12 passages. 
5 The cells were seeded ( 2x10 cells) in RPMI-FClO in 35mm dishes. Twenty 
four hr after seeding, the medium was aspirated and fresh RPMI-FClO was added 
to the cultures. Thereafter the culture medium was changed every 48 hr. At 
the indicated times in the figure, replicate cult ures were trypslnized and the 
cells were counted in a Coulter counter. 



















Growth curve of UCT-Mel 3 cells in vitro 
A metastatic lung deposit from a mouse inoculated subcutaneously with 
6 
SxlO UCT-Mel 3 cells (69'), was sequentially passaged in vivo in nude mice. 
The tumour removed at the 6th passage in vivo mass cultured in vitro for 11 
passages. The cells (2x105 cells) were seeded in RPMI-FClO on 35mm dishes. 
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Twenty four hr after seeding, the medium was aspirated and fresh RPMI-FClO was 
added to the cultures. Thereafter, the culture medium was changed every 48 
hr. At the times indicated on the graph, replicate cultures were trypsinized 
and the cells were counted in a Coulter counter. 
Note that a period of exponential growth was followed by a diminished 
growth rate as higher saturation densities are reached. 
The generation time of the cells during the exponential phase of growth 
was 86 ho urs . 






(ng hydroxyprolinefa.ig protein) 
51.5; 37.2; 123.1; 80.0; 79.4; 51.2 
2.8; 3.8; 2.7; 1.1 
2.2(Pl); 2.9(Pl); 1.2(Pl); O(Pl6); O(P8) 
4.5(P6); l.5(Pl8); O.(Pl); O(Pl2); O(Pl4) 
O(Pl); O(Pl7) 
Each value represents the hydroxyproline content of an individual tumour. The 
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